ࡱ> [ 0bjbj kiki,(#(#x#x#x####8#$#O(((((2Rn4t4<NNNNNNN$RTbNx#51@255N(#(#((N@@@5(#8(x#(N@5N@@Lh`#3N(b\7_M{NN0OoM0U940U 3N0Ux#3NH55@55555NN<4555O55550U555555555X !:  Programme Details 1. Programme titlePharmacy2. Programme codeHESU0033. QAA FHEQ levelLevel 74. FacultyHealth5. DepartmentSchool of Allied Health Professions, Nursing and Midwifery6. Other departments providing credit bearing modules for the programmeNone7. Accrediting Professional or Statutory BodyGeneral Pharmaceutical Council8. Date of production/revisionMay 2024 AwardsType of awardDuration9. Final awardMasters of Pharmacy (MPharm)4 years (480 credits)10. Intermediate awards BMedSci in Pharmaceutical Studies3 years (360 credits)Diploma of Higher Education in Pharmaceutical Studies2 years (240 credits)Certificate of Higher Education in Pharmaceutical Studies1 year (120 credits) Programme Codes 11. JACS code(s) Select between one and three codes from the HYPERLINK "https://www.hesa.ac.uk/support/documentation/jacs/jacs3-principal" \hHESA website.B23012. HECoS code(s) Select between one and three codes from the HYPERLINK "https://www.hesa.ac.uk/innovation/hecos" \hHECoS vocabulary.100251 Programme Delivery 13. Mode of study Full-time14. Mode of delivery In Person 15. Background to the programme and subject area The 4 year MPharm degree programme will provide students with the knowledge and practical skills to become, after completion of a Foundation training year, a General Pharmaceutical Council (GPhC) registered Pharmacist. The course provides a unique combination of science and practice as a healthcare professional with students considering the role of drugs and medicines from their design, through therapeutic use and patient counselling and prescribing. Through University based learning and periods of experiential learning and inter-professional learning, students will develop their consultation, clinical decision making and leadership skills. The course will be delivered through disease based integrated modules which increase with complexity over the course. Learning will be case study based and delivered through team teaching to develop integrated problem-solving techniques. Varied assessment methodologies will be used including examinations, Observed Structured Clinical Examinations, coursework and continuous in place assessment of entrustable professional activities (EPAs). This course is being opened as a response to changes in the role of Pharmacists nationally to become prescribers and the regional (South Yorkshire) shortage of Pharmacists across all sectors of the profession. The University has committed strategic investment funds for the development of appropriate specialised estate and recruitment of personnel for the delivery of the programme. 16. Programme aims MPharm Pharmacy aims to:A1Educate graduates to meet the Learning Objectives set by the General Pharmaceutical Council for an accredited MPharm and Registration as a Pharmacist.A2Prepare graduates to be evidence-based clinical decision makers able to apply a strong scientific foundation to clinical practice and prescribing.A3Prepare graduates that will be responsible for their own learning and continuing professional development and be reflective, flexible, ethical and professional practitioners.A4Prepare graduates equipped with a research basis to critically evaluate practice and develop their profession.A5Prepare graduates with a strong background in public health and social accountability ready to work in the best interests of the health of people and society. 17. Programme learning outcomes GPhC Learning Outcomes: Person Centred Care and Collaboration On successful completion of the programme, students will be able to demonstrate the followingLinks to Aim(s)PCC1Demonstrate empathy and keep the person at the centre of their approach to care at all times.A1, A5 PCC2Work in partnership with people to support and empower them in shared decision-making about their health and wellbeing.A1, A5PCC3Demonstrate effective communication at all times and adapt their approach and communication style to meet the needs of the person.A1, A5PCC4Understand the variety of settings and adapt their communication accordingly.A1, A5PCC5Proactively support people to make safe and effective use of their medicines and devices.A1, A2, A5PPC6Treat people as equals, with dignity and respect, and meet their own legal responsibilities under equality and human rights legislation, while respecting diversity and cultural differences.A1, A5PPC7Obtain informed consent before providing care and pharmacy services.A1, A5PPC8Assess and respond to the persons particular health risks, taking account of individuals protected characteristics and background.A1, A2, A5PPC9Take responsibility for ensuring that personal values and beliefs do not compromise person-centred care.A1, A3, A5PPC10Demonstrate effective consultation skills, and in partnership with the person, decide the most appropriate course of action.A1, A2, A5PPC11Take into consideration factors that affect peoples behaviours in relation to health and wellbeing.A1, A5PPC12Take an all-inclusive approach to ensure the most appropriate course of action based on clinical, legal and professional considerations.A1, A3, A5PPC13Recognise the psychological, physiological and physical impact of prescribing decisions on people.A1, A2, A3, A5PPC14Work collaboratively and effectively with other members of the multi-disciplinary team to ensure high-quality, person-centred care, including continuity of care.A1, A3GPhC Learning Outcomes: Professional Practice On successful completion of the programme, students will be able to demonstrate the followingPP1Demonstrate the values, attitudes and behaviours expected of a pharmacy professional at all times.A1, A3, A5PP2Apply professional judgement in all circumstances, taking legal and ethical reasoning into account.A1, A2PP3Recognise and work within the limits of their knowledge and skills, and get support and refer to others when they need to.A1, A3PP4Take responsibility for all aspects of pharmacy services, and make sure that the care and services provided are safe and accurate.A1, A3, A6PP5Take responsibility for all aspects of health and safety and take actions when necessary.A1, A6 PP6Act openly and honestly when things go wrong and raise concerns even when it is not easy to do so.A1, A3PP7Apply the science behind pharmacy in all activities.A1, A2PP8Demonstrate how the science behind pharmacy is applied in the discovery, design, development and safety testing of medicines and devices.A1, A2PP9Recognise the technologies that are behind developing advanced therapeutic medicinal products and precision medicines, including the formulation, supply and quality assurance of these therapeutic agents.A1, A2PP10Keep abreast of new technologies and use data and digital technologies to improve clinical outcomes and patient safety, keeping to information governance principles.A1, A2PP11Apply pharmaceutical principles to the safe and effective formulation, preparation, packaging and disposal of medicines and products.A1, A2PP12Consider the quality, safety and risks associated with medicines and products and take appropriate action when producing, supplying and prescribing them.A1, A2PP13Take responsibility for the legal, safe and efficient supply, prescribing and administration of medicines and devices.A1, A2, A3PP14Demonstrate effective diagnostic skills, including physical examination, to decide the most appropriate course of action for the person A1, A2PP15Apply the principles of clinical therapeutics, pharmacology and genomics to make effective use of medicines for people, including in their prescribing practice.A1, A2PP16Appraise the evidence base and apply clinical reasoning and professional judgement to make safe and logical decisions which minimise risk and optimise outcomes for the person.A1, A2, A4PP17Critically evaluate and use national guidelines and clinical evidence to support safe, rational and cost-effective procurement for the use, and prescribing of, medicines, devices and services.A1, A2. A4PP18Accurately perform calculations.A1, A2PP19Effectively promote healthy lifestyles using evidence-based techniques.A1, A5PP20Apply the principles of effective monitoring and management to improve health outcomes.A1, A5PP21Anticipate and recognise adverse drug reactions and recognise the need to apply the principles of pharmacovigilance.A1, A2PP22Apply relevant legislation and ethical decision-making related to prescribing, including remote prescribing.A1, A2, A3PP23Prescribe effectively within the relevant systems and frameworks for medicines use.A1, A2 PP24Understand clinical governance in relation to prescribing, while also considering that the prescriber may be in a position to supply the prescribed medicines to people.A1, A2PP25Take responsibility for peoples health records, including the legality, appropriateness, accuracy, security and confidentiality of personal data.A1, A2, A5PP26Understand and implement relevant safeguarding procedures, including local and national guidance in relation to each person.A1, A2, A3, A5PP27Effectively make use of local and national health and social care policies to improve health outcomes and public health, and to address health inequalities.A1, A5PP28Proactively participate in the promotion and protection of public health in their practice.A1, A5PP29Identify misuse of medicines and implement effective strategies to deal with this.A1, A2PP30Respond appropriately to medical emergencies, including the provision of first aid.A1, A3, A5GPhC Learning Outcomes: Leadership and Management On successful completion of the programme, students will be able to demonstrate the followingLM1Demonstrate effective leadership and management skills as part of the multi-disciplinary team.A1, A6LM2Make use of the skills and knowledge of other members of the multi-disciplinary team to manage resources and priorities.A1, A6LM3Develop, lead and apply effective strategies to improve the quality of care and safe use of medicines.A1, A6LM4Actively take part in the management of risks and consider the impacts on people.A1, A6LM5Use tools and techniques to avoid medication errors associated with prescribing, supply and administration.A1, A2LM6Take appropriate actions to respond to complaints, incidents or errors in a timely manner and to prevent them happening again.A1, A3, A6LM7Recognise when and how their performance or that of others could put people at risk and take appropriate actions.A1, A3, A6LM8Demonstrate resilience and flexibility, and apply effective strategies to manage multiple priorities, uncertainty, complexity and change.A1, A3, A6GPhC Learning Outcomes: Education and Research On successful completion of the programme, students will be able to demonstrate the followingER1Reflect upon, identify, and proactively address their learning needs.A1, A3ER2Support the learning and development of others, including through mentoring.A1, A3, A6 ER3Take part in research activities, audit, service evaluation and quality improvement, and demonstrate how these are used to improve care and services A1, A4 18. Learning and teaching methods A variety of learning approaches will be used across the curriculum to enable all students to succeed and to allow all educators to work within their preferred methodology. From year 1 there will be an emphasis on active learning, using application and case-based scenarios to reinforce core content through workshops and simulation teaching sessions. Whilst in year 1 significant material will be delivered through traditional lectures in the early stages, this will move to a more flipped approach as the year develops and as the students progress through the years. To reinforce integration and contextualisation, workshops will be delivered through a team-teaching approach with cross-disciplinary scenarios developed by subject specialists. Experiential learning and interprofessional learning are key aspects of the programme. Students will undertake periods of learning in practice, from volunteering through to a variety of Pharmacy settings from Year 1, to develop their skills and competencies. They will learn of the importance of team working in healthcare through interprofessional learning activities with students from across the Faculty of Health. The course will adopt methods of learning that incorporate social and participatory dimensions including peer-learning, group working and learning from patients and the public. 19. Assessment and feedback methods Assessment design is based on the GPhC 2021 Standards for the Initial Education and Training of Pharmacists Learning Outcomes and the University of 91ֱ Assessment Framework. Key aspects of the design of assessments for the MPharm will include: Ensuring authenticity wherever possible through for example simulated activities and case-based approaches. This will be facilitated through working with experiential learning providers. Equipping graduates for further study e.g. Foundation training examination or CPD. Providing consistency of approach when using the same assessment type to provide clarity to students. Assessment criteria and rubrics will also be available on the VLE for students to access. Ensuring accessibility of assessment for all students and signposting of students for additional support to University wide services. Integrating an inclusive approach in the design and implementation of assessment in line with the expectations of Higher Education Advance. The assessment strategy and programme will be informed by appropriate theory (e.g., Millers Triangle) and educational research (e.g. entrustable professional activities) to ensure graduates feel prepared for practice. A variety of assessment types will be developed appropriate to specific module learning outcomes. All assessments will be mapped to learning outcomes and the mapping made available to students. Exam delivery will be in-person and timed. For synoptic exams, we will aim to mirror practice by providing access to key resources through a locked down browser. The types of assessments that will be used include: Semester examinations these will take the form of mixed MCQ short answer papers. A number of MCQ approaches will be used of increasing difficulty including subject level single best answer, module level single best answer, extended matching and extended reasoning. This will enable assessment of both breadth and depth of knowledge (Graded on 0-100 scale, 40% pass mark) Controlled open book synoptic case-based examinations involving review of notes / prescribing data and clinical decision making Graded on 0-100 scale, 40% pass mark) Professional portfolio (PebblePad) (Pass / Fail) Experiential Learning Activities and Entrustable Professional Activities (EPAs) workbooks (Pass / Fail) Laboratory portfolios to cover scientific laboratory experiments (Graded on 0-100 scale, 40% pass mark) Observed Structured Clinical Examinations (Pass / Fail) Calculations Assessment (Pass / Fail) Project reports, essays, extended written work (Graded on 0-100 scale, 40% pass mark) Feedback Feedback will be delivered in line with the Universitys six principles of feedback. The feedback method will be determined using the principles of the Feedback Benchmarking Framework and will include embedding of practical experience of using feedback in learning and teaching and staff moderation of feedback to ensure consistency as part of the internal review process. Students will be encouraged to log feedback in the feedback portal and access the support mechanisms. For summative work, detailed feedback for students who do not meet the threshold criteria will be provided prior to their supplementary attempt. Additionally, cohort level feedback will be provided to all students through the VLE. 20. Programme structure and student development The approach adopted, featuring six large credit modules, across the four years of the MPharm, will enable integration to be achieved at the multidisciplinary level of Hardens ladder for core delivery and at the Interdisciplinary and transdisciplinary level through interprofessional learning. Students will be enabled to develop their core competencies at the Shows How and Does levels of Millers triangle through seven vertical integrated subject pillars that deliver increased complexity through a spiral curriculum. All modules are core within the degree programme to ensure completion of all GPhC learning outcomes. Within the Quality Improvement module there will be a level of choice of setting including the possibility of studying with a partner University overseas through the Turing programme. A choice element is also provided in the final 5 day experiential learning placement. Horizontal Integration The six proposed modules are shown in Figure 1. The use of large modules enables the use of synoptic assessments ensuring students have overall breadth of knowledge alongside depth, enables contextual people and patient-centred learning for students, delivers flexibility within credit allocations, avoids unnecessary duplication of material and provides temporal flexibility in experiential learning and inter-professional learning activities.  Figure 1: Horizontal Integration. Note: Module names are preliminary and subject to University approval Year 1 (FHEQ Level 4): Year 1 comprises two year-long 60 credit modules: The Science of Pharmacy and the Patient and Society. These two modules will provide the fundamental underpinning knowledge to enable students to develop as clinical decision makers and prescribers. The Science of Pharmacy will be divided across the two semesters with teaching in the first semester being focused on core scientific skills and levelling out of students with different previous academic backgrounds and in the second semester providing the specialist skills basis for subsequent years. Thus, semester 1 will cover cell biology, anatomy and physiology biochemistry, biological organic chemistry and biological physical chemistry, while semester 2 will introduce, through the lens of the peripheral nervous system, drug design fundamentals, pharmacology, analytical chemistry and dosage form design. Taught material will be supplemented and reinforced by 12 practical sessions including extemporaneous dispensing. The Patient and Society will introduce students to the pharmacy profession, dispensing and the fundamentals of law and ethics through both taught sessions and experiential learning (Section 2.3). Teaching will include the underpinning legal frameworks for the sale and supply of human and veterinary medicines in the UK. The importance of professionalism and expected skills, attitudes and values will be addressed, as well as teaching to support the development of ethical and professional decision-making. Practical issues important in preparation for real world practice such as risk management, consent and confidentiality will also be covered. This module will cover important legal and societal aspects of healthcare with a focus on equality, diversity and inclusion and recognition of key public health concepts relating to health inequality and the social determinants of health. Students understanding will be consolidated through an experiential learning social accountability project. Year 2 (FHEQ Level 5): Year 2 will run as a single 120 credit module encompassing five disease themes; respiratory diseases, infectious diseases, inflammatory disease, gastrointestinal diseases and endocrine disorders. Within each theme a patient centred approach will be adopted with the first learning session being with a Patient (Carer) as Educator discussing their experience with their condition, followed by epidemiology, underlying physiology, drug design and pharmacology, drug formulation and clinical decision making. Each theme will finish with another Patient as Educator session where students will pre prepare questions based on their learning for discussion. For each theme, the choice of exemplar drugs will be made by clinical staff based on NICE guidelines and local formularies, for any drugs in clinical trial or no longer in use a cross disciplinary discussion will be held as to their inclusion in core material. Appropriate and relevant laboratory practicals, up to 10, will be included to reinforce knowledge. Alongside this, students will be taught practice issues related to different formulations and associated patient counselling. The development of clinical reasoning skills will be supported through responding to symptoms, further teaching of evidence-based practice, development of consultation skills (see section 2.4) and through understanding cognitive biases and human factors. Students will also be introduced to the service delivery within Pharmacy settings. Year 2 will incorporate both simulation activities and periods of experiential learning in practice in both community and hospital settings. Year 2 will additionally include teaching on sustainability in healthcare, medicines design and manufacture and prescribing in line with TUoS one university pillar. This activity will also enable learning through internationalisation at home for the students. Year 3 (FHEQ Level 6): Similar to year 2, Year 3 will run as a 120-credit integrated module incorporating 5 themes. Whilst the 4 clinical themes of cardiovascular disease, cancer, central nervous system disorders and mental health will run sequentially and using the same teaching model as year 2, the fifth theme; the story of a drug will be year long. The story of a drug will consider all aspects of the drug discovery process from preliminary identification of a target, design of a drug, developing a formulation, genomics, clinical trials, licencing, NICE, marketing and post marketing surveillance through the medium of a group project incorporating both laboratory sessions and workshops supplemented by taught sessions. Students will be required to design a patient information leaflet for their drug and identify key counselling points for patients. Year 3 will incorporate additional simulation activities and extend the periods of experiential learning in practice through longer placements in community and hospital settings and the addition of a primary care placement. Year 4 (FHEQ Level 7): Year 4 will include two modules: Quality Improvement and Advanced Pharmaceutical Practice and Preparing for Prescribing. The two month long 40 credit individual quality improvement project will be delivered through an embedded placement in practice with supervision provided by academics from the school and, supervisors from within the practice environment. Placements are being sought from all sectors to enable student choice and relevance to their preferred sector of practice. The Advanced Pharmaceutical Practice and Preparing for Prescribing module will consider ethics and clinical decision making in complex situations. Students will develop their clinical reasoning skills, critically evaluating available information to solve complex problems in relation to patient care. Specific patient groups will be targeted, for example, paediatrics, pregnant women, patients with reduced renal and liver function. Furthermore, students will be taught about the legal, policy, professional, ethical and clinical governance frameworks in preparation for their prescribing role. They will develop relevant basic physical assessment skills and clinical communication skills for the purposes of clinical management of patients. These will be developed through teaching and assessment in simulation prior to starting clinical placement and further developed under supervision whilst on placement. Two additional foci of this module are: the development of pharmacists as educators, which will be enhanced by an interprofessional learning activity with speech and language therapy students, and the development of pharmacy managers and leaders. Vertical Integration Alongside the disease based horizontal integration, skills development will be achieved through vertical integration around seven pillars as shown in Figure 2. This approach enables spirality of learning with increased complexity as the students progress and return to skills through the programme. To facilitate skills development, common marking rubrics will be prepared which will be used across years to enable students to track their improved performance.  Figure 2: Vertical Integration around Seven Skills Pillars Facilitating Science: A strong basis of subject specific science training will be delivered through the Year 1 60 credit module. This will be developed through contextualised application in years 2 and 3 culminating in the Year 3 group project. It is not intended that any new scientific teaching will be delivered in Year 4, however the knowledge of the students gained in the first three years will be applied to more complex situations through the year 4 module Advanced Pharmaceutical Practice and Preparing for Prescribing. Critical Thinking and Clinical Decision Making: This pillar will start from year 1 through the introduction of the pharmacy profession and the roles of the pharmacist, but subsequently developed extensively in Years 2 and Years 3 through interactions with the Patients as Educators, scenario-based application sessions and experiential learning in increasingly more complex diseases. Students in Year 4 will be performing at the Does level as they consider complex cases and situations and the prescribing needed within these. Teaching will include reducing the impact of biases, use and interpretation of diagnostic tests and improving clinical (and ethical) decision making through deliberative thinking and justification of choices made. Experiential learning: See Teaching Methods. Communication Skills: Students will have opportunities to develop their oral and written communication skills in each year. Working with Patients as Educators, students will develop information gathering skills, consultation skills, diagnostic skills and information giving skills and through interprofessional learning will develop education and teaching skills for other professionals including the development of formal presentations. In year 1 students will be taught basic communication skills that reflect professional practice, both orally and in writing. They will also be introduced to the concept of shared decision-making. Year 2 will include taking effective drug histories and medical histories in preparation for placement activities. In year 3, students will further develop their skills around shared decision-making, for example, through the use of patient decision aids. Year 4 will allow application of all the developed skills within complex prescribing scenarios. Yearly, the students will prepare a piece of extended writing, targeted at a specific group e.g. patients, other health professionals, scientists to develop audience specific approaches. Public Health: The importance of public health will be highlighted in each of the years. In year 1 as part of the Patient and Society module, students will be exposed to key public health concepts and issues. This will span health inequalities and the social determinants of health, as well as basic epidemiology and the patterning of health and disease; communicable and non-communicable diseases will be introduced as well as behaviour change and health promotion, with an emphasis on how these can be applied to Pharmacy. All students will take part in the social accountability group project. As students progress in years 2 and 3, public health concepts will be returned to, as they are applied to particular conditions (e.g. the determinants of health as applied to obesity and diabetes/endocrinology); students will also be exposed to a more critical understanding of public health and will consider how to evaluate and critique public health interventions, health policy and behaviour change interventions. Research Skills: Students will be introduced to the importance of evidence in decision making and basic statistical analysis in year 1. In year 2, the students will learn about the differences between quantitative, qualitative and mixed methods research, as well as key research designs (including experimental, observational/cohort and descriptive studies and associated hierarchies of evidence); students will also undertake an audit in a group. In year 3, students will be introduced to systematic reviews and meta-analysis and develop their critical review abilities through consideration of published papers. They will demonstrate the use of evidence in the preparation of a medicine information enquiry response. By year 4 the students will actively be using the developed skills in the individual quality improvement project. This approach is in line with the University of 91ֱ education pillar focus on research-led teaching. Interprofessional Learning: See teaching Methods USPs Social Accountability: Social accountability is a key aim of the Faculty of Health to improve and enhance the way the University works in partnership with others across 91ֱ and South Yorkshire. Building on the experience of the undergraduate medicine (MBChB) programme, since 2015, and to develop our students understanding of the social determinants of health and the importance of interprofessional learning, we will develop the Year 1 group social accountability project. Here students will spend 16 days over 8 weeks working with charities, local community groups and local schools. In these placements, the partner will identify needs in their organisations to support health and wellbeing and students will develop resources to address these needs and provide a tangible contribution to the community. (HYPERLINK "/health/social-accountability/partnership-placements" \h/health/social-accountability/partnership-placements) Sustainability: Sustainability is one of five actions under the one university pillar of TUoS corporate plan with teaching in education for sustainable development being a requirement of all programmes. We will address this in Year 2 through the inclusion of an online transnational, interprofessional workshop programme on Climate Change, Sustainability and Healthcare with Universities in South East Asia. Internationalisation: Within the MPharm, the sustainability initiative will enable students to experience internationalisation at home, an important approach to ensure all students, regardless of background and personal circumstances, can become global citizens by providing an opportunity to engage with other students and country perspectives without travel. Additional opportunities to spend time at overseas partners will be provided to all students through the Year 4 Quality Improvement project. Working with our international partners we will identify projects that fulfil the same learning objectives but where data collection and supervision can occur in another country. Employability: Employability and the development of 91ֱ Graduate Attributes will be embedded within the MPharm. During the design process, activities and learning outcomes will be mapped to these attributes to highlight to students their skills development, aligning with the employability action of the education pillar of the TUoS corporate plan. The mySkills portfolio, including reflection on development, will be used as part of the professional portfolio in each year. Students through experiential learning will gain experience of working environments with an opportunity to experience a specialised area of choice in Year 4.Detailed information about the structure of programmes, regulations concerning assessment and progression and descriptions of individual modules are published in the University Calendar available online at HYPERLINK "http://www.sheffield.ac.uk/calendar/" \hhttp://www.sheffield.ac.uk/calendar/. 21. Criteria for admission to the programme Our standard offer for year 1 entry will be AAB to include Chemistry and one other science (can incl. maths). The admission criteria have been developed with reference to TUoS policy and are in line with similar courses (e.g. MChem Chemistry, BSc Biomedical Sciences) and with other similarly ranked Universities offering Pharmacy. A levels AAB including chemistry and one other science International Baccalaureate 34, with 5 in Higher Level Chemistry BTEC Extended Diploma DDD in Applied Science (including the units Applications of Inorganic Chemistry, Applications of Organic Chemistry, Industrial Chemical Reactions, Practical Chemical Analysis) BTEC Diploma DD in Applied Science + B in A Level Chemistry Foundation providers Applications will be considered on an individual basis with respect to the programme curriculum. WP criteria will apply: meet any two or more of the following criteria at the point they left Further Education Lived in an area with a low progression to higher education; Lived in a deprived area; Received free school meals in years 10-13; Received a 16-19 Bursary or similar grant; Was a young carer; Lived in local authority care during their secondary education; Was estranged from both parents or legal guardians during their secondary/further education; Were the first in their family to enter higher education; Have parents who were unemployed or working in unskilled jobs; Have a disability; Access to HE Diploma Award of Access to HE Diploma in a relevant subject covering sufficient Chemistry units, with 45 credits at Level 3, including 36 at Distinction and 9 at Merit. Applicants are considered individually and must provide a course syllabus Scottish Highers + 1 Advanced Higher AAABB + B in Chemistry Welsh Baccalaureate + 2 A Levels B + AA, including Chemistry Irish Leaving Certificate H1, H1, H2, H2 in four subjects including Chemistry and one other science (incl. Maths) T Levels T levels in Health, Healthcare Sciences and Science are not accepted International qualifications NARIC equivalences will be used. Applications will be accepted from the University of 91ֱ International College from the Foundation in Science and Engineering. No guaranteed progression will be in place for this programme. All students will be interviewed as a standard applicant. Professional Entry Requirements: The suitability of students to meet the standards for Pharmacy professionals will be assessed during the Mini-Multiple Interview process through the use of scenario and situational judgement. Students will be advised during application of the fitness to practise requirements of the MPharm and the requirement for a DBS check. Numeracy requirements: All applicants will require a 6/B in GCSE mathematics or equivalent. English language requirements: All applicants will require GCSE English Language at grade 4/C; IELTS grade of 7 with a minimum of 6.0 in each component; or an alternative acceptable English language qualification. Good-character checks: All entrants to the MPharm will be required to undergo a Disclosure and Barring Service (DBS) Enhanced Disclosure check during the first year of the course and prior to undertaking any placement activity. This requirement will be clearly advertised and included within offer making correspondence. Guidance on the process is provided at the University level (HYPERLINK "/study/policies/dbs" \h/study/policies/dbs). For students not normally resident in the UK a Certificate of Good Conduct/check from the relevant local police station wherever resident for over three months will be required. Health checks: All entrants will be required to obtain occupational health clearance during the first year of their course and prior to undertaking any placement activity. This may require an individual assessment and/or vaccination. This requirement will be clearly advertised and included within offer making correspondence. This is to ensure that the student meets the fitness to practise standards on theHYPERLINK "https://heops.org.uk/guidance/" \h HYPERLINK "https://heops.org.uk/guidance/" \hHigher Education Occupational Practitioners (HEOPS) guidance. (HYPERLINK "https://heops.org.uk/wp-content/uploads/bsk-pdf-manager/2019/09/1521730902HEOPS_Pharmacy_Students_fitness_standards_2013_v5.pdf" \hhttps://heops.org.uk/wp-content/uploads/bsk-pdf-manager/2019/09/1521730902HEOPS_Pharmacy_Students_fitness_standards_2013_v5.pdf) Prior Learning: We do not envisage accepting transfers from other courses or providers onto the MPharm programme except at Year 1. All applications to consider prior learning and entry to later years of the course will be considered on a case-by-case basis by the MPharm Head of Admissions. Contextual offers Student Background (Access+): Through the Access+ scheme, students applying from a Polar 4, Q1 postcode will automatically receive a contextual offer of one grade lower i.e. ABB or equivalent for their qualification. Students who receive free school meals from other quintiles can apply for the same contextual offer through UCAS or the Access+ eligibility declaration. Prospective students who are care experienced or care leavers, carers, estranged from family, parents or forced migrants can additionally complete a disrupted studies application to receive further consideration on their offer. Access+ students will be prioritised in discussions if the offer is missed at results and will receive support for interview attendance. Contextual offers Additional Qualifications Students applying with more than a 3 A levels or equivalent will receive two offers as detailed below: 3 A levels + Core maths AAB or ABB, including two sciences + B in Core Maths 3 A Levels + EPQ AAB or ABB, including two sciences + B in relevant EPQ Contextual offers Participants in Widening Access Programmes Participating students will receive a contextual offer of two grades lower i.e. BBB. Examples of such programmes are post-16 discover, Realising Opportunities, National Discover 91ֱ, US in schools mentoring programme, Access to 91ֱ (year 12-13) STEM or medicine, Access to 91ֱ summer school and Sutton Trust summer school. 22. Reference points The learning outcomes have been developed to reflect the following points of reference: General Pharmaceutical Council Standards for the Initial Education and Training of Pharmacists 2021 HYPERLINK "https://www.pharmacyregulation.org/students-and-trainees/education-and-training-providers/standards-education-and-training-pharmacists" \hhttps://www.pharmacyregulation.org/students-and-trainees/education-and-training-providers/standards-education-and-training-pharmacists University Vision HYPERLINK "/vision" \h/vision 23. Additional information This degree is currently being accredited by the General Pharmaceutical Council and has been designed to reflect the requirements of the Standards for Initial Education and Training.  This specification represents a concise statement about the main features of the programme and should be considered alongside other sources of information provided by the teaching department(s) and the University. In addition to programme specific information, further information about studying at 91ֱ can be accessed via our Student Services web site at HYPERLINK "http://www.shef.ac.uk/ssid" \hhttp://www.shef.ac.uk/ssid.     hesu003 ver25-26 PAGE1 Programme Specification A statement of the knowledge, understanding and skills that underpin a taught programme of study leading to an award from 91ֱ  -.678IJQRSdelmnxy     F G e f g ϵĪڢh$h56>*h$h id>*h$h$CJaJh$h5B*CJaJphh$h5CJaJh$h idCJaJh$h55>*h$h id5>*h5jhUmHnHu9 .7$If $d<1$$<a$ 78JRob\$If (($Ifgdkd$$IfH0 g(   t 0n(4d4 HaApytRSemoi[ d$1$Ifgd$Ifkd$$IfH0 g(   t 0n(4d4 HaApytmnyoi] d$Ifgd$Ifkd$$IfH0 g(   t 0n(4d4 HaApytoi] d$Ifgd$IfkdL$$IfH0 g(   t 0n(4d4 HaApyt  oi[ d$1$Ifgd$Ifkd$$IfH0 g(   t 0n(4d4 HaApyt  G f obT d$1$Ifgd (($Ifgdkd$$IfH0 g(   t 0n(4d4 HaApytf g obT d$1$Ifgd (($Ifgdkd$$IfH0 g(   t 0n(4d4 HaApyt oi^^^ $$Ifgd$dkd\$$IfH0 g(   t 0n(4d4 HaApyt . / D E F G | }   3 4 ù욋y#j h$h idCJUaJjh$h idCJUaJh$h id6CJaJh$h idCJaJh$h55h$h id5>*h$h55>* h$>*h$h id>*PJh$h$>*h$h id>*h$h5CJaJh$h5>*, MB44 $d$Ifgd $$Ifgdkd $$IfHF l(   t0n(    4d4 HaFpyt / E YNNNN $$Ifgdkd$$IfHF l(   t 0n(    4d4 HaFpytE F G U 5$$d%d&d'd(d1$IfNOPQRgdkd$$IfH4F l(`   t 0n(    4d4 HaFpytG } Jkd$$IfH4F l(    t 0n(    4d4 HaFpyt $$Ifgd $$Ifgd5$$d%d&d'd(d1$IfNOPQRgd  UOGAAA$If$d<$dkd $$IfH4F l(    t 0n(    4d4 HaFpyt    % & ' - . / 0 1 2 D E V W X \ ^ a b c w ʿʿ{qg_hECJaJh$h55>*h$h id5>*h$h55CJaJ#j h$h idCJUaJjh$h idCJUaJh$h id6CJaJh$h5CJaJh$h idCJaJh$h56CJaJ,jh$h id6>*B*CJUaJphU#h$h id6>*B*CJaJphU% ' 4..$Ifkd $$IfH\c"+(FsU  t 0(4d4 Ha_p(yt $1$Ifgd' . / 0 1 .kd $$IfH\c"+(FsU  t 0(4d4 Ha_p(yt $1$Ifgd$If1 2 E W X b c x y Rkd $$IfH0 ( k  t 0#(2 s4d4 HaPpyt $IfgdE$If$d<1$ w x y  yz{|ABCDFGOP޹h$h id6CJaJhECJaJhEh55CJ\aJhEh id5CJ\aJh$hECJaJh$h id5CJaJh$h55CJaJh$h idCJaJh$h5CJaJ; lg`+5$$d%d&d'd(d1$IfNOPQRgdE$<a$$a$kd $$IfH0 ( k  t 0#(2 s4d4 HaPpyt z{|VQJD$If$<a$$a$qkd$$IfH^'' t0'2d4d4 Hap yt7x$$d%d&d'd(d1$IfNOPQRgdEC $1$IfgdskdL$$IfH2'Q'  0Q'4d4 Hazp ytCDGtii $1$Ifgdkd$$IfH02{'I%  0Q'4d4 Hazpyttii $1$Ifgdkd$$IfH02{'I%  0Q'4d4 Hazpyttii $1$Ifgdkd$$IfH02{'I%  0Q'4d4 Hazpytti[$P$1$Ifgd $1$IfgdkdZ$$IfH02{'I%  0Q'4d4 HazpytaqtqlaTa <$1$IfgdE $1$Ifgd<1$1$kd"$$IfH02{'I%  0Q'4d4 Hazpyt`apqrvwZ[\bcdhiEFGMNOST{|}кŮввввввhEhECJaJh$hECJaJh$h5CJaJh$h idCJaJh$h55CJaJh$h id5CJaJh$h56CJaJDqrwlaaa $1$Ifgdkd$$IfH0Q "u'!U 0$'4d4 Hapyt\c\ZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 Hapytcdi\QQQ $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 HapytGN\QQQ $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 HapytNOT\QQQ $1$Ifgdkdh$$IfHFQ "u'WxU  0$'    4d4 Hapyt}\QQQ $1$IfgdkdH$$IfHFQ "u'WxU  0$'    4d4 Hapyt\QQQ $1$Ifgdkd($$IfHFQ "u'WxU  0$'    4d4 HapytalZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 Hapyt_`aklmqrhijtuv{|vwx89:=> !h$h55CJaJh$h id5CJaJh$h5CJaJhECJaJh$h idCJaJPlmrZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 HapytjuZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 Hapytuv|ZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 HapytxZOOO $1$Ifgdkd$$IfHFQ "u'WxU  0$'    4d4 HapytZOOO $1$Ifgdkd|$$IfHFQ "u'WxU  0$'    4d4 HapytZOOO $1$Ifgdkd`$$IfHFQ "u'WxU  0$'    4d4 Hapyt9ZOO $1$IfgdkdD $$IfHFQ "u'WxU  0$'    4d4 Hapyt9:> $1$Ifgdskd(!$$IfHQu'$'  0$'4d4 Hap yt\QQQ $1$Ifgdkd!$$IfHFQ "u'WxU  0$'    4d4 Hapyt!\QQQ $1$Ifgdkd"$$IfHFQ "u'WxU  0$'    4d4 Hapyt) * + 5 6 7 : ; !!!!! ! !!!!E!F!G!M!N!O!R!S!!!!!!!!!"""""""""f#g#h#n#o#p#t#u####$$$$$$$$$$hEhECJaJh$h55CJaJh$h id5CJaJh$h5CJaJh$h idCJaJN+ 6 \QQQ $1$Ifgdkd#$$IfHFQ "u'WxU  0$'    4d4 Hapyt6 7 ; \QQQ $1$Ifgdkdx$$$IfHFQ "u'WxU  0$'    4d4 Hapyt ! !\ZOOO $1$IfgdkdX%$$IfHFQ "u'WxU  0$'    4d4 Hapyt !!!G!N!\QQQ $1$Ifgdkd8&$$IfHFQ "u'WxU  0$'    4d4 HapytN!O!S!!!\QQQ $1$Ifgdkd'$$IfHFQ "u'WxU  0$'    4d4 Hapyt!!!""\QQQ $1$Ifgdkd'$$IfHFQ "u'WxU  0$'    4d4 Hapyt"""h#o#\QQQ $1$Ifgdkd($$IfHFQ "u'WxU  0$'    4d4 Hapyto#p#u##$\QQQ $1$Ifgdkd)$$IfHFQ "u'WxU  0$'    4d4 Hapyt$$$$$\QQQ $1$Ifgdkd*$$IfHFQ "u'WxU  0$'    4d4 Hapyt$$$$$$%%%&%0%1%2%6%7%%%%%%%%m&n&o&u&v&w&{&|&*'+','6'7'8'<'=''''( ( (((.(/(0(6(7(8(<(=((((((((((((((((()*)j)k)l)r)s)t)ҿh$hECJaJhECJaJh$h idCJaJh$h55CJaJh$h id5CJaJh$h5CJaJK$$$&%1%\QQQ $1$Ifgdkdx+$$IfHFQ "u'WxU  0$'    4d4 Hapyt1%2%7%%%\QQQ $1$IfgdkdX,$$IfHFQ "u'WxU  0$'    4d4 Hapyt%%%o&v&\QQQ $1$Ifgdkd8-$$IfHFQ "u'WxU  0$'    4d4 Hapytv&w&|&,'7'\QQQ $1$Ifgdkd.$$IfHFQ "u'WxU  0$'    4d4 Hapyt7'8'='' (\QQQ $1$Ifgdkd.$$IfHFQ "u'WxU  0$'    4d4 Hapyt ( ((0(7(\QQQ $1$Ifgdkd/$$IfHFQ "u'WxU  0$'    4d4 Hapyt7(8(=(((\QQQ $1$Ifgdkd0$$IfHFQ "u'WxU  0$'    4d4 Hapyt(((((\QQQ $1$Ifgdkd1$$IfHFQ "u'WxU  0$'    4d4 Hapyt(((l)s)\QQQ $1$Ifgdkdx2$$IfHFQ "u'WxU  0$'    4d4 Hapyts)t)y)))\QQQ $1$IfgdkdX3$$IfHFQ "u'WxU  0$'    4d4 Hapytt)x)y)))))))))I*J*K*Q*R*S*U*Y*Z*+++ + + +++++++++++/,0,1,?,@,A,E,F,,,,,,,,,J-K-L-R-S-T-X-Y--------- . . ....J.K....hEh$h5CJaJhECJaJh$h idCJaJh$h55CJaJh$h id5CJaJN)))K*R*\QQQ $1$Ifgdkd84$$IfHFQ "u'WxU  0$'    4d4 HapytR*S*U*Z*+ +\ZOOO $1$Ifgdkd5$$IfHFQ "u'WxU  0$'    4d4 Hapyt + ++++\QQQ $1$Ifgdkd5$$IfHFQ "u'WxU  0$'    4d4 Hapyt+++1,@,\QQQ $1$Ifgdkd6$$IfHFQ "u'WxU  0$'    4d4 Hapyt@,A,F,,,\QQQ $1$Ifgdkd7$$IfHFQ "u'WxU  0$'    4d4 Hapyt,,,L-S-\QQQ $1$Ifgdkd8$$IfHFQ "u'WxU  0$'    4d4 HapytS-T-Y---\QQQ $1$Ifgdkdx9$$IfHFQ "u'WxU  0$'    4d4 Hapyt--- ..\QQQ $1$IfgdkdX:$$IfHFQ "u'WxU  0$'    4d4 Hapyt..K..\QD <$1$IfgdE $1$Ifgdkd8;$$IfHFQ "u'WxU  0$'    4d4 Hapyt... // $1$Ifgdskd<$$IfHQu'$'  0$'4d4 Hap yt... / / //////////////000 0 0 000a0b0c0i0j0k0n0o000000000d1e1f1p1q1r1u1v111111111222222223333 3d3e3f3l3m3n3q3r3h$h5CJaJhECJaJh$h idCJaJh$h55CJaJh$h id5CJaJO/////\QQQ $1$Ifgdkd<$$IfHFQ "u'WxU  0$'    4d4 Hapyt///0 0\QQQ $1$Ifgdkd=$$IfHFQ "u'WxU  0$'    4d4 Hapyt 0 00c0j0\QQQ $1$Ifgdkd>$$IfHFQ "u'WxU  0$'    4d4 Hapytj0k0o000\QQQ $1$Ifgdkdh?$$IfHFQ "u'WxU  0$'    4d4 Hapyt000f1q1\QQQ $1$IfgdkdH@$$IfHFQ "u'WxU  0$'    4d4 Hapytq1r1v111\QQQ $1$Ifgdkd(A$$IfHFQ "u'WxU  0$'    4d4 Hapyt11122\QQQ $1$IfgdkdB$$IfHFQ "u'WxU  0$'    4d4 Hapyt2223\QD <$1$IfgdE $1$IfgdkdB$$IfHFQ "u'WxU  0$'    4d4 Hapyt33 3f3m3 $1$IfgdskdC$$IfHQu'$'  0$'4d4 Hap ytm3n3r333\QQQ $1$IfgdkdxD$$IfHFQ "u'WxU  0$'    4d4 Hapytr3333333333f4g4m4n4o4p4t4445566"7/7|7}7*838@8M8889999⺩Ҙ~~~q~~~ghECJPJaJh$h5CJPJaJh$hECJPJaJh$h idCJPJaJ h$h55B*CJaJph h$h id5B*CJaJphh$h56CJaJh$h55CJaJh$h id5CJaJhEh$h5CJaJhECJaJh$h idCJaJ$3333g4n4\ZOOO $1$IfgdkdXE$$IfHFQ "u'WxU  0$'    4d4 Hapytn4o4p44\Y!8$ @ <$d%d&d'd(dNOPQR1$kd8F$$IfHFQ "u'WxU  0$'    4d4 Hapyt4}799999::}{wnc x$Ifgd( $Ifgd(<jkdG$$IfH'`'0`'4d4 Hap yt x$1$IfgdE $1$IfgdE999999::::E;O;;;;;;;<<C=D===>!>Q>U>>>l?n?@@D@E@[@@ARASAAAAƹyyh$h id5CJPJaJh(CJPJaJh$h id6CJPJaJh$h(CJPJaJh$h5CJPJaJh$h idCJPJaJh$h55CJaJh$h id5CJaJh$h5CJaJ h$h5h$h5B*CJaJph+:;;<D==>@E@AcBBBdCCCD!DEF x$Ifgd( & FVx$If^`Vgd(AAAbBcByBBBBBBnnnnnnooprrrrr8su u2v*B*CJPJUaJphU$h$h id>*B*CJPJaJphUjh$h idCJUaJ#jAh$h idCJUaJh$h idCJaJIJua3$$d%d&d'd(dIfNOPQRgd(jkd$$IfH'`'0`'4d4 Hap ytNrstuvwxy'()DEijk012>?˼xxlxaVaVaVaVaVaVaVh(h5CJaJh(h idCJaJh$h id6CJaJh$h idCJaJ h$h55B*CJaJphh$h id5CJaJ h$h id5B*CJaJphh$h5CJaJh$h5B*CJaJphh$h idB*CJaJph)jh$h id>*B*CJUaJph h$h id>*B*CJaJph!uvw_'8$ @ <$d%d&d'd(dNOPQR6$ @ $d%d&d'd(dNOPQRjkdb $$IfH'`'0`'4d4 Hap yt()EjMkd!$IfK$L$dG0"  t0"22 d4dapyt x$Ifgd(K$ xx$Ifgd( $Ifgd(jk1ree x$Ifgd(K$kd!$IfK$L$d*0"  t0"22 d4dapyt12?nree x$Ifgd(K$kd"$IfK$L$d0"  t0"22 d4dapyt?mnoTUՊ֊׊STU)*+<=>?STX>?@de{|}ԍՍ,-.89}~ABݏ߾h$h id56CJaJhMh5CJaJhMCJaJh$h5CJaJh(h5CJaJh(h idCJaJKnoU׊reZ;;; & F^x$-DIfM ^^`gd( x$Ifgd( x$Ifgd(K$kd#$IfK$L$dG0"  t0"22 d4dapyt׊U+>" & F^xx$-DIfM ^^`gdMK$ & F^x$-DIfM ^^`gd(>?T?ree x$IfgdMK$kd$$IfK$L$d0"  t0"22 d4dapyt?@e|reX x$Ifgd(K$ x$IfgdMK$kd%$IfK$L$d0"  t0"22 d4dapyt|}reX x$IfgdKSK$ x$Ifgd(K$kd&$IfK$L$d*0"  t0"22 d4dapytՍ-reX x$IfgdKSK$ x$Ifgd(K$kd'$IfK$L$d*0"  t0"22 d4dapyt-.9~reX x$IfgdKSK$ x$Ifgd(K$kd{($IfK$L$dU0"  t0"22 d4dapyt~BreZM x$IfgdKSK$ x$Ifgd( x$Ifgd(K$kdl)$IfK$L$dG0"  t0"22 d4dapyt$VEh[rggggggggg x$IfgdKSkd]*$IfK$L$d 0"  t0"22 d4dapyt ݏ#$:UVmnʒ#ԓՓBCu˺˫˜xa˫RFh$h id5CJaJh$h5B*CJaJph+5>,j *h$h id>*B*CJUaJphU# *h$h id>*B*CJaJphU#jN+h$h idCJUaJjh$h idCJUaJh$h idB*CJaJph+5> *h$h5B*CJaJph+5> *h$h idB*CJaJph+5>h$h id56CJaJh$h5CJaJh$h idCJaJ#ՖÖ#./23—×Bɷɔԃn\J# *h$h id>*B*CJaJphU#j,h$h idCJUaJ)j *h$h idB*CJUaJphU *h$h idB*CJaJphU#j+h$h idCJUaJ j *h$h idCJUaJ#j+h$h idCJUaJh$h idCJaJjh$h idCJUaJ *h$h idCJaJ *h$h idB*CJaJph+5>BCDEU#3?gh%(?Z[ @ABTUY[˝̝ !"#7øÔÔøøÔth$h id5CJaJhKSCJaJh$h id6CJaJh$h556CJaJh$h5CJaJh$hKSCJaJh$h idCJaJh$h id56CJaJ *h$h5CJaJ *h$h idCJaJ,j *h$h id>*B*CJUaJphU, ABUVkd^,$IfK$L$d:0Q"Ig t0"22 d4dapytxx$IfgdKSK$ xx$IfgdKS̝!rgg x$IfgdKSkdA-$IfK$L$d:0Q"Ig t0"22 d4dapyt!"#8_N9$ @ x$IfgdKS$ @ <gdKS6$ @ $d%d&d'd(dNOPQRjkd2.$$IfH'`'0`'4d4 Hap yt78&'(YZ[}~ˡ̡QRѰŸxŸgVNhKSCJaJ h$h55B*CJaJph h$h id5B*CJaJph#j/h$h idCJUaJ)jh$h id>*B*CJUaJphU h$h id>*B*CJaJphU#j.h$h idCJUaJjh$h idCJUaJh$h idCJaJh$h5CJaJh$h id5CJaJh$h55CJaJ'RskdK/$$IfH'`'0`'22 H4d4 Hap yt @ x$IfgdKS @ $IfgdKS @ x$IfgdKSS]3$$d%d&d'd(dIfNOPQRgdKS8$ @ <$d%d&d'd(dNOPQR6$ @ $d%d&d'd(dNOPQRRSTUVWXXԣգ !"#$%&'()*+,-.˼˪|xx|xx|xx|xxpl`h$B*CJaJphh idh5B*phhdojhdoU)jh$h id>*B*CJUaJph h$h id>*B*CJaJph#j1h$h idCJUaJjh$h idCJUaJh$h idCJaJj0h$h idCJUaJh$h5CJaJh$h5B*CJaJph!STUWX{ $IfgdKS$ @ gdKSjkd/$$IfH'`'0`'4d4 Hap yt!"$%'(*+jkda1$$IfH'`'    0`'4d4 Hap yt +,-@IJKcݤaVM$<:Da$ $<<:Da$4$ 9r $d%d&d'd(dNOPQRa$1 9r $d%d&d'd(dNOPQR4$ 9r $d%d&d'd(dNOPQRa$./4;?@AEFGHIJKbcܤݤҼ߸h$h5CJaJh id5B*CJphh5h id5B*CJphhdoh idhB*mHnHphuh idB*phjh idB*Uphh5B*phh$B*CJaJphh idB*CJaJphݤ:D<<:D$<:Da$50P. A!`"`#@$% Dpn| x+cxYq]PNG  IHDR1t2IDATx^]oyEEڻBho #}2 Zx"]\no~ME wջ{^^ v),3C΋V8/Av^/QY9S8lnЌaJ3 +:vH+}s&g.%FJ̶jm3Yk3s][CL;3ؕ^kS0ۭ\l&YZSfIv+|:Lb7i;tN?*g{|{6qs ɟYh*5gЫ7;j5:9stlڞNRG3dYeܛ|$@Ԕuss߆69asqjLrWva9^͵ZoNx8g*߭2[[HNpǜKpWB|8np2c ]8Ig0rqKL* N} ]8Mb|uէR cFr;gprqodbm$wd6sB-83t|4u=#Xcv '9)'`@l}u9JLpƕKβrh1'2uԥ Δ۟K99uKq8 Ar*/gtJօӌ9GyS?>kgq k1C8yj~Z椶';:ɏ(/'2 Nw|$i&:!ڌӺp1(rzOkjzC JƢ<^,wtչ8hЎF]+䓬51 N?(rq><-Rzsy o{dG1.GSп 8ĩTŨqutAd ްi>>:7̜<ԉ7+ғG&8qgq~66冮K9b˞bX,×Va/NSFyS^HI$?ʣ<8 O1l4ϥ<>}8G;q>y]v=8Gp>&KniL xe>SNщEÉ߽5@y:CJBz@O3l y{>?t o؟˞N32pJwߐ~NSߓSs*[c :qmX/NAWNeb4>󳦰­6;ϰߟ5Erʗ&Px)01mI)srk87[Jpܧ2}kbe*z/#\#'?5N-'d)Nru1N$S}^ɹ۞@BE9oMq = _b[eD)˟H4LK)괔X9?oI?TSג'Y8gICےAӑOn+8~s^$.'r΃+ջpj)Nz{醓 D e"NA1oNlsn$ۄ)3 ,ls='ϜW'L2E/^g9o)jIӧ^݀vl_!Emo޳{qP9= m0]r =Ph|5qKd~v]&-g/9/8 Mi8Τ̜ebU_nJDf6D9 ~,KY/ u3L2KcTlu2sKMuhϑ&'n^XFx5n-|^{'I]8mp )U_c8pRI󦴴_'Q>ct-a1ǿ0yks#NSs]q|Cm K>̧"I ؤYP/qkE9|dM,}4aӂÔ9D(NA;٬&lIWS9}t$ޝG68m5ݮ'NµBHf+NKZ'윒sZӑdr⸘Sǚ^m&IwhtrpĉGy@rbo%Ω7>}47ȯE49[s'uJirlR.Nʪhn2ljJaWN.7pq:'%[^]88u '1bp1ZNS.N(Ε'uώ|S85i(z3\"Ο;7'^0q14ZgT=ҜΧy2S8 τEƘS?L\NZm8#Odh1C-|3sqJ]\6~2S8%# dU|:qx4"JL$S;L|b슱hw^]S[upV[!#0S|#5F9J=W:Ap>qξڵq.&8]M'Ksq*SstqJ:T㤯y2{ifuiOΩ8$g.nsrr;U.˼ʸX6i$8'& W[眪Ãm!ki>Oup "NgNp=VGMIq:)Nq"Nũ.pCoEɲFacN,g|go6|&'iLT9fl"}r陜ܖA'g/9F>{Fw>3FlN -N]U=@Έ0zcEIN8CɈWMBG t3<̠TU$rS#n+NnV7ȯgvog;q!Kr‹#MWsi \C1d ipC=;qi8JF"M=3iZG>;'Oqj{Y$,hq"Nn kyp/LYRq_kEGcB@0,T }ʠ7;%RCNUz%$*g#4s:2ٔt]NU>N79ңɗiw"C>z)+PSo 1=P=U8}Htmg ^ʩ gq eH9=NsirqrSu9yS2s:R~doT}Y_pVt%+'5t>b9ySrp fup[6 =2sR0AQ;gU9^Y[;֜ g Epxp9wၛ9C '`T [?ɾv3G̜V̩~3RP[Τa>sbQ=5RB#qڭ WV΀8WBt5߫%2g(3*~*ATy#ljQIg0ыvN_r$(I3xqt)q<{񳔙=86QlR-E@(D9-Sp8U^iQvN=+pM1ϪT@'ϡ~ ˀx y:cX NF'fXҟ&'VM0`X4E:DNZ+@{WoҒkcR7TN2bN:i(X*'*Z@5NmKd`מ9P RJWSym9HqFT𢆈3E59&C6yu象ʙAΩQ4k!eҜpC5 e8L͂Q(өGtqu?hT6Ɯ!qbԏp,2pZ*O;ҷ$Hs} S%.t|dLi[xh:l.a !rFHB9uĈ(_Ըj7DH8]Ɲ4ʌ8!Am?*L9 PnQƢ.N8B: O_1qX&M4+-Q,D9UDDf܇!)KT86ư`XEsS-3>rȜSUq$_V_ ]Ӌ T9LGwbwIwgW#9]tj`ԩD/Gs-[bNr K?+d *Q;RqNȡroرôaUHaLJSswZHeս+G3['NP9;+ɖr8NuE1':tD8]8v5V¡b _YCgӖ^b}['Xb pX~:pW!; F:<1oE5&YsyPut>;"C^M9LĹm۵ȗtjDP,HY8088Cd91G6C/(NݲZk opտ44NYRY UD[l/{*S7-d8,j fэu{6$U[Q68U<,NX5R uxmWSʆ)S'DaC cn{iD{;؊\}}I# Ks+ 7$W4yvw2Y`)o{UQy}yJjrZjh8[Y4mq(vVnER!)-F1RZ޺c NOCg7N >bZoo=A^ϫLYT좼{;T*=M488o-nɯSq2+4V;3N5WyUs*ueDù aaw})NI!{-60PpʥA]DdGpkWNoyMX%ؗ0Æ\p UջViGZ TxK !E">`ZIUUfߌM_ѧLXC|C8C9w՝7'fo;0eڃݴ{׏w7apq?h W&N1)ZJU}rlFS|oww3[U{73h+(lW&NϪ-4Vm^+'[AqIn#yC.6'Σ?2qea *ýc#CGm{mgL2g qy(wMxH2qJ^[svw7sK9kOjxlRun:5woӣ}ϩu(00RiGFo]2lNd߳}9Q`m {.c:qlrGK97}8RXr*$NDC[V^_AdW>61#}t L9q3)#;kBՇ Ͱz wQ:5,ipAvXe.m #n9`LŻ릺Ʋ~ʌ&9Y`VSوn]'$s_/RȨ0VlϑB3[QȌNq2pZ2u4gj&:qFQoN*Kӑ;u6~XSR,S73N'p-.[7`FU gLuAxxQ䒨N4i Q OrapG^S P(]1','lȥ]]wUȜ.HB*BgO~vCŜd-N5cppWz\LCm$1xTɌsUUʉa w+[:8VqX:TG< xBmـ禷q<)a'C0ORwo_S$HwK5asb-h%s9k܇^q;v;89oљJ'6([z?1d0,H;7TD^79U^pdɇOR5Ӧ 3`o^=0^&tc8)J{nI=*.sUSdm;kܬïw)̝nm2kZ2͛%stwco2i05ʼnZ?UhD{{U5HrERhm{+$ΝOVaw!@Kp:/L4>C99]]wd_DI NGn49*뽔cr"ΐ8+Mo8'wpY3`688mL]O6zsRK;li5Né#T] ?yxx!"u~ZO^}64۵k!GTğ龉 6rRh[;e^ I'F>C#3$^mTZש"NBs*DﴟS9IҥS%gr6攪sϜp0xfg\R+& pN"ͩzYsgMĝy׋98UC{Rt.,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V@J2\0SIENDB`$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfA!vh#v #v:V H  t 0n(5 54d4 HaApyt$$IfF!vh#v #v#v :V H  t0n(5 55 4d4 HaFpyt$$IfF!vh#v #v#v :V H  t 0n(5 55 4d4 HaFpyt$$IfF!vh#v #v#v :V H4  t 0n(+5 55 4d4 HaFpyt$$IfF!vh#v #v#v :V H4  t 0n(+5 55 4d4 HaFpyt$$IfF!vh#v #v#v :V H4  t 0n(+5 55 4d4 HaFpytDD$$If_!vh#v#vF#vs#vU:V H  t 0(55F5s5U4d4 Ha_p(ytDD$$If_!vh#v#vF#vs#vU:V H  t 0(55F5s5U4d4 Ha_p(yt$$If%!vh#v #vk:V H  t 0#(5 5k/ 2 s4d4 HaPpyt$$If%!vh#v #vk:V H  t 0#(5 5k/ 2 s4d4 HaPpyt$$If!vh#v':V H t0'5'2d4d4 Hp yt$$Ifz!vh#vQ':V H  0Q',5Q'/ 4d4 Hazp yt$$Ifz!vh#vI#v%:V H  0Q'5I5%/ 4d4 Hazpyt$$Ifz!vh#vI#v%:V H  0Q'5I5%/ 4d4 Hazpyt$$Ifz!vh#vI#v%:V H  0Q'5I5%/ 4d4 Hazpyt$$Ifz!vh#vI#v%:V H  0Q'5I5%/ 4d4 Hazpyt$$Ifz!vh#vI#v%:V H  0Q'5I5%/ 4d4 Hazpyt$$If!vh#v!#vU:V H 0$',5!5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#v$':V H  0$'5$'/ 4d4 Hap yt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#v$':V H  0$'5$'/ 4d4 Hap yt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#v$':V H  0$'5$'/ 4d4 Hap yt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#vW#vx#vU:V H  0$'5W5x5U/ 4d4 Hapyt$$If!vh#v`':V H0`'5`'4d4 Hp yt$$If!vh#v`':V H0`'5`'4d4 Hp ytBDd %s l  c :A?image3.png"bBcm=TArHnAcm=TPNG  IHDRLQZ6OsRGBgAMA a pHYs&?IDATx^^ŵ7+PhR(P[qwMBIh"5{o{>ѰC$^DPPPPPPPPPPPPиiD Л4(\[߉/ǖ/&-}L G9тħ$3&x~_':9ݛ[1d>_"!} mPChЀrm='d t\l9V _-fN,a4}¶ 2 =Ih^_8Is$8u>rJN + W,W>iD" ~Y,Gڦ^Kqz 0{^ ^%6~s;oM(4 % Y' =3:Ѡ咯&)y ~\nB)#nI@%tOyBc[!uuw1S L(8,~ yC }ր]@Zʾ;J9 E%' 3G$=yIB%4iB. oH)&/ & h^+I:5[މv`UBU.hr}[˷R B4`tVvJpo %PA w~fN z \ f@[^, 7ǰb}$AA} 7%h:ޑ W$w,X4ӌ>k>OB3V`܌r>n羲4~rMRYρ ,xIڏO nsG~I0{{OIkVM4BH@&kf9+/}j~d&m-(f>>ΝXP|,6[l %`؛E,7=/%nڬsH(Hzc8ωD`sLdݹ,o}kfjD/"`hKX8'`>8 i9o߸#sNp;v BV/8N|Ufu9Z!K) ZB!wey$ [a $ 5vPfW?1&0vޒiAl %`2I+` W.K-eoR |EgRYBIg [Ia?}%/=$,Vɘ⃂ -}nRr얌; j˽>.&`/G&4i|{s׌v!A'8M9_J7WկJpNZ~Is*.d9 A8B$8g,/(s|*< ;P3`/|r݌vY~mmPn[_f(x-=oR-ߤr/2N@ܷ j ^N- Ho=}e} ]`wZ㜠 }O 6W3}tq }sl,s˼*/7_`ie%U}|[9yv f%KlEE*~6+q/ay2K/`/+@?؟cs%oJ.y|8Xȑ͙|C{PPPPPPPPPPP`'ԜU7Pc/w[\p#s^ ${ ڥl̾N^7bڨ3`+TV>ʎ0<_PQI$lY}.uX"?V~W 5eUv7 ༠pM` kۛ y=fDe_; ra^ۛ=ࣁse/~x>o*/nwZIzX5{؃RfP,i!A[\O|Y~2Adpqw x,>{| .zf}q ֗Ͷ2f?Ԛ"+~jN%F]W~JI^.kΕ6KhGO(?φeFwR [O͝ʅP7d0V%'GD,kjA{KK !Q~} J~H)x*3ʻO}^D^yey!z|dE~f[-tCe['b k%X6iBI8h& G7񑄁D'! o~0(((((((((((((+K~^Pno2}W5}@MP#n߷9Ḏ[!& ~;|}&;ps=@`"{;{*iӞ=;G@ .ԣ[zz}aUm@ 0}ꀾ5sm/>蠙0dACGխز.@ =7^ݽs2dvw%(H>p]c{h[uêVGz^uaDaS q\g؈^:|`Խ{אaU#I<:1u@ 8s#O Y21p?;h`ԕi^9`c Upe'?RtK]Us;݁@ 0q9oTלtuщW:;C9`3 =pа:>>s^>u}@ &<ӟ.:_Җ',zvA϶o0A] 8SA'S4:Ъ{1A]ztÎn8, z~^]|҃ACFV= a*t<2ϴp}ݙB= ^CyАQՕ>Vn2w}]},m5Sg.;h.:s"A@sdYZ4lYM[GaVwĥq@sި?j㪞{a[%F{4C@ :bOzk;xv&Nmmmw?CV]t}=1$m> FT= ݮ>?dzZ̮@ "ԣo Qu7LV{6A_i~CGTxƋ3|iØ|y!CN;@ L!:dsC zyi]2u?d=F<}Yh4/,Ǫ~Ït~g=ej/u7?vwOiUv @gϽ<Ъ[A߽wیMWu32V e~d ѳgoRCn5,@ _{?w7O~ݵ *Sr\׌=|!`=@ _UػE=@WA]"`_VD@ .J/+"`@ U{@ *R@ˊ@ tDE)@ eE@  "`{ "@ ]wQ=ܸת;}嵉rZ_=|׫{/yuot=M΁ػ(u<  (S}խg4?t 4 -G_,) ~>QWx{V׵OT%^61"gu]%z~r;Z5r3,[;_N>L 31v6 _=S\0Ƨh"MfܹHO(9(9^|& M=Ypٯ%_\?`Q9nv?&d{Jܕб8n([͋/ӏIػ(u (/ʱ7kOyh\gQWݒw¸3_ou-١?uA-g2Z,q>tCu OT':|>gFz}O04z]UڡMܺISL~˸ǽAT=t/[7)1)S?UͲrvײ G}ҳ_'>]ݕuet5lMǟ]=$'u/WS59[;x'yI>M[K{]#oo,S\wYyY{Mӻ{+Ϣ'49F=  :/A+~ ى: K}$G?Qw1p/dړMO`.:;a5v'"u:Ÿد}J|R(C.pɯVҤ؋XdoL͌駝:pY)|QWAe=V&IR0L/Y]ڋYQs]i39 _jV λX>eŁ\uSQ}/^3o5Wߜj,KM3C.=6 }K~Nv2J `3nVhMgZKT=wg75FU_|j>ef m۲\E|,`,"gê%Y19r r&&vNo9GˬS6\a.ս@vj9IG}tۢ |Z 鶇.;U߽qoLSYɦ٣<2 z f]tGܛ '4~9뮴e5dU:w1ixK;nҽzǺॿR7UmWNH>iyU=:_\5 V3N?sճwOdvqxucfmg~#ۣi>g/قviTo帾/|ܱ5䳧ճϳܲԱ쭞<N g- 6YoSޘs~:Qi4Lnn)`>PKAW [:g\!}>ZdWݦ:sĭ2.>j; ί&P&04y¢ $,D$I`}dwjϭ`Rժ~'X83BpS0MEr?=h#qahD r=ohQix7>?P[W5Ur|ߞgwQ/SR׎Jc9ϩ؍^_Ss1 OuЪAÏ8ߛpq@3Fic_ +?׬z%ߑ'ؕGǯ]6^%`_kͪYgyY~ڦ5WߞkyYɷRpO)_?9`!ՕIk&t 3rns/ӻ[T/Uc>68yٵ𷗳}շZqm}Ԛީ,\nδ2)O3>28-5:1Ø瞜(׽h>*况3)9ѳ/U|GՒ,?C.ޱګ5𰨶婚3{@:&.m.<΋z VxnuYs?ahu O沠)u5_MW{@/9jfwYge'nƤzdvʯOU vjmuani:iȵ@,|C]1vNܗuK-[ƒ s4o¯?I@3$ M8.aD'r44.d11Dˤ&|ݐ^lj><=/ o&[  KN|MR fEJ7b\)kN~&ϑE\}:cĭom} ܗ̴ܢcQ{.;ܾ3¤{(>ϴ,%Q<{)߫,TGF+*{ _9[KS׳b ;ԏg-_GچǪzvߜ"'TX۵LڰF7<;`uuNC6KЙ[zV+/^`辗f@KJkkp z=tv-?>9ݳٰ⓹<^GxPpxq,_[N{=c{9}}xnLm?_vciG.g~.9}1TSL;lLߚz<a|gK}yQ9qa ~6Lbx-ċ<~S}ȱťV `1Lyꄿ:y( 69 ecߣ,)'S 맢/ԍ,z'ʘN}cIw>c5z"S?}& \3GM^ExK9q(F7F&_?x6''AO}˳ Әr?*uNG]uS P {^ ʵ;[>z;&ŷɳ礈+ԖǶIٴښ+ħw]<'d_bϼ8 P潺{}(`G$%D aZ'&2gYLM݀|Sw2)`71`(;3 w;%3zhKr&y;H=yv喬g, 8qdN(9\ Yv V6LջcX9joZ j9&l yvu.#r]2.ƒ#1Zd%Er7BYs)mKnV2ۡIקo8cyT>gYjmP%&w^֥S >}2L嗴ܽڳ͝)uy'<&fehwa2 2yz{{vؤ{6&?gUΆ쎾&[:(޻-59<>J,џʩWߡﮜ <mrljge&9R#O.HyݓsQ5K:ف΅Ȥl©-LlY.dȕُv5,sWn_Mn5IK!0K~cyDF\'&v,'Xf;xrly<3̒C+В noԢ+CE~%붍sݓ~)pgκ=MrkBc儁W@ W[~| p~׮f;s2o x(قY$'п)\_7]uy|ctn) ػ4.cLvݠE^dr9lHB۵U%V8?uP:X]smrdsWMOˉ"(û,c}mvOyQډ)1s;-Z'3cJM9?/!K,|<,*ՔI*`gf~<ûu>ϱ9ΛڿArK}LO% |^*_ԍcf͂؂Kgn;Ͷ۷<~<ޒhCƆia4FYi HkVgLS.XQn#b:dOt?m_Oc0lN$z5q|4vJ8k:N%L_ %Ф]F%|;;Њ,W? hR ̘q(r4hLn ؇v?-+3 ݶ>3u+*΅3ſΦհ(Ϛij.=۹)ٴs)c86˸鴥0پr9K.\*˲(أۗ3x<ㄗ\8G杺3xa1'.)޷(Ղ, @9p-4--xe"X=`r3}3fy6X#'3%xKz{;d՝S6C%`/3'Cv8<pF>?ǰHIlޞEК4 ٙD|=T.?(33 䎏6M%6 ,0G~X5Ϯ6dCEFozi13Vρ^/᭏N27͉bRBS±6k)cU]82 > w24t3%4k:faɥ)'e5NJ 9v30;o>'~(cIx"{=~J:=oitS]U(!+g3F hqv7î~94SO򬻕1(1J/8ެg,d՜RcǏfi<^e)P73ϳh<%+gd3K_X]{Knygg\nmgI|՟Ɗwj3v4\%2lSeg{n~xS )Xn +~;W_IIljfC0}u~fۊ{f> oG^W)C"Gܛ?ު/-vdWbL㌜dT'm1I uc,D -t;qYGcF1Yƭ*ͱX-O v~@gv3K&_%Wd9{b/qc\%_\3X?wG oL7RӺ+8*1=W"#{_ [?cHoV\g͘cyF$Ї%9|IݒO`ߑ 8 VV_+!s6%R*'(J`hkDǮp X2sQ1@9lec!Ϊ[e)63IOUUffcߊLj%AƔ@DdqfUq2۩l=~j?tU27tM]>:?7]T1RdV@X;愔1F$(l }k wVo=_J;ǧt@|Y2b"?b%ye()y)ڎ|~4Z;KINߺr>Ԙ;ꕠnHX9A sC0opм'$Jx;:&= Òcz{ec͊\) 2>HCI ` ^o +eFyS nY,*N~3c`9b%R%]2:1`d}g$zd'c'Oj jۥ_fE\mr({k:K,[_žz)&w&csRcbxi@P ⵤg$!GDH3 s)ʩg},2`guy$e[+i$HE5W9}mz×*ˤLBQLYE+4=bfk휃CzHxEw 4yG*ppݸzSL^ E̘f{ҪbA4~i38E[?J_I>%ֲW9r=non> 6rݯ";ɱq)Ƿ{5<;˙}+d ǽ!;!f{צsFݕlq-&J6 iL:[q?w(_0۬o-Kgdqnj3N]$1`VX9WOJ^>G~xXE?7H= vtL^nL kf^n }Eɝ9 ܑÎ6nzD[/\1WdElI(xkJ 5<7I` _H Ⱥ=8,Ix,D[$G%zMeI)vI7 ]рADg d~|Ds.# cX/zո}j[g䇺 ;O䰲$x흠|㙿Lc]r/qNa<`7wJG$3$)7.LϞ hm<#J$NH%';O Ò8C. \c\> |d lJs|{vtcȀ:R.ga( UJr|;CɀrE]9,>ySc>iY;^MSMwsPF9i/qr- Se$v۲O3$[K𾖷pel>˨ēsSke`Ur@8ˎ]m+î|># sf.3gf(1N5#$`fH(mƪ2,3 xqJ>H0~W͚Y:_s9ǬoxeQ6K`|#MfK-|v8[{ldw6jmBy+9/ 9Enշ˳^o~s=+G{}tb4W+,輺Ye+H/.5FQ*.ψT^Υ~1''$,syC[ׂK][ Q3n%rv!:JpF6~uuK@s3fVV-S4fՇ9m# E0cKLf`!tIqn@Nz>7Vvh{ 9D{ Rlrv+ ?>g؊AfcKN(m r'iVUs=i]>.`-.%`w\lEGCQ5\uY_[ytO%s֊g73.HᛙF[jY{z tXgp2Fǫ]fbO_a˛%3䣔M:_M$%Eңd>/ݬΛ-"-3dϲuW+[iϴ+ھհ29C;wXc)5)>.=Ǭf8$$/%ҹɄ>g(`~7˫+K<`G>&Ä fk?+HO@%`8s$ydN$I*`]OԖ?FX&8\s4ao =O3QNN|M6pi ԇ8[.LI3L0 }Į*>ǜc9hՓ㢞 g`3S^Y3cx 츺Y}asKci>Ynl 8-s3`t\%a76|}I3kٿ:^2>Mn)4à) 9y}`A ]3`W_F-m3F#P2thC4 cu Ž873vrθ/fNp.,;L z%϶ <|KJND4:)1vq4=ȩ0;Ɓ![m 제A  vz}7}orZ蓜l&6$яYVz*grO ؍쾱QlYgL1k0='v\{Ι$N_ͯĻ_%`7VB3*W[;E4ve)S%`Nn셕L3?+Pp} .qi>gٽo6γcC1[lc̀ݻC4 j= 79>' 7:d#KS[73tΩ;gP_j I'۟dT"frqNlvY K=䊽ȃ/cSzǀ;s,3Ζ?NƧ$'W%`s t˷ON\mp?S==VӑRKJAU[,63} `%+Ȕg>OW #{:vq:9R3瀙XW߸󒟅xZup)07BR¶Q/o82`5Њ mGW³DKS9 Ͱ v(`#oxD27㍿ /F[t؜[=(&w˥h֡V0/I<~{]j]7&`:I%#fHy.Pc" N4o-z+,so%V $[ѐ~,`ƽkѤ ؋1Yc}A'㘪zRs /m9(%ߞ'J,_Ң/k?6 -vh"] JMy#$*맞_TD &%i뎉'VZ]i|=CYyQ.'po2bq1J+oUG&^h]r0diXa\ *En_xyw^k{6`[92J9̀/}`xxuNKg>s=I`wCyUZm SgsyMꞳFޑV/&VKп^[i.k=_+lpƌ!V;HSƉ NJL{2*ϮA^-V[~̖fs?2I'Dd0]aIZ_nv律ƞy|eEHw}%X) Hz96]޴nR`lY٧3SgP_`liUH}V.x^…_ [VT1{ JZ[ǀ^IrqwU2[':ad*Gng?ڝ1K⍷|,=)om̗s2ut1Ʀ/.~wȮ٢k֟4`)x3ipF1X| @z;tA;o`{<,=o ȃ%)9!y+o~??WKxٌ Uloǀ]_?X/??w|VιO{tGvm>e q3~ |bFaYEMU4;g J|?&`'{óOl&{J|qlmV*۩$Pw+?mwXտ۫l5T' Hr:'d M骳F6:`șn윶Wft8޵3maoF?Gi*=,\? 3<AEʕmƃ{AUuޫ|MV9~Ͼ,9ǸN hN+^ ~t9ns~Tƥ>t,K:=&`*AWK}'Y}xƲg5,bxKg2ؾ߉I3>xVpɞ?|&_%8p݇>̴blzNJcIeR.i7li5`32a` ڛb5իY8˒3s\V911v|-=Nps}\vNJA7=aVH`o +^+/Mrg?}oqkIy~XS6f}#::9qnִ3U@u~CJӕV>Y.#+rV>0`ruZȧ2}4CS[9j@F%W5[.Kyw{qxIX{}lѫ| ;'nU-5ck?)#ۮc{.oI4<}L$uܛ|؉;3)>J$|yJK(NoFV뇦N$ 2Utix?xg{: |l[LoQY0 W/$=_ p yiز2JKȕ BEݶ;VoLn8K-ї T=YY+"6[Ӽk2KN~dΓˮc翓yHة-D* V!jLߚ%k~>XJհ4'a]f]jճүı8ǘϜ<>`Q”7]_iVvJxY`EG& _D1?:2˽%ST)&Y\'X̀a>o>% +H#YMGO AM` KƉ1c=߫VIQDw!_G&%}7Re5 ۙLULRD/~ :?E]?FwX&Pc"o&蟎_o/͜/D_9 ?U~\ǀマ+`+L[6/!$|?aꄮE2`)1AqrҠLex8HF ($~4Jβxj-$ =AV콕1AwORם\gԃb*-I=K0v{=M"gF$'O|s'`gH^iTRX #(ni!%'`Yk@τ5< *ƖgȆ\fbl1ceB ϵ3Dx}5֜iT1o|F1 f6K8L:s8Wp=X>b'qƥڄ"YYo:[U`ij~hqB-ҹ]j{}E\,ֿ o_}A?-fd+ k9R"ale:Yȫz ~83o*(k}Ɲg$,K$erǤU[X@;`L;~,[yVs#~VI~2`U/ '!p?#KLI7p;y2b! ,rauPXϺ9WD\KzW$fՌE2M9u㌳.LӗaՁllpwz78iϽh'Kl/1uc,v-},pnۻ x)`YT[>ʮ7ܰ¾=Ƌ̿泄G{T70)fqΔ+f\rvLsq=k)xkʞ1o eK2ԯۺ|L״[ 64=?y~gWuT~9GS'iTn8,e2UVx5-eiv{j#~ks᡾.zjS$yUX@yc>mtWd/#2s:ֲ1o p){ލ=)KpJ%x&甁w?"A<ڧw='ݫϊ^?s_w6y7ιDZzC𮣭i=Y,7ӯN{WT럺k;_Ek_#>qmq}n ; t-rhU@ V jU3$ r_zt):=ڄ{/5yQX!|wHt̳x[CpN_N`4_˺ǎ/\-\}]H~Wjsx^ٷ*kګN2'2MI|_z͹2stkxG5SwG}G %d(7)`?9ᚄu4I 7%ܛpc6 ~ %xֲvK9wl<}~Ь ͮId#e{-LQHBvPr ")6Jc/iTw{o໔v(ؕڨg&U ũ ^Qf1\,X\ύv6Dmfs 6|>*cvЦ 7~rdvx%=Dz:֢> Ȝ%y_&x (.5/F>>Ϩ+X͸K&&恧ձӱʶ+ݶ1ǹʹȗ;<k^tOՎobxsO~GC Wn{qGQxflmkճ?]]Gp #/9HeԡzOXIhgNl;7ZM; ?o1YY1F?#K2>Z2|.1 x٧xZ?5\V O ح[u}>ZF~Y6Ry6_& k%#GjYD^1IpiUkѴ܁0l-_c )uGhY{j)|mcyM26}󤍠XіߏjY+=g^89F)(uӺ V3veYo1F%` b\JK-ϊl,C?q@YPj ͷDrIƷBlJRuW*+V&̠G,DmB@ʎ'{.#GkʌAg @3_bɳo;q)EoFV߶x:۪lmfm@/~͢9^ @|c]Z㈜TΗ wQL; #`5@)ľlRǬw2˶'0q |鱏佩>C>[e'$Iq-0e'LJ@W+nV IP[[yxZ=x-/)+~ OPBa[o>~I:m$WdD>.DE M靝1HJjY}I@W5Y|~VN@k~~I2wQ=|Y{ ػ(E=@WA]"`_VD@ .J/+"`@ U{@ *R@ˊ@ tDE[Ak{ ҡ؟,@ bߠ?EE!<1$ZK :S?B~~7ej/7^CE@Ku?W=ckU =d IB+ N;ᣪ>]},7Ҟ)`?{y˲@ :iWduQU^8nwmԣߐ[n;{b)|ipo 袷2n=ܒC>FTٮ>5?lރaG\^rOGǒu @ 2zwVU Yu7dTi2bTkp[uaWpuOYwE@`bӟ8渚TҖ03SHun)@ 0!q/o\x}U[۩yVᣪueo~3t?I@ڪmGWmNFzz Lt uRuȰCs;= }g۴Mv!#9xX~FUCGԲ.@ GR~xի=;pзR|TӾ},t`a$'n~~~@DGo8nޮ0޽t= ۲G8p oK }cTtwvw%(5lk^޶mv4kmg\@ 0!O޶7ݒ.B=c9~[߁wࣁ@ @ p{uO1X=ǻrȴaZP׾ֽߐ]8 z^FTUqzuW7_TuU'@  ۯ|.`OVwO5l U69`-+RC:( B#˒p)Psr|ou=0)R~e/tBWmh*"u=>K*dZ]*#_O]wQ[=w篫cO8V:-OJ|U@e߬{F'zߤwVM|w*Y_K_|^4Ύ}YY`>K'TM HҾxox Lj%/7PMk>-:z%hqy毴Y!NџwQؽߪn [>ӄv3\OS2Տ7ܱWxϤƋ|ݱղCAT/ۖM᭹եܙ1>oCȨ('³屷Ԗ=}׫آ76ڴdٛʘP9袓ԯn8ﱱʵ/3!/)2?e5ܸ9/<DZu:t6ԺՃ׽V}uٯx~!?MzL= @F=ZqժGo|HcteM"ut)դ%;lw{הߵ!{; v[m6Y[߻.WqU؉b۰9Y>ح}?ƻx極]>޷\ϰ-8".ҷòѱc,a8ܷɱҳ󳦳"/?&r/U{3/ҳX9<.7y[|o|=zyyߘsgZu3lsW;ot __:6w2jln8ќ43Ҝ9gE70f6۫c1ZN5xZ:V^)x$v,:V~^Zli֑hW5GTØ{8nNV y}}k^2RӇ\vANz39Qqec-|o)c/W=}}z*U}`t =+9ק̼ԻF%6gsx/Mt,ߚ~Oɥ\Ү̫1}%H_n镓(<wC$;;rjiρJl:tn6{5\-ݫ Ñ}Ou2򖋟C]V?ϙPR?Nyq?;ZA}ٱg9e{Xp,[/ݎn=Z1aGx37!Llg~%xqcI~L? TS~,6庥:)[u8ϵdF{?~VاMXJAJ ;1 he0}ހ"CK>ow_4S0ߜH2מPV9!,|ҟ_luf^2(=wrpȦ~3T'O_\'XˌAgRihkvC^[dn%Pw2H\k9yi=u٪اzW|:rc K쏺?Jpo}"IE~eqYJ{{iK|L2YΖg'%ey:Mͱ`á><[gcNN[yt^ ΕեȀg1hK=_OS~ I6O.[Y3"ާߌEB]9|O׽SܓyuzXRv㧝zϾXm▋NjGNF| /ķx^zTO,ɸ{AQ>;R-EVnw)p'ԩ8~Ϛ#s6u{\=+cCﺶ}Y(:egXy yA^z_;.KGs}z~omSnɼf-2y6̗MqxqQtxfY&l:V+/V;=gswsvnoڟg'?c .Impryޯ]c,{ o>sqƻ*''_`r2O4oQ=XlgklO:tNuUsXd-(q} N/ݔzc*}OV=5ǮGUR@|sA>\3 ;Ⱥ$z6o-0§;" Li9:1̙IwGd{̒+fޯik`Q_b|'!;%ڻrÝ{ɀ%Jv(!)R^:`~Ok}Cz۰|2 {>,:§Z0Ұrΰ맾J[,Ҍ۶Q19զ>Bsɯgܻ唌M~O6<K,2ï7FX[x2zfrmnY2uzr-bFSZt%,YNC ɺeC&YA.F|E4/2ѹ겹،2ُVܳSĹm97G¨'ŹǑA-Œ1몰w۶/?0<d% M}L5 0#`)_<_eY-߬7H=o4SU4 y)gs]5Y*ǸN̞eo$kõ̳UGŌ3 $ tD>Ք&bA~l55~AV` =-Po<ƣݷ)`~%3M3t M/l9$<1&s߈13k;%`'KY}N qdO<_g:Qz3)q+ zojMvO>.XT:ܷ?Kr>"NU:,d9\{_3^O? v6d/rRG繻ړޒAvB˶$涖cO7R[VC?]%c0Gc;Atg4z_`ןJwa瀘$OYqf=I{X52='BwcБ| حR﬘\"w{;aԗ L=u%ALX١,&52{faQuK<4{MwɷKN#e)ITG~qVqߒ}(X.2&l$c;d3a'%}NӯTrcW{lW ߹S<EejDߓ2_lGg~w\CGc>SeɼGc4eW{KN狟?`B4ԋO](l›?#i(yj, x 3 ~;Aq" G5͐'ẄKzB!G%vS‘ M(m ['\0,IQBy6)A].rhqb)8X(aAŔSN~_ae)䘘 N-+0ad9PF;&g/W9`̠V\$$ͨ \@8ƩvN#EEeI<ﲌw93jA=zggO1`8./#b2`,SmgTdu˿f3gv0WNѨ@俟'{+⪏>1+ 0dg Y9ʹ6)[{& ardwd)KfM&3@ {:^>Wnj1-;eBsyY 'P}9JΒdy^ wx(c\;.2sC:wۦ{pF-Y}rȩMBc)0! :&p26/Nd8M@jӪ6^K;B9ڳy fgq<ԩyݘ vx3g6-;[k޾v䐳3$j=|z}gAG}L#>=k)g<*d#tGN Lu"dU]y;_XU{&TYcI0Ct%y,:J"Ǯ  }ǀ]?2D>c5(~ch%DQV3l^[d/1GN7H(Y%.8 aWQ a 7-Tu^ꦩρ(Eb}v̲nįK^WqonҗdGQmrI]^AβBOH,+ˢg?.`^vݹ38KvʤBG'ۭ]ʹ8{3l$a%Oz Z+XާR=n՟ r%_PA6>7̈Eȏ:m;#a϶̱D-ﰿԷƋ%#⃲ǢKБw陂:{>ܱ+%ǰ+۰/:=0ܲq?{b$$9Ķj?7Kme=ٍO<~ oZɿG}l{=Ηۊ|GcG+l1ڧ?|Ylc#| o&9^,O4 4`>Ӗ}:L푠͏$? /&X2fNx =N{җ2klH0ڷjG_x*e.W Уdcbƈ!?hyPj{z58ag g *_צ +$EPe0y_ЧH xr&ղc=90r4ڳ+p7g74_*?eWCfvߝNE}1^kq>'|`-O%s:wIa(o7)LFlT=~\n"e`8x^h:N$U, tMR2xxgA\!QΨx1`KYEE_-dv8%h(F .O=Q ȆƀNx2Ԓ!x/;f66r`cvNWTqvZͰ3~9.`g\c22y~2K0r]ZYR=B ;QgLިd.X2=42Hdo.peA"#{8^jG3`}]A9!46HrN~Sp^nӵg=e|YK>ft;GKvɷ`L0cyg Ur $yS?}fV<3C R>%E<ҿ9`H'`ϳt mnY7ecnDD 6>{&"o$ǸYV7^g뜘Gvp`qVqNȱ1K%h'I%u^^hO-;)(ь3I' P/#V@p`,rƘic l_6LWy{`W$,xsj%O) yi: m13eW+<~mm;jY}$o-3d׮ S U}{ ̼0ɉ[/y&ze&EOdڷ'd{*Ժn͒G Uk%Q3u 敫E1=odʎ{$֓!伏bd3=BzklT}3>3ws|L LNx'zG2΄~ `) Lp}Tv '>Apf¬ ]Ȁ]йs9/0 v e $C13b̂e3ao^g(l쒂n=fa=:+x ʔx1g-A$kwJAdY2$--u^ /}>/d(ڗ[ -/3ΌtAV' ˊ +oUB 3[}*;_Εa+`ڀ]Yu!/EQ2y6TnmИ0 iY^ӏ 9`Abf\{,U#B3dqk2rj)J+kCWccCh pNOsƉmirqE<ƿ>\j{o^o|ouY!3ԛH\uY?KŜ]mc_ƥdַ Ƶ$xx;9_?ʨ@q'S(hƕޑs}r{9C/mO{9l`(8c/u/B` "(`xRb>3V2`ZLiSҏzƇw,g}d6߸e*; r_W>U/7ݸ8Ϻ6&ӷdUI>;gmS|SA]*'X+C`~\n@L;OOA:̱/3Yl›oy&&7v+1=_VI2|$P$?0JƼeo>E=+ jMtqc}m/\bI"T| GbI䎏+mɘ9~Dmsf~-O߼W"rr<'n5k+PI=ɧvl:EƛvCUݤѷ3e\u<v 'c<7;$`fѲurgTSM5ހ]Io|ofEN.ܣl3;/ 9eRo+R":,7('_yYcT?O9ɘr)I|hRi/Q7eC(\ϗ'@rOxs /J_tҭ9P4)_(ڎ|pؔg% !<Ͱ1 ̺Q0<0Jʾ&{9xl99xT`о~6gs Iwꀤȼ5JMpY"\РX]t_ ABM <}M¡' ʲ;UW@3>R!XA~ƑwJ,@ԏ430xiJEz?;@ r,Q&(&NYEN?t_Ѧ!ku_ݢb,=]iXL1 /2q՝,`%a6H[J X;Kd>1N$N}[ M|0Ɉ ׇȀ Q`bvs{XmyK퓥#-1uy E}1o2qϦmǧ xVfБk_}idQTOc8H VKIRZ`,/>ȄW^i.4ݯV"xlG&'_PvBv-g~0c[%sK7clcN=O,yc}( 6I?$ KHmN%O6*o8+!"1|ᯐ1 =MKh]}?#;d@KO m<&os:2ley՛'?5YE)†t,o ΛrSA?N&/ wl5y+jR|u {M$pK^e[N WGŹ^)$ԕ91F{[Nޜ'|.*柑r(AC7;V p˪Av!l1.뭾y~ E6 1s*V*O.rvϿ.>>!7R'~$r_}kf:V[t&V+/$%J(N'Mѫ%$r@RNf.:d KOҗ}$`OJ}{v  |+[Iƿ|ЕL7IYEW>kU$?b]s>`QS?-u|ln|4EwVi\eBv{3m&|Ӊq߆oRݖ}ހ-|̂t()ԗs cM@;$g>r[SYElPJrd)TμHBJ0b`{ZP)3)}۠ͳ[wt8mf)"u1S{і4`x뭾E?δEaQa J%r_ !@(Q)OW'Lfo8 :[8o,߭d$}k u%xx*ZʫUv~$83PFi_0% L0]\_sR8 뭱E;#: 3G 9', m! K)@nozY!`z}ֹْ*('4^Ԝwxr%L6+Ybi鱾Ɨɇ/U0Pƞzs9faK VFeB^_}͸WƇxosI05f{Щ%H~Ә,_ $ی'3|Ӌʌg>71Bo!\]W ȅwT䐲9flcl|1e|I.ЇfK6?nKz| P />$NBvrIⅺxG[7ƀq^dKHPBOvёs/8X\[w/X%-[MEVhSyeG&YѺ>$sn&{`F- $oxqW忒~=$q{$(]^`\Xe>"SE'-e&7)t|ׯm[%Z\A8 n XO=,K6> zB3$&1A Oo[T=l %xxAo}ug/(/Zm5eܓ3+}$do|X?eto^dFm9SDL]_rcdߓ 0d/ʖ'[xt'ܚ'lāLjT"BW ߍCeVlU;ƾwcqd*\/q@.ZFI7c7^m'Mfٿxv&,OlWOȞu6N"L1aN+ø&7F|x" ɺC|c`૳ǒ7'6|hD h $ܒuSڏ̰ ?0}WOOi9=G7`g,á;׼@7l凾<|쯌mY&pKqTƈ# l  &@qv(ѳ[IAp0(_=Q6c}SڮS*pYZ+yMNΩWqrz5U(F1c}^vs"S,@{}sRsvgt]S,=+wM]SϹ[ʻrY9m<1I㏺{}$L{̥v8f|O_ :~oK&p2qyWGGs]xSdB߸Ol9kW9brNN"Cԁ\ 8Im B,娏),&saʲ|M><3mor[F} c+L}f9ԟ J ΍rE]kѳڪZϐǭ 3OF;r ǶxpV^^Nu%w]]_u5yr^dV?y{zsTC/ϳël9#2vodQ9KY.pZ:f+[B>gf6hf1䶤:Vs_d\iuPu(2Nge^g|r\ɓ%"l{Eyoꮮ3B6ֿQf^3~Aֳ=YyYͶ+8ˮgDmײoB >_.G=njOb0oJE6D]J9K:z³qLm(cս 2U-R,y/ e]];{%}@N d~3! 4ȇgWa]2R=ѫ3Z=fɊI E'RK{ߧ59/4yW^+>fk_q t n/oS`Vغ==w=veNB&^GO#0tv?{V({9*%_B/XAM>U%=+u^?_~!X 7}Ohk64$l9|S2.$=f*vM*vܽtDW#:^Mx{S2ȆȜaH 'V]I7.f&$#u_!`/Ap':ҹ %/x*a{~7&q&;StK't=7i uoRdܲ0 t_=:B\фs* #)ʪ Pq]oU]< Sֱ̓ӎWWu\rr[]$pukB{K ?qXpqgٵYrv硌Ϣq,g1g38v(EM!r^9`fEbˬ1̖븠J=#?T^9nTp~le}}i]n-#}iu0zzOR':ڱu :}32]TPmmqpLmdwg1_[!rGcOQM_Ę>aA2 [@, [;)41!s/-Z,ü&$`"A"`~={Sg*̶eLA12(|̘%fC fzhGCmM)[lc_V]l||MӸVA}DE)@ \ f(9՟dY} 0) (V: $\SwQ=@ :7"`{ @ tnDE)@ @ ܈R@ @ й{@ @s#.J@ @X{AP@ @ й!V;o{=c{HU^=@ :!j\r;]9d.LNAmՍ>Q={/[ G @ &WY:Ғ&o邾ԽmzQw܅ wp@ @`[GQVo\Wa!sA]0XaX=xkw@ @`;?nux1[Cnズ nk[O6y]WX=篫Rm@ @ |Ŭ~~Î W}= Jt?pW{ mٛθoy0@ V;?vW>_uU!#CڪK8ӳ=C^}y)'_QzU W@ @`ꔓ<嘬ǀ!U~CN޽m-d [' ]=}eCWC^C@ @`Ǡ!Usаr㾇 \=N oި[߁?tP @ &;a {F{X4h򶶶@ @ L lSk: 1p^kp~dC> @ !8ڶٳô}{0 UC?~ հ#@ @ 0!0ꎛ'Փ^=@ @ xr vT#<%fë>CG}-+R3lDuАY8z/z'}/@ @ |X]UA+<=| JԭACGUBWY7} @ &~96'ރGTZ8t0.+PGszYxC/_gKa @ ćz^u;޽{}թ{A6:2Y@ ΃w^SS~b݁o}թ[AV|#{?[K @ /›^Cڪn}}թCs/?R8@ @ 0=qOw3}= *S~scE@ yuH ػ~})@ @ {9`??u8p.L@ @F3`o#`"{ @ tnDE)@ @ ܈R@ @ й{@ @s#.J@ @F]"`@ ΍ػ(E@ wQ=@ :7"`ez17]~IUo7]_s[7q_^_:Ÿ&\_27_/q򼌏q/V׺ ~z~ex7`|V׾Ojur_9Hy&Ll'gMto^lWIch%[IGu< d貂|9r}ʗOxmyYbZ:Tlbkxb\[OsslyGoW8ïsə7Tls_bתU]}hobBIR([ocu9Tƺ3~g _WQ}0O F?gvZ]$ /?AWoMտW[N45 ?4V;9//yJr$^V_ti,-눬_8\NEOՎ餗{z[Z]kuɣW>j]ߧz*w5Axno=7b3 /&>s-6ޮǻT~]ӏU &:d:aՀ#.iuM}I~IMcO/wܯ:ԫ?bHluB2lþIG;^޻v.:d#;?oE uSާC^}YZ], =$m{/[ܧ۠jf9{܋?&萎|1'LUrI_思3}˕U+.J W3ysjU=q m,PqC5ՔS@3wS 3J^x9xWt5ӌ3U= A36QO>\sS;բ Zz< Ts6Wr0 ẋobA]ۮzzg j]{TO>cC8ՠ)ѻZ#@ژao՟Ѿ*o?ϰ{ɪdzյIJ߫;۷,оҰՏJ|ϱ;_;tՋܐăU:)',xչ'۱Ƨο=ݷjl><ىڸ|mS:.mL>uմN_9']QqՔ_sn^|n\=ճI@[dj%~GȮՔIrje}'I_/S:cgpY $]6_l.{i#rr>_z~t-ؔ"+ y)&vz >6K5(Oyz^|ޡ˹&F۩EۂoW91ԣ/l[!B&(uFuT).ֺ~Կ6g+yO[շ3&B~|{5մgsNX܉DS'e> %t *N;]mU9pؠ331PqD(yuŹzF5dS$ٙGI~ FMuyY1wg^y=$%~uvOQPfll|ح0Q;^Lt[>Ӿ*:)麄2;(7|5=<{rT%VM7Xg\_P\}᝙oR%ӬvzWjnVwصlS:Ƴu p{3ܛҖr|EwYWm-/p8)` ̕/\=yϒvlӦ|;UǟVYqj\)9ImJkUNNBz%oYGy1ē߾믎fLd*8kgȩ{Je|o ԹsI}n#J͗1Fk25mr,`GJA]lgݼZs{[%K}wݔa/Nz`֛~zϝ.ެͳc .Pb[D`Ͳ#~|-xEMzH?_zs÷at2̒k=U*G=C=e\vZ6S 4~*类^{fa\!Z]fp=׌!Ǐ<_W.q3cȷ>4vT泮 fo; \s{V|tɌW~J+7I,p²+~au5ف^{M& wdf9uɸs}ڢ%lG|-$?H 5R'ݘ ޛy:Yڅgo:wƝmŞ7%}X|ӸT{=:Uߖ;ZkʕS;ʕI<ڢr2z!;mGe5ϼ{?~U !SXxkz ;:IHq{ɇKe1{^uMzv;>cmSJ;% }7]vCy.3Oٺ-GJ+^*?S[,(ߛxPd^]I7{VP9\mx༿彠nezG90MHtErJ>C$ir}i'4G 'Xf&K(^LX#ЄKP}U3O{r < z)):(gKnr͚q(S\f^va3+)#+rpImNYQ.]s|"Y,q(ȳO,ٺ^}Wl_llBhyswJRz_挺qsXn0~><[99~+e\ʶ<~i RHK\WlFFXoCr9nʠ2ükz:_rեZ6[&)j~wSYhK\b3vNˌB .߿yV 5ٞ[VM34՜m-Of]YwUk}ЂP'|:8g H01RʖMqrdA?3,({K.r}F.Yg-g@g쫭v7<6ɠ[me1;&GӮMIg_yjmD~sr]s;ۖ2\rEgi$Cwɱu~U7lV ߚwyj mbW[n}׷g.ƛ ϭvNi^W;H':cy2jT qm5 쓮I]jernP$LJ=,wK.tg$OccW?vvP=,4raoK-Zm\71u:&1۬l 8HSn!.#|ܡg:3iNG?d8؋wv1t 9VH7p9yeu7I5ww:/;;뭹qrQ:89 6p|}`I//uۣwv$$Mp/X=etTo 7ԙ琒e1Bf^jlV|i3`'iL-k4&V\nj:K$h  ɹ֯(| 2$.:\_AG <:77=k~m/f9g,+dU3K-~,ΡCȾAӭʰ سh>Gƹ./&K9y}5v'7jVHMdtwOz~4nHnBzֱ?:&RLO'A݄B'3ᙄМ '&)\GB$8DK L$ Lkß-Rv 6bww؊ 134X(*&' "bPJItww̬̆ Ou]5~Z{} 9B9~L_ Kyɏ}}- ϭubG.Xԁ,D#:92qf`/P}1N _N ,tD%X\XTc`@(q  /a!ZF,v)6X*fyҁO42SV%dAr[(/:ٽi>zv/lo ):2$ %Lݣ`ۦ@4xov۔IJceC>^Zd{L#ݷs %CiO'hB]8iS€^Gס"tA"aPaOXY8i-昐8p:eE`, Mt%7(8"Q6yLy6U;ڢe ۰ǘf"dKM1ak.ƪ¸.Y<2͛ƭ[\< ;pwv [So?coǨ[(c`sd8p@Їּ3V ~c1^KnQzGkU)/i&Gx;AAuJL~7\x勅*VN4J |F.00Pj)5#llaW ;:5^9&W\|,ʖ\))'zS,z:ꅺc:S }Nh=[G)Ga7x ֟_hta5}+𢢌(XiO#[3$sW)T#;MZ=7D1 3d3; S$ s;V}31WCCssꉹWHig01~F;Q~j1Gh3L0_(S(@)GH;I~x>o%(LvWA~P4Alѱ%rM\4\?kjPSVvX@aM>PJQ'X%Ώ; #ϹH.QRpބ3W2pL]L) K>:e1sh8`pxOy rQh?HՔtͻ}ލ8apfzP\25ø{C_oc}~QA|^-F`a 7(']UJgxkF*VHp๲\O' L0 g ҡ,E4 @SB^хU,DlQP Q&^5@`) 6,zLLNGc 1p@赧g™O촓Dܹ4~H7^&lV&EJ!]ė%>`GgB;AYz:vM`ƠO>(UgE')cuK}uH4}+QOڂ O?Z HBI8O,tW E@">Z^&[ #}Xo:ME\a_vX]tq4zzLWHM9$?m`RF3dHDD^zd$xm7k]y%Xn(?qs79n\%oسOz aga5!Nر-x~蠞kܗ^x)./LYQv`Nc2=uF>;3}$#Oo,( yE(>!RG9x_xOY4PY49}י%{ͻBy!Os[ܾk iĂ<=sc قC y7"Ķ4Rb6rQ$@) o>܅u6|lQ(a;1±M/ꈱ# x7y3꒰'FLlHg!03|d<\ /wm`on$Hսr[;rS׿R~ {>UWQ̫\P{:. y^3ę3N؃Kqd?ŘF^( $4Ny NCa aaBs*n;bQ|!;B}޼,XDy&|][\θI#.Xe_~Gxg ; W"d)hgڌ3'Kx3`eB6xq˸̂z4ҨvV@[,ny?"(i8,hSBamQX+ +ic5gLVoǛɧor>.fƤ^_ ,9j##x¸I>;qD# WuIr~ d"NO?߱Ax 012'q䍱GJ>mnZ>c/c1 s[8Ж-Y,OSX1|Ȼ IC8ۓwC\CB@wb%mlc&Nر$$v޹SN:M]3/ZuVE-/c (dLo<3&3ޓʇwu }>}P.Xb fdna B?;Hζv&c0i3ڎ%#3ehNYg?{'#PJq+ ޶x_yd1?˻6Q6xo ٬Ct緝.r#^ꐲw̳3ɨ_x¡dgqbon&X7+/|u,MٿA G+)&(f+3ą~pFsBQ"ɢA&,ʘ =SyVĝbxay ;xn4W8ag2BȀ,,=dEaga  Âɍ8 ,By· d` OLY ~ɞaoneOi]0=.ζɟEXbc pK7={BK EՔ:Ir;Sb(qeya0fcM'b(oV_&",#΂\ִX`0^"+"h׏ sy!꼡4f@`dH9pOF {¾A>k`³¸Q;<% ZF!v&Wͤ ĽE6ZZLZn@ۄwUaYdC>[c.%ɼW;9¨?,uMgw?gYSA"]tdCYi?jaLTw3/Ծ̢1UKfm!Ai74>X ;(}rC*ў2 6BIwp#4:QW`3vvC#icn19۶/agžX_-m!g`%z Xt6L,| 0FZ(P솈@vR2Փ=H?yq'/s-փ<gȽ?h+;C2ޥm!^?D(_XlϘ=N2N_>{X/m)jhDaDҾXSݢe!iAnyS 6~M8£Tb<)4| {l<; n1^cFGK<8_q.Dߑ*45[35q JlGΣ(Ph2Na7mC~Z^I{"#~rXN{s.X[Ў;}lX93K׭]p`Zcl|Z~F]fag̦+c "F[HsѶTXwp ev[Oj]5=G%ބL؋(~S"ΞvV@S@cS>{bn A 1' Tk%, QagÀ-32@tYT5wy?0DE,Jx8NLz,dP@0-i`jk" |RG~).,R35$#/2BƢs;hVy~gvHPJ%Q>O= ]fe: j6:&h3y+ qmb,&#O&6QqSׯ)AA@KB@qCO-< m8±_;Fz'aB?ۃuC7#<'u2L_ox'xXLV,2*@]ClXe!nw$:S½kU#<ۨnYWBg ;vǘ'XGxwxَ-ڐrR79.'[ g "N ڇE1^U=X KqPlYNc}ӔZx]g aR[ie7pc[4va#ƔAjٲ8 p}`;ٖڷj(< :^L|,8t xca f#hkꀎՖ )Yg ;P9\Bh9x8\]xz=z,,q  `w.l8T@C]qh už:gboV﯇b6cQM7` My-~O3drX &+^,>8 k5g.,n1e!<‚@6!0bMЬa?s+vꆉSW2 @.|[Xz{;ڙ=ipW>#8 eJtp[!"!vâ>a7L^O{V +KxP@YHܙ}?~b̵ {K>57rbf ÁuΟi)>2Y$3q1BcA-‹ 7U ,~WAhYQF眜vTR(B^E^'+#_[d~@yo86 oⲰd,Tz ʂ79XX^' kHt# @y1%{[K=څE?ĖbJtmiru@|{w?e GJH\sM%.Qq%텢6FIWA ,`L8ݼF瞨`};'q(Po <$|?bTac 3w; EC?aJ}ŋ/gܛYا} '] ^Ҽ;o҆s/Oe$ghx/3AX]9 kTeS&p-}ow7_}9sX{S }ORWI[.: ݧ,(X,PҰEdBW֓>mxg 锓w%'!<;G)3D^xQPV_6j;3 U% <"v@;JA}3ϠTa@Ag{7Voڌr=ҠYt*~SNAuceJ){i2Ga[4v3aǪRAcA˹ A+*LG.TXQo,C'K}xvZq_Ʉc6acf n^1BE*~c{ Ǜ ]80rX,&!,`Zꂀb^' (ΐلM0#.Fi"UXfEVAg94Ӄo#m3\ i1d ",Uhh! Ke]M%ibCC˳L]`n}=CC" yrA[N܆ bN7`aN}87{hCi#m`mm1D}RhO= ;|cB <K1NyY afbg7Nk[ P 6"D 5 п(LJ&Ŋk1wMڳ6k<>JxgY9P:@B,x3n(\)dECXձ :Sv,c嵾BB]-[?#ʘ{v:OҎl`o-{}b'9fy0+3W2)ʼAQ@_33񌺨fݣ}ē>#^6yK@77u;a,C 9ˌ3ޔ}'s Қ)!}]Ơ۵m8ʄ2z {ә_:<ʄ lGo}5ΰVP~r:c6{؉BECfG{OAl%"]<-M8NPnUj~t\A2x8pc}ɥ`EYŖ3Pw~ΘAAQ.XІ|…ol=b/*hO#{1e&^ȸsc=Q䑾Ϙ/oqHºE ͜9E/m Ͼ/?7B< PQ(Y0à/!䙺cUcxf1;nޅ[5|E NG}`էښqE-.Y603P?裤ioY< _ [ ;q W(*{W((N/Pwq5W +|2˲D1C,I6X'p7ɁISN@DV7 Gw,gghYH$}tf5LwH+M>?4?%{,X>D'4}#粹8g'+?3˳;>?9!60=+ճބ9"ӭ8\$>(##&籷;ǚ<"'-ژ '\P&Z(7Y}ځtWFf\~3sS&Fgb+u ~,@~C]',AqPv)7EMzM9goXB=|,;>y^KuNW {cesZuDvS_P.ځpeCYXs|0 { ~]FYy΂+ Xy!k<@ߴObh q&AT#,xi“Co{CQ[/[͚k*iP<KST^1 y^}r hدGxh{ ҷqI75 16Q/:;uzG'q.RQ}E^BlK`vbx|=B->Aψ ̌'*9y&r>a'x_X>`Y>\'PcYϮ{ڀtYxG">~[1 tԯ[]gGY⏲,dE:(;@㵾=)}h!/-hi;/kVg842콉*`]<~QN$,5-@0scuD]2>2F!<2[ g1kK^g)ϒt/]eg ~7%3ۙhO((JffŽ 7.ɄϬq? QW8z~$I/tK Ak JɞO0;,kpEQwZ@|4ـAIDATde6| >} օQb<7G"(7#=i$# p! vv#pgۆ<h0qFU@31x]n3F{4Q<^@|wLkL?r'AO=PYww&r҃,odm3r'/CԆ!O y φxt&^x  wmɋ1)\ Xسзo}[&xN'$YI„g>3\#׈S18>?xYyU/9%_ [ 1Lb}0>+o<|Hq^='r' #1=r{q7J;?c*,O(=}'gMyY+v!1=<teWzF!O ^ ^N†Fx';q,½0%+ L0rX|f['qlLv{&Ї1wVPǻ-O'ñ-HٿaOng[ t(-Xۻ-:@qcź,e!e3mp5/j;(DP lɈcKJD9 ;. 1wxu8$סvdKl5cld [ĂCD&H毷u7nng/ x!8v P8Vw_S$*V8aϡp8;2~% ?cY9pfAXW(;v㟏iA]2˞o:oR`e ۜ:pHes h/!.܁&X\lR{wEj{Q*i )5?-Y~4%'IJgY1TH>mE*q|#Ƭv8p8.$}Ose%3HRv竤ʦo.9Q^ %5eRf-ˇ-:8p8cK7>ju'+W#=\WK.}H6msR-52Ԫ3זS_>p8p8v!L`+ʧVFFDzj]M\\*UJvkVI^p8p8vUU|:W{]\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\rTvt7ThUF>k)p8p8b媧)A: -[Vl%FS)5jO.W#C@J:p8؃0nV3#KYjKNz[FzFR)4}`iip8p8v;cIW6Vf)2ʦr.9AWW4FFf: gdZYx^p8p8=^%)U4R^{NJZe9ѬBZiYgY4K_/q8p8ƒkeFܛJ*fԓt.jK2e*^ۼMY(c/(WO"e}|WFsV/͒m%?-fFWD5${>m  ӼD;c N˦-qžC I28il)X}zhnP?J=fJREI#X{WEy԰ rW[Zn5#yHA,7yK.] ,K歑kA=|akk?Y$"ݔy߽H!%_#޻+' fT¹IXnmR1ȦVa D }~[7/" gL2aZkEJcqX)/S#UY;عpžC I8ΚXf44;^>hsbp#"Xㄴp|'i͗SN>MJ\pUҾkΕ-_ ĵK7å^2۸o 7N?㠚x| !#a=K߮uv!ʑp8n[ݪI(ZLN;4@2jՓϖghu+2-=PQ-;dE& qAj-.ā>e:i ^3fk ,71/QF CzqUo߀" d~fypo\*adOoE'"o'D5Imo9HgO:Z1 Vmₐc1M9&gnTrg(q"7qEGygt]iﵒ K\ba h_}ͬJ^쌳~P?=74#~KrꩧL_h_,vE- Ku[~ho\ta?=wgJMX$4Ľ*kH.>E'ߡ8c {'#2#ΞC \!7^]Ⱨ#Y주dԪoVfM8Imi$a[&!hA>ﭖ2߰Һ;9ȣgH,|Ѯ0oܓeӳ~6/+׳ʓ+%{Aɳ۳-Z؟R(ʖ >LMk8cr62ޒ톧7fӯOQ6vw[I'- δu#ρZ>cJ$S\9^ʕ(;v7@%xcT;-ǞN%_#GGڦB&֦?o׺̛PL%NX'j]%ɐT`o:f g/[nݬl{'~WˬP"R3eګ7%FKʽS>˜V5JkOL|=k,p&8aϡpT@`vD9ed8dlO|%ߓOSyY MĬR∧g*s:C<&Ck2rZ'[-\94OjUjZXRR c}͛]tSoA E gnָRc%=(/cmo-W\~u>+?A<@S\X=hgO[*R?+Wdنb]F"rls޹mOz*B՛t@MUZ_GL?i R>Cq}Wn/Vܹsː7r-w 'mIBM/ \/~x yWtꔼ~?|hxqS9 / `ua.~R₋%%cگVN<:P*RjkbzИl 5V~G|x;'iߘ1yc7 {'#B#fyn ˡ_J&RF`ay\Ê 9JL(qco#8\Z"]icvI?_|f)>-mɓGv%|a \7rCru\}w~I e{Wh t>[gOӸ!3&-4XpPPF|ŗ/L,;%:eEq@9~>::/W?'G_0LZ囫rmB@QLu u^ K\l ~҉'KrUbW6w믽Q_n>|VߜE_NZ.B^+[PfCypک/CKԶ:"Ns 䌢gZW^%G7v64:}CZbvp8'9T; pJ| /Cl0- vC$e2Y~ҥsO)X|۩Yay5 :#Mt|Yy2[Џ:·i~ aŞk[ !J~5:3|bN0+ӥJ[1+>rŽ5["gH/rêV\0+vK}6-b R->5e5#C =y _hxIѳZgwAROZtw$(H8\nҭe&[`sTd ‚w1k< 26yͨ'Sw~(~^%h]Y}k^idjpNF'-g 55ˋO;(NGNvN;] :J[-F'~in#jAS-.ȊX3#UJF\hNgK[#GnvB)+'#x.p&0:aρpT@@ 7()+^;{}sk>3m.X-_j}rYl/z]7?Steﶴs3\]RK|C^i3"y&p5q#lue=+/5nj._l ayʁeaޗ5Ĕe#%ayدO|A9[;ݾAc7.= >)ʱ|#;{҄Sڱq}}߲y0"g,7gu7 N>Tck5F!YGCD?sc֖n| =G;$ϋ=M6ɒ~| +8s(8tn %sJQ9\?%6q}.?W}I_>GAklgp>69b2aq(B8pklYֺm]wHᅚ\3@ ((2[wO2rf}"oXb[PPLoXS 'Ҟ7o^~WrZOhf7Iz4SpGiĜ46} }t~'V.^o'ؿr3#o>Z= yJxڐaf?syX 7c׸G( =|FYD=>)ܟ9⑕7<73!lk{|CbZ7x'$@]C ( e7ncbҞ%<𛿔 Du5!Bx4k }&>ahδ0(\}ˮҰXkJ/#6uLz9key1N!NCˢ+9' -(/[Zv@RpyhS ñk=vÑAįAV!=u%pH㰰JCĸ$*Č<q<muY^ 7ζtL&\?;$k|Cڣ|D o(o7Hk+z(3iOb0._Nm 9Ӗe6~VL/ >}H:7?̀-(q9cׁ1 {'p^@!]x9ԳF<&/!W^6yC/2jɎ7عE8nTܬ8 ٲ'p^@cwz=YDp"<5bw#|?p8]]D؏Q Qp+}qU pa7ʾw(S~W'pp:=%'p8ME)RV+{Ed} .F!ي 0Pϙp8p8nB~brT)]~mgo(^W΅lPVTQhHSZ)EI3O/RP 'Np8cDt':rZ\E!Ef lT@q_'ܯ}BKSp B]/h L&k6n;p8 s#^W?, pOSLW R@+BNC WFtEM5 ,B~Vo[Q_qb{RYAnaVkVŴ2tX/ߌMAp8ñgvY| Q$EE X *Wp;E Eav"ȡкH vGBUP̜Hp8ñzb]hD*דr5Φs;SpC$#.Ĥp=~kCH X{۷'NؑjժZV>j7ޒވ)9p8cƌ"ܰ*3:dʰѢڅڹ~ռp+*؇<גRNA+'KiEURW"_)p8p8$8{L~R֑4nWo HkLEؓ_ O; {;[RA1 N^3BfUU3JR9ԨBzp8حcSTM*ߔoqY$m$ dyqx!?*=\NO>1;}x6'UTUfFKZ×]od)2 f,w8p8D6xuVaz[uoV@%?SvTUW +em >;$?HU.e9OȸBu4YLdllw8p8nEV.d'0RR )iu֖Osy6sKYtOhGH p8p,V.͒6uvJ|]ﲷH:Rv5u}?Yq8p8Ǟ^ΔjuKj5lJoӌ'ñ}^`Mv߱@d͠QdvHpM@RMM[RV|ٔ,NcUh6~Ȫ%c,>ٽ"VN%%VXQ˽2NJvp8pi e-užC p12&ơ+6WϿK3WV$K߬e<3D0ȑO,^dueңK_|!M=\Omga,IQG1D6`4e5bu2ҳ[~.RߡRtyoӖt{o&ۼfk(6Βj{o}$kt8G=vÑt^SO<'O*.ERTJ=gxTi;r F &s:;p#k~1wg\.},cO+!RW{9i-9CR!X  Yc|L5zihtOf^9wfŝ0fYgGzS'Ε+.J7I]pǨa-@F@܇BIgy2eœ- !O?WXp%/4hb 52NP2Q)jp}M~v*+waKon| ~( Ё֭ȔԪsMؽ`|vž pD$D>_A:hUCv8B:.%Xn9j嚲Q Ӓk8}֦= B`^ž7o>P峦نxե`9߸6>X/;/4339˱^-{>۷<3"{|]xF!lVeʠ~#7䖛nWb~x(iۤt=w!JgZ:` qkm6z+8O:EZ~F &ٰ2S]koK.\N<$uGk:Y^7 Zn򊫭iPd>7͸l~D E| Ε5s:g4IL1p57i.m?B6oʔf'_5eY [r 9,,ڻʢE^or&MOz$w~5@jRtyC(}nrAk/73Pm#lV* { d RAV|fĽ5_# oG+Ё#,O?ᅪ)Eg6 0J ($S+Ô(,U4{u`q@9lErwKD7 Fw)pG!vy4)Whs`@Ы{} {l$ZZR`a#윇wS+ xF|:c {'ñ;"Xr :NOH jg+)Z0{%֘[.\ĬOzVyq# u^4sIi!!mG) 8f]c*N2|^eϐfn<0y^xTHjVt_YwO?:ܺCJ䇮, 2;--.вɭ1ʅ?r0$%(<C:x;|U+EO/f=YWޒegc!|J9!)q/XOi]叶}VWy- ŋ>  9ּ~9;.cPwL-'͚fM4oriқrHC=/`aqӧ/@ 1S Z {'ñ=v؊v,ʧ|| #;w0$՗ߔ +J{衹gS屢~]v9{#'츲?S{PI[u[tL=\Pp\Frb$+=oiF_{R2W;蠃X̺8zuh]&Vt\mnݾ%y,ta7Yj )P)7܇mC9EHX)VC'?x"l;byL_؉x)ƍ*VPoHX(Q5ʲ22?$(#}>+,<Igma9 OGmJqK[o{+UfKC1~K_V6<fm? vJ3}a{~HPn'ñ=v؊K9 y࿏ 2n&JHi -i^6lEƫH =)r"5Rk[L }<.񸨏es mΤMG"=4Lx;Pޓ܇6xo4 >}}8OY'$0hXe6+u-oRAq aw:aw8='9T;V@J=Vy{VFr!5|k%346br{J8s] ŽNtýJCy>d͝\v}We´mQ&hzg,72_`!_[drN8I.vZ}#X A~Լ:ǁuWd)^$g;KF8ϡ8bêm0=C6Hoش-%t/ʲp^l<; y#f&p/2jճφqh7'=\N^|Mڈ!cϖ|5 Ϥt)vu _udo}2^t бޕ?XbXl}L%f~ҍ54z!N\׭l9N_xɧ,|T)1Ds> J{4{=˭ MxnxHrsmu6Ιպ)\\|eedͶ:<_Z\zZ'q !x:i 3 |w2N\vg mPLSe2?QAq(v(vh`{ޣp Mُu|19BpiEˮv|!n6mvڀ]<V8c {'ñ'BOqa $ RCX|5=Ɖ سz?=@oy7 0xrE\@^w~1?M;PN⏅K$_N5ϵss&.7yC!iz C)7AH38aϡp8],X9x3p6c)Otk]޶s,ñ7 {'pz`fO?iݞ˾p8v?Pqp8p8{7ℽLjR'9Dֈ;:aw8p8Xث-*[ { iuJF}vvp8@G2Yia^J\ٔ,eVW:~>1mq8p8毳O~ ^OUHϦs.v)vNŴzYI>?ś!p8ñ7[p1zJ͌>7ιIQ;RFk| ֽp8p8 f~mԌiKN)WvuȐrjKp8أPnVzԬLjZl lՌ")_R޺|p8؃ܬlҎΦm.................{NDIENDB`5Dd '$ l  c :A?image2.png"buэSMb< QPnIэSMb< PNG  IHDRrmsRGBgAMA a pHYs&?IDATx^]x'efffff_2qll%ff8ԤI&M7K8nlI{inow) BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( B1<-"Fqп BP( B( >f`e> ńә2S ^T\ʜL`g* BP( ED3,Pe 3f IcC1R:[1A&SEIL\;x66(Pv:NƆ0}ͼP( BP(LSgBD<3aCtgbq[O27~s1 JA6( zx^/b* BP( EDq BB/wp\1/aooX bǘ.  ~i7_qEyLlQTcq6D2IP( BP(M ak[0g,$Âẍ́JF f:aי(^f>b^ax,hs0q,e4}1Y̷ A4Ձg ;}0σ + y7k5/0q Ox.&ۯ2qu1O0ܗGxVbij1_c☏P( BP()d1!^L`~`b6g=<ݘb "K̝iV| ` zP!Z!acgȄ8g`^hә3MA|`[öbBt.3c&f>e/(.e[&`0'z@f`#)>̂dbOw62ÏEPr|  Ïs+ BP( EL Fxxw!h}?$B$}fr(cn0#sof-Hx3 EId4F.mVD-}<19 C.LS#q> Y~xOqİ&1@s=;a۬0W3b `[ `@q&!E7a b0|$Q( BP(BWLlBS}'0 2XBf@.2 / 㳗i+QH3iΛM{=`_&ʅ2/ omc0!/7 ƽF￙;Pi)60q؆߃7.葅P4ةLxaF xvĀ80qLCoHf mL<7a8vhLBP( B( 4Mag^=s&6|uA$B-|#LS#b A ƼQsۯLӫm³ Qfo&C㙦045Mņ0z)ƒFטj0}×j67 y 0 !>M p`qAA k%"y}7率 `܎#BP( B(nkCm A600/8S|;x} `NS{ÁRqTD F.m8oT(ViaoArfnC&QhzpAxMvL; 6>ם@ ֜gܦռO.q९ʜ45k8ga $VbNy-p {7zd zfn9U+ BP(c&=!| ϮDfc5c;<+{s93 { ̂5! -dņaɬsoAfVn|i~WXAyw(3-5&?BM/+4QP;,'3Q'0*Wx z͐xF#[6.lOކXP( BP}z8F!T0T&hE'sI98 "M  .cZ!~Ȣl.9pA.ꎴ ff!g^C⼸& zod BP( X$WͰ\x  6&ug㈹F,-nX"n bp|gK103Lci!s7E37x{UqmfX6!´r1"3]a.D&g6\:óC^ `%LGAu&2[ „۰RGíLwUL+ BP( Bpp(oU( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP( BP<3 OMpް9}J;S1:xU nyvG Igv{r*q= /+9ܯ^ow/0.=&YLcvDGcv{[$vwժŝd\~᫯Ǟ}}kX$&? ^qq1`0Xz9~u=/|#xq˷, `'%-W'.Rd&]ƫR,e^Mt*۝M?Z)։Jpxkßw'my/))vD=XzRh\ߝ쟂Z:(ok'Irg}V1{q;tͩlN\?}|=[_o쓯d/?/g`N7۸QgQ=~q߯P7iݾZ3\DawJvHf[0{T ~l*hE;P?ܕkmnl.4 sIʣd6*ըpq8+Nٓ嵖s)Aʿ/9=Կ_ uݡӂ2}d"ks_7nSԠu-_]08A2WR%u#hC:5K*!c5lIƗBN 5t-_,G}f(6k*hE !.\Tp?<ٗj#zphJe6ɞ 2~'k[j (-vM5oumxVlխލRAB˖dܮ#}폥uR^n h[ùH\/W Y"Q4il% U찻|Yy"sY3P*9Z`qvrok&hDL;K)!#^bc>.9*Ðհ2ٍrisK;Nwd5n_#{1͟3Frsр B(!QV׎ c3<2[~qJ 5Idl:Cʪ ϋEVהDo߸}%$CdZjVLOAʈ?/@`r^K}fܾb靖RZB C˩TbrLg N_PD#AR1E}l߼t+nB`d3sGUiKڭ$Jeih-QDqOHvJdj[Kc; 2UmLڝƵȼ?vS(>ܻT°O#ݲģڭeN3"!/Ӱ±<#ڭ @I.)Xl3[Ybs  6oOY80~^#ۭ:ջA(TkJ@J:iT{*CDѠfl->%,vazOÚ4YʲWQ0$eX4/1X恹uCܡk_ڽwu4e|j Cn{$BH/^ Wаv˔2VQ~iƴ+Io [/j+Cn9sd2NTgyp2|ߤsXgQUYL7:ms~R~,vToOtٲ@q>#h6l%؁[+Y_G#M[̔A'L HpxYl`1\7jUZHYV8m^ͧVEVR@Z( slh$X毥_I;7mu7̢r!BK38ih%4\ELp9wz6C3.퟈D?Mnp?Dptebq{Cx{-eݪz IN --v{Bm@n!8}N5B7`bGblSJ bTʘKL1OpS2¦O br)c;P cGrNPD#.95ӺU[C_iu|ʝz6ȏi{1[ˣ>-fpg^L_x+`fuh4vq4_0aa--V۝XFiesT4|fՑy6q6DB >+iDXS8\,v$dz͡$Tc:5*ܧ\Ur;wk8\~ߪ\Jei"FIujt@>pl"`w/Htxe{ ڻobg 筦d̽szŧ95+$s÷ R6-bLv;*ezcJBE ]*`츒K*^abA f*eQ*K+wm:$o{q:(6ׁ95і;~G?o,avwb\\ơBeZ R=ٔ| Ʋ(~UҒRr4^ bFGwZeY{n^3ĉ6n7Ӽԭʦ<:A% ۦ}^~ !N;BbtHEʂ]"89#x'!IkFMKYz9>Vs"UPD#]9}Ԭueİ}; PB&Ith^($gf㣶.kE4ȕF,eĀOs(EP'g*g$[ ̂آ CqAܙ @),FP7dAϫDޭy pAN,/.QAl#\Z{˲)tayjVLp 1"j"nnv'yh?Ļ6F?EU4ʝk3/4tyM5 «MÈt<& - - -FJۜbfci|,˧T:'vE nKx.1^E!.<.=ޱi xFb-`iH.O4¦u]K:P*KtYE:.!wVMcΈ#8.Ρ](P͉ n1˲),ENeAϫu*yvwF/^x)KGwA^NU`.]+F`$ƍIvwo~ayrS"DqB308Vm%U%R*c@\{|cJ  .:uSAKTA[ A1R9T/,ٷ(R|)_>n>7"Fw֨OVbܹidص/ {`{ip4EQ*Ka`L辎Lv-g@l7EC?DTh9IDUٔrRY1yhPDZdUDq*`bL]n~LY:ݦ`im*+'7lޞlKX&?]XxoBtBby6l~ԥX1xFwʣTq!u)-+xoШ qq{ِ(PNJq+Y`YMy(' AA܄>BsB\#*=ӕEsl7ĝ"#n6D͗cUF26`v +4 dOM2tA$ʩY;l 3`~R?@Ϋ*&W 2ɍ W߶3[?}OU wH`81‚8xXVeS UxNdQ:)A܈1ñlZOy0DZ !ACoSͥrYJeq\4Br bAӨh'yq5i-EpAbM⦭:Q 7%c54Wj2bغR)1+i<&zA(S VyD72݁?(=X`YMy('AϫМaA\1cuP>sd1`s>KQ m7&plUN28zjhq_BIn6+6o cS2Kc~._IG&޿2}7,nc ?Shv_T4X-tg8ݍ*\9"uZ(夞rqV;N鵁71Aܾ0}^@z!U#, Nޛ lwm!4׏T*cS{m:W_}uQц4܉\ѣ1tABuɕS iđIkPH &mwz>W M޲B)lcB\cF?PA\tF\VA|,TA[Au\ql0҂න/M׬NʄAT*chv^(ɃawrꮈF$dz>juhMMFmSRhMi *hCxтy xʤT(@-#$;;m>5F?8DdAlQ塜+‚ ,,ʦ ⮑ ^_7}y2Nx-ʪT agh=ln/ #FuWD*'۝jЬ=77ҝ69!qBȑHzBzqʘjZ%An}N2qE iMEr23FNb0eSʩ}X7dA+Ca{^m#(K{8b)愞khd JM No) 峈MDۃ~.-3"r]BF*sD˶?hɛWR J.׵,W%Ԟi}7ZV.2C5S9>*UCqѩ88ąd4` '۝BWZ+G˲*@8G@gWFUWD#TOfVeڰv,d%zFx[J+>&%bD*6=Պadz&2!2?¥6x¥p<<ԛ @2)>륽AlDXMy(1P"chQ#&г*`}YD1`s{dԧ1=V1J?}Mtoa*@;pLѳg1INmBg.ȽAayJ #1ɓW'Hú,P^k wkZpkTb SqlQqlQql1Zq|Rhj U*mv(!ܨhCsw;St9UͿ6mcQlwx㌟)K\†G6hrzV*cz%,eUXp@k.\C9zAAܻm玁ٸh(p}^}:)A܄ Q< u},"+҂s6RYTl,R͜{Sի"Glc44"!onuZh}԰Y;J 3~P';#u66CH ^oTb SqlQqlQql1Z1`w6ʭ/e2ƈoXf9dwꭈ6@&9]1QwߖBXg_4v tsvh\"@6ykӨKŸ(R+1`իݙlnó],0YhQ.塜GR9aZ$qSy,Pl/bS졎GB'Y7) BϪ|ʃ {kL ޷XHOdѰn S}ѱJ5v_`ToE!5{ݏGў",Tċac/O2~P < Pciz 4W.21: ԣ\$Up Ƃ b)XcCϢlC9c  iGTԇEsr_= AYAq;})cb\2X֨ڊh if`Zz;=iOjٶ%NtOq8vO 6rBR*3n'AFF.6$ϧYMy( baj6-ʦ<3 nҏ"%[u >`H ,&qjU>+:19}TnDӸ*Rw2%Sӗ`TmE4kdo6nM[Cvu?ԯ(-ӳߖqLK$:MӃy TQW׊զ@I>H;ͨņCe4i MıEıh@&;WVu~wO+D׮`67ZmHHu_ϝƪJ,ZGr\¥Mb5+6IiL&Op*?[($fOr`ЮshoR՜M賊Y5(şÃ*]{,t)%<:N8k&j A έFu 1p#:1Aܰ'?"ʧ

=8!?Y7ذ.R-D9hթݑln/tАw(u?}9`*ڳ٥ ffpGol Ry6@'yu4m ' ]aO#Q*NıEıEıhqqq'\nа~WyTF7YFX6Y-JϮLvg ݨҊh݄jܢ#;شRlFB 6\Vk]6@:bHV^}Εk 7S TF'3g 5uދ%ǶTFC12)XW ĂXW9k ĭY*4g bAuq=u2z9miQӆ6m%e *D ,VK7] wn'^&:2č/]\r(+RٔhNg{*;ĵhDB"9'-"';O)lZ5AA?` ]ꃕh ޡIV'&V-ܨƊhOdQzMC8e.Nq./}WE(쌹#utQ^LȕN2zu)Xcwo6q#\칐f fC9kHdq.X4*,LENwi3R1pП1C ӄ~Q(]D|ٵTF' 2RUp?bTcEmNR8eqmfsUϧ5%jW(7}^~z }VSc?o6jי>شǕ4;4٣z,<>@Nȸب%E آ آ b b 孓̥*Ul7HduD-ie[VvY 3pc W<62@`fnL*(?jUu7/?Iyma6ڻ.9wQ}ц$vDv=箢6S|9m l8!=4»jL%[on[[_ӸˤC:w#/ Ͽ.R͍ ^Nhl^Xޭ&駝A|tKR.lG<~btMFp'=pctmglcws:Џ'~8, cwSt{ͣqل=T˃"hΗV1H'pUA 숺$ڵIgϔ[BPA\t - - -F :+ٓ%S-l6/V|ȶ\}SŢŎY/g)ʲͲς\2ZD*۰Qц932״3i9)3ۏ֪"h+3ӏL'xu4&</7쾀{5zX/Ǹ_۩c؆/8‰s4/ع yth$b=tҝ/{g#=%wMuu3z.2cbr-`^?+wbuإ!7:S+qMỵPU_٧)rCJ { T*c*c*c, ۀUKu!ދ+n'zf }>9;0ݰ,p6ղ4`2OFWJŋ=x)VpNт vr~yOz@g؄`\39n5".y_* ^$ 8wy |6L IƵ!LKܑ[׹d"/ xo(H GNCl~}qJZQF8vTܿǛ׎Ë|^sn7_׎pC7Q^K-A .:UUUYL8`^}C\Es}GIb[Uv5US#4Æa@?`avېhǙ -mĶH/줐k X Xe߳m .D]."vi=r _57ו-̿m͂1RJ!?I﷡Z:p^1)_+{˶?h%ϥdo1!?@YUc!%5Mxg6xhd%̄żW̗lH?KFȾnR;7xC'tɧR7}kHc82kImFv)}A?M:n %~%پrӷ'P\as]As||-r/VG%Y?]~U@ZYOS)K'5CT T~r:Δ/s*hsD롂rSk==kx4!LPƺSáX>lxc!2ha^/~kxyUN Q5/*!6H^?7 Җ T*c*c*c.Fc%gVuNj8шx 6;Hzb5$iۤE^bk;Y'T8V*})D\xT֎`FnԊY۽٨Vy&]IޤbG" BPmi.{U/+ط8lR`;y/T<] BorM ~'n V؊ ف<Lr'VHZ͂ϤCˡ --(TkQ_L͙lR!:]NcLSL UۜYem^b|BB*YU^LosC2"ay wHW?nDN<$zw!D쇹4 ś;E;’!>z싹y #M{'lT 6~E^.<zd𩧞 i00%}2,cQ~4VܧGʗ?A<O[PLkϿOgqoV_|@+&*+o=|9?+ӤqE< yw\/2p }CR<| SqlQqlQql1qQGxH0\W6u3q Y sjg}v6LDр$]vUrm0&,uc<+6%l{e߃o]v1}~%:$Y|9g—>&sط u,az)W-r"]cK?ud&#<̳51/sNSyN11klM6ԴӸh-S1j؂6E6f)^Ҷ?(6msxW*c";vkkU! K4Lx!0 " 徆xFcEUC9eF0.xT1WR fF1js'@XbT |7n=Q5:Ԯ@a1%+'wfxoPAa:;Gě)Rl#ScPgޕm/< */c÷i} 4{?R;wgo ٔ$ Po{7 ys[oK]ܓgCoxGtO l| +E.rl9^lı"(aV,d` Z1d>G+x."d]Խ`ڿK$¦[-b{W |\/ʭ'!Ey\H}N>!Őg.G`{ n_Y}#fXt 7SNHD#cy}k2OmFtO%15FqO PӏDW^vni=w.=XSXc`8sᾘ <Z4fl'zQF9h>ȋtõYnȽ /E!:6M8@Ly7GjDPqѩ888.3-+\h, q·E4BaK$5d[W\v/e14ӵ(qz.٩PٞGlVIn"p!a;K/RTB^N=4py.Ex6!8R8* a¾A~e>y\l}R{eAm( k9QpA GlF 燳eΔhxa0rVD#c0|4}"Z-ӏkS^ȅ1(^`s_Gl~/^bS~=,x,- 1 %((ha-Ecc F/J+7wAbƄ>+a—˕+/#1,!< ҈I?t-Ӹ1DÇF85g bs@Тs] ύ% alYaw?.½=|q&0/: %T(qmnF{#ġTA[TA[TA[A\1Hӿ.OVR Ę+;Vȍ aZ}vb  ah>N=4 UL`= v z#qfL䲈= g#(Cށ󱽉io؞OD!nQ_}QS.wJtx,C7oׅkMU9vlqII NF\zvrk֗%L ?` eOE<*l>5vh0nT+-JNnxMA b$ J0]C86!fa};3Y _v)p =s/m7#ĩ^y9X 8+A|ĸ{n o 2W<0c>+eE= /JY#+:r(1{LkO .:UUUcA3qcBϏ1`i`A$¾'؄] A .%1[7#"gAIlٌ\z!xkHbS" GFypY$w?bљ{ %*p쐇yh›_AY6}lmI!3zE F9&[I:moeVD+E۵ڽ =;ɓɚ?,ԟ6xT6C7@utV0٧$yNj .` O3^# ƾrZ 'Uxp^4c1r}؎UU_'ͱ*xFM~r, b<Ǿlo.yuWDޤr!ytj5ev ϝ\@qѩ888#왾Ā4Ȳd -d_ i# 6zWf<`KCa8vTؚX.тitbDo0`ocL ?Aw [P>{IL۰}cN4 b\) 1ٟXY^sՍ?/ =yګn#蓶kv(uS>[~X- iuk=ӷz9GER#yܑ6Cr*>+/F^Ts3#D/irv@c1|d;L!˗+O/?C4 mXx_x"I:zWDA(C8AiU/ǒC* eUx7ba9"x>kd o{PF`\S Q`H`>0e4|H!}p,'Ʊd3X*rqhϹQ1]y,oe 4XCMDB<74jB4cz/4o.srF *NıEıEıX.5nbiu$lO[P^p@4K*!vD'Xa"VO]Li =KOb3 {Ͷۨr o}-v O)x_|T/3eAd$D6c.2"r<Ћ"pɿW&v,1Qy'?,e拡Haay)}><3% ʇr~nE_@+n6"^qD݆c.jœvn!ˬ6Ĺ\؝q.kU٥ м+ /~(n`M@ZNiK4F 1}=tp>ːK[TB"32G9?KFQC$xQ'1ڽڈmq_}t 7d{s\3Z(p7G@("G@$z˯y#f ׂ$WVR׋1w yxɱqr]4$U?! 4B,<5{K'0jy!QND6yo{9Ҹ|5eMPB!GZ_4Ȗ !/Jzs0j,> #٥3ĥ{n @qѩ888+5RTZF]GDqJ:___& ;oD')bc`pdg,'@a>WMuڊ;G)`#B&瓥BvsƒGʁP|eI'؝Fi."W׉%HM[D-D+!G\& QL9{ÙbڰHuᔺ)Lj; A|Q1b]}Ah~ 1 ' wpn)q,WwEn8dȳ .=΋/x4o48]:P6o`TX\B4=<~#eo! A n +7i@iH/da^ED1Fi0Ĉ`z)ǠμP͌T*c*c*c$mOYa݀.ӥY]SIv&iF; Aou``9Is1 Nmt *W,Sk,hfNgs;O]HN ޿ZpMǡk[/A8P6%<?ʈr|e߃FPߙCN8O$\2[ QSj"eȮQnC;7%MZxh-<(QQ 0gҐXUԢ ^|V+Q644ͳ>hpፖIpߙGڧ sqUyA o}#En^Ldp#rCJ) Aqѩ888K8>%#Vk,e" B~5< 㩰e3pP/;4ڵQj ZSf*vwq=%T9R٥ ם sR7w[٦\$:\jԠ͋#!ntJvU7JxMN]r}ֹ #E8a_ Aqѩ888K;#2+DW GMEW7ddC'x';!gN_Bl\vD~EyP' #+F D? JcUhNjt~%#G27IȊZg"Ӫi?€ HaTˈAqѩ888s?J>KOz H@GCmD?лD0ܟ>wQ-_٥1WwM!;mQ. l`C`?.hL6y(4:hDH=bViBiYXnQ%# E آ آ b 4.[[ b'b+o}#+j${hD_1GQ*< =ӞEMItx-k%&GE3WI^4tMY"Ĝad$O֟\o+U2PA\t - - Zq2r& ͷ,rǚ Ȩug:}be 2stFTDI~ c˜]+QI;[ʔ†F[(~`v\_FԊTHծ`n%Dfc'T*c*c*%.VmcƚKÖkU(X@;`KI7"96Q SRw,2x2 lmNb(YUB4:tQNZ| :vT;VthhacKϹ^RE=!nj^̗-l' ݌ZMg\~nnh-n6H.ˍ=FU8T*c*c*CpX9i}IxxJ.@\x]t%4Ro5p-6!t$]x%T/#gluX@3M+ :N|(VEa;ՇxsDگ4{̗7m.o wj6p]%ŗC) ^}٥ ^&:QL7`TR ;]"Jh.r$IgZߚv>Fx.;}MbTۏӝvm2N9TzOŃpt7Q[Xy9֗\K#Zw4>I]xi10@а~Jr#v; SqlQqlQq4[o A'Ӆ_L(^GSO9Gc wLil>;&@3ú㲵=谭t<Вqw[hل=Vn5o;ܒW_^(J!ovWFk_Aφ ӿˍ9**ecD|%x_l='g>ٵvհڰV C؉#-8?~r~㸂ǚ kQh&H 䒱g;UPmFdoJn.7Yh"D(32%2|~r npפaV/`qPsoP'<{<> >x@ŽĝId'1΁F 00_3D,sAqcp '~ ޜ=}Y7zvaz5_T@qѩ888`zꑗ[ }VHt@[bZ>% f <[qZ\6 #X`<ۂՓ|i噇^ bզ`Ȏ,u D&档-eSL/#Gwæ X#">\9KA؂;QND",gC]| W\v TK{-;| jڏ*9\Iv8n2"pioLC w_wm)@GJF8H0rԨJ7-p.ɱr:7M;dC*Wk7]z/>_xM.gkqA̿q2FT*c*c*&^DxǒX 1K,NL9j,VvX8˂؞E:,ԕh_~0XA :& _.nJw =rb}L +PĬ,Z5WH/<6uK]|<;.b:3іmC?|k:3lσ:̠.Vw>J_8 pO:dXa}ҷ^z lӞ@<2%XI; ː-c9oE!(!3&z=#imв,:*פT.%9uTqbI"1w#`oBzm!Gqe9D˶Kjojot׭ݷ?h4Z;(;69ߊIJU\yːi4hqx@ vN[eZο AQ>lkXe a&4/~ :q2b>k0A-o4LḬnߴ}q-vhFZ#`NS)՛CiJrET*c*c*eht! b9ԗ=-V)Ʋ lϐ@6լF;VFc0"'xy>Oss{3qVLzFXHX6$!D:;WO]um}{fm=)'"敓K5z? ٬>8ܳ<,K1M},\GAӥޭ'H+Ͼ+JQo6݊{Q~蹀2)ŗOASD!Nwf;w7HkVl[ʽ;&-;ɚl;ݸ"pͫڔ_%%Fc`vqJc$#_čI9xt1k?+tIJ4&/=\eM䚇C.{ȝE_x%t5$:g4X47Ϲloc1(|C4#-ac~zMɞ|]QE آ آ pb2p OI XNoj'W7^":G>MHZ֔@a^Ux`| vZZȄ>˩%n{ s6Jf|-W~u ~Cϋ6?,yYJ4ւ!/?6_ιxnS ;{2/ϰWLKzae8G~LT)um)'nֺ3mi͵=, Z{8lv`%o)%%Fֺv_;$tFsRP# z.n$TJF3v٥ ٦׭F`6Ld}c\Qr]/Np{],K.z17KZ2b/'‚/,d0ynH@h ٣ 4jRp4m l~Cx7!A<2Y譗>b5԰ӨAxq#:2Вi?㲷*c*c*%hބL> / BseYP< F+Ͻ'st; u2bpse404hhT/K.s1ǚ7:x 53>W>|E.'B0_c>ɳ"e>ΛRS8$1 -P7gp٢*NıEıE!(d\Mdkb&Aouf bT#ԡq}aӦ |h|{$%Oޭ(of[=7z>H}݄PgxyN DZxFzHjԲVoq=}Fo7=AJr(>sT6!..$6ᱹfh.Ր((e6ҹZ4h<2 ׺v? sFGZپv@FmMu?H?+^I6v2t|D*1? ۰09?@-j^sxxDvi#s u3sdFK2Ę3!tih?AE$κ;DE,x j`D|PJtɧy?K2 F'#*J#l rE%T*c*c*Co1> +O jEmJh0ߊA܏lێ9C`44`JLCd{ sȼ\c~1_8gv)1۲3"&lpAnw=R0_Ah<7pCک]=ZgTʕr)GOߋbi _Z *xq` Yn|eJ .:UUUс>׿  N% Oe%zԢI#g=]EɶAg@mT+]y5`-Bd6{qt"z'#DZ~؃I݃-zIPMG{^~m;q` 51x.W$ {)p(4;Τ=Á߲I8$ǰĸ%Ǎ]|6Al_Dw2 2FC?ثt qLba&$jc[p_Q6 vÖuÞ.]M [B*R [kd4¦K %nŸCx@obRL r1bB\!ڦH63tʅ43)ƿa~kk;l؎rw9@ /3F(Ѩʅ8>8Tv{,|₅^͂860FF :{|gu|qSqlQqlQW8'DLq隫n. X'ض" ps/OdѠnO,HDy!mȦ&Ǵ@s%|oN/Cn f~mw>FQzHD&cf EB[ٛ:-P'[pd<_9cL1i%2c6vrTCD]r$ox:.q֕\<PϊpX0`aiġlu?5mP4Gb$G# VV}HȓTXo)dsy2%}بbQhx t*H-ˤB[UtҊ00B٤a>q jE-Um+.Fr X ˌnOd&(I - -eA QkNK_S#&YsxTw\w08͛#um5+f5c٥UJКɛ$r,RpD5bO%6"qq|ԻR.mײMɞo>*2$80wd`j("Í'X3ܒШZQhBO ǽuЮsNߏ2w=|S*G bYbLH)W f{PvF}I4YyL$Mn fiĉNxڷmGG )&l2)9w(L:sut GvGZZiFRD2}/'dz̪L+nEaӍDvA~~ ƥg'b^5׫ۉ ^ QhG/ PLf1jE-C^#w<,˓SNQatùdnʣQql, bLR\Ynþ҇:ﰦMI4 bN)\ j BXt /eʪF4Q6%{W!mKg.{ Nľ6ҏ 6l;k`!FPY8"[ s)9B ba `|{7'§\G#6v9ʣRql, bvm:R xdFllF)6ʴ[=ӗdHs Z]RYXzodwcJۍj&$%y.ezW$84|RL %?+{ٸ">Jj YԫĨ;!!LyE~A<NH0X FZD 6y76 InQ۩xQ" آ bC<|- a bL2R[|,bX$yVvzw Ak6Ub 2L)s_3ͨRhCI7oz͛n/=MܴOj(87.@#nw`Hfh;"`H2EOĆ"(T;ıEıŲ, "w 2UDFHlu آ آ  1ϨNhBb6ʴdE6F[sM6qs;ҽب2b0(btX~k HwrlBu!Vt/rNxY:C0j=eCsx*<1Giud_W.}xos:.L C(m!JMԩH*c*c*CD2>'`FCi}ZIFA [}dV^w []R9,dc$śwR cD\0t6~bNm#Kw/WPf A{ָGE$O<5i\eQ3w$\;lE \7|WExYN9T9駞Ǽ귴<ռ-O}E ' /U!=J_Ig~l{P55ZBdiiubfh':A ̌XZ8888Dm?{/{5Kd pX+mUR,8!׿_m./ :C$VׯT͂s!F5RD=YqcO箤;H/x:`Q|q; [xnjbpԄIC LJ/ĭde>ȋt<`t8w w9esAtb5{a 6=|zgdxmW)ɽ(\mxQI9n6vs>Z(,(D3ͯhr>|ln&I"||t%t#-GI.\ƘA4 bxxօOS%PTA[TA[TA/g Hz,gS6gqHdfeRǥUܾA`MGjUetY)-#꣈6$:9)٠9m\vmRD&٦{LOpx(l<-<;v4!V/AIhxbtکgo|!sZ͟On"8qnt֙Р3hltɧw=*bs]xS0A 翳H԰2(|䚖8#״«F;%+X$ڰܯ87<kx$Alt󝄆MNyVT>,gI")@”Sc"m=?zꑗ %If"Ʀ88_"kϿ/QS!|mr4Kxk1W}{,-۶TKû;%%xQ}фDaNgq7kRV4riTn0nQa=͂gGf8sG'T# 󺄄癴i.%Q'ON >R9<S&Alf;qϨ[G"h%J*c*c*CD4U鲋죣YQy2 uXy9<>(#229u>@C$ZJ$2y>%{K{޸7GEsG4 P;pA(eizS#TDޭ'@~gO2GbChb[/R7J2WDG F߄EC24Xt>ke;7*UyE8x_6ȱ 1"-ӻ`|1hĨ8ܮjBU=)Uzp=:gqRqlQqlQqHuukXjH4 btgr(_Ft{tS7{K,:G2}/sFԼ+hҟ] 1c~R1mFbo/>ﵐE1ezW7q ޛeh0֩N"S3Mxe)/.͏<HyD*X888_.d믾YV~@[>8tv',ӫÄB<1N[ ã٥v/^ʵҺ}˶?]^I|OV6tL 6okE-Vtw=Fw =p{q1b" >ٶ;5{E>ܳ"Iٱ?6'}ϗ#S(Z~>v$ʨ#hEˆU"Qcԣ/ϴܰ&74(b܇RDܝI?i!8Ƴ$Ѯ8۱y88<i#eΰMԱPJpy`\L`TB4 b~ Y^C j~Z57 DqlQqlQDߞ+rte^}/*Fh:Gq,b[?7_ZJi#tL) k *( .ēY4alڻoڶ2][~uQV:lN_m66g `}=FdpB#vC6Hgdo8/\\Vÿ3)ifU"T@܇wxUR*I6s&ANm8ϑ`Y Y4e졛nK򭈵7 l.h=:m2Io6(Hp82naK hs6=~^玔u"DfL%e1mT2J!zzc}z*$B$CN2_NG$^qlQqlQDfs0@*I qfg.wyaL^(1pzS%y$rɔ ޥhٮ;mt 2Jxnj,fܾ[uT$:1WL:H+lRû/mVA Bwo6nv+e>4r2Ez [X888_+bx&cs!<[r{DjJWYU~+#F4YȥČ@L)}]vfXFA[YenimYiB(nܮžc%gV5nPu5ıEG$-d8Dy6]}ʳa63ϡޭ'ҖDv뮾zp{C7ˊ X'y(+\{$WQFh`3!$?2"|4zX4be*e2?Vl#OnuJ1qێ {ו#_NmkINY##ƛ6Ig19QlъhĘ/Xr<.-y*c*%&6@ێuXGJTSqȰߥpwj4VNO-IפJ7Z1WȏeOsKϖ{ڸuGFODg=F1P 45#-j0U7nYptjT?^i !1;<>%{OlTEbQdPe؝C\:wd^9ʣQq(9^K[,asѕ]Cp'LPSTA/%}SN>B+'\GCclSA\;)hSmB('ʒ!ۉV?7K%SjK$4eڱ7}nvʭ06&Htz;vgUQۂ3D[ۺy\q #Q}N>.47ʕ/3-1< ɷ.8"}3u˜ml$8?S ՊE4 bx0؄u5MxqKEjΣ آ b#Q#nT+-+ 2G>餍sIbBw#*!?J{O%mc@Ɖ'H=?ã\`Y"1ӲrB{䣔akQ$v]_3BMHty`Zxʃ濩i. Šl/hh9F2F"Gzب)'MdžCx//e&w0tz4MFm=p$tnh0]cwy5zr{پrҒI' d"&RvF=>o 2jt\/#Xa 6AH{~&С[$l:\l^HF:iNj*c*[ӑՇ~CBs/ |: d-V) Z5ޡD4a]҈gk}eYĕ\؝H~$+AY[p6kMD_TΨhb_O'@m1wx/ _c~3j,dsx'2n]r% 7͛!,! #G:趛+/*5-KCHf>ӳme\)٬й"#/p:05%26YfYq⡖&߰<8'~8.$=W$ ccXyT6nݾ*8 kѨ^ #>x.D11Cs~F'^وnN:ēgK6FF19DUkDF xV Lm"( ;b3 0MFxIE~K;!U!thϭUD:)AiQha[$ZRN 1Xm$Jbs71`<RԮӞA)h;(KeI T#DކFuPD❒]iNϹ^}]zG^VpC$9NFܐyC>65Y/bpe'PLvS\'?-S=YZpw 3V'Lop=1jJn ٪l%VALa@ 1au\Is-Q #BQیN94y^y?MN^u#f4yJz= *_Ik蛏|p‰Ԥj7Y_?~Ga+˔ NtsfU~y_ E J >ۈ7-.UZI<ěֲTB$ۼvj׃Am<*lJd1Sfp$CQI/@jm(c$xї(+]t%2 u<% %aV,a×Hz,D2 NI+JK~{j5ޝ4"97 oCNf61u6O^}^E6?(g1wx-7:V FWXanu%AcNv <_G Aܛ1_s$L@kZg>sbba Lg:v-#?-5V,N` ʂƯEJ}⎍P*=_~`?J<ߏ@Z3:GIq6#$ږq߯p.6E^K)s!}LMvcK}1k1?HxhR+fɀ'9UDr>yyFns7!'([8)#x;MԻj!%\aDnXmTE4K65iK;7NְS?' :9mړ>h#bf "K=;!D6E:Ȭ/,L!ݥ_A*{=|o9揁XG;ͤ2g-nV;y|b8A˻ng%FhΈhLE6v|2;}z~w ¿q L~Oν#7.go 4O]sI}T2~٨ĩ ͂UGPEsn8HI3:hD6u42\Էdʨ&Ȅx:x-Mv οXg N:<jf aq*e^w-~:3k.uk>R m2X]wI?G֭vz%;7qJD A܇1=( {t]ҩf5tg$[u)sKAZYQA܍H=^V<]o# ٙ$Ĥ/ $= m{a8h%Y8- b~^20`Q"=un2ʗ//}OR,')Nbb7v5A ؝T؂y՚soCCz̢ pnTE4!s&dhłmݯꟕGᮍPӖ%4-="2} n?0L'_.+Hpmcz-E5H_:DBdcy䁫yW¦ݷ?cD;%wgw{>wp6ܑhlņ 52Dz<0qNNä\ja|:}Y!A0aӽLovk.)s͂Nv""<҂h ZYs蔓O"@>g)=tgx94gO bH؃0Gp'"MeQ//mzaxgJ .6U5w[$8D=m7MkgNC̒gԬFھF" P><}0fڶ1Aܭ( *[qJn?v*;Wr2K0l:썌 nѴ*_qi/U4><9F[n&[.)^y%}ςg">^Ǭ=,oX O~VNGA'LaA< fgA  6nܓ\߸iԻxgd#K0(; t_SA bTr#% [$cx茲&qO%mf23USޤGP.x:ާ6aZ$`b y:ǯ&\rTU,G{hêԠi{6"wq[ 6L!&ӤA+0I ^͢u67Ce,NM6q뱴 N1ylFFo&wR"#B>f1 VCR+iմ_%d+ ,qY,qNSwcAj,;y^ s ҉haƆ+B8h6j٬1vTj` b/ ,!CIPPg1 b8Bu%jFN>;0J"o>~ɳD{N>.!.۴ܝʿH _;dfa` 49+SQA}%3ݟKz[PY\QcCdWD *T?DvMӎ +VJ2Y/\$[dwtn }01O~^1JEb{iD\Jq_+G[S~.ª0 ˘Z4~;-&dZ1ufqwgCúͦI `E<Z>gJzԩ9Ϭ?9޹PZ2y(^&exǩnNЈ+[𺋛`WFtI!Zq,, bGoW}?"@\%s/ >ėy[ usˢ H aZ-7:yKe]w8o&Z9u D|`6xheY23/S/ʦP&a^r'^M.-x~óD;ZV>D)rfO]!aʔTl6[L?=Nm( UoGvx0mRjOڽ(+̟'}EY}W7;T+Uʒ}pS;-j˹q>kaqԱ 'IT/=- e`yШ >NE7_@R '~Gwrgj l[RA6,Z_mn''_zp XX< 1x&A>/И-6\%ͨ%0uēO:⑴:oI bx7HZb:O=n#U-^eAq)F>!Rx=uP.Prx+ .P~kSDlw;V?G;O2m1͒ ^XU>[i{拾`Z5W9e| OF;W>8q8%v2=8xqyc6·%%D?-&tI[_yk))ڷDIl*T(T%9h\%lo (#:Q1M$| b,Uxp-*[qs1R@V!]fJh.;?Bo{iJlv-#(ۏ*5~K c!LH_fqΒ~P#%[ F{(mEKXb0˯-zs%4V-n❟:x59eO.{K!0MMyԹ0B$n;76]M;=R|Aۨ [6~\[yܶ7k\>n̽|\l 6g/[2",^(塄Wi!;n.*jנ?-`A^mۯ|(3VDK&BK(:xnsH㑗*"3@;%ފ.%Ix?#*YsoN7_; 4U¿_3c?}]r3j#Sme H ,Ky_9u *b3G$* 6E:1A܌1`Q"+HZYXGg+V-nVVqBFDg%ztCnO#qF",~CǮ$|7${+f8i@q"ĞDrs~$㌹ Gm>"$tw'DSփ(0\4auj2:Ysq+-i4$ PfxNK#/UfA kmT/Dz]tˍwD́xV(NEA Xկ܁nw mDHɌ}r^tE [X19FZ Q9l><%- bc؎z.G"7˺ NJJ:ەQf>gԆ emA95":=XR4uںf?a/Zf!Yl`D kUْbR)wk(Հ^zMzOq4u*Z":z] (ع$g_+c T5ҷr.%,mKI-̑L3~c^H-DEnY:{є]5~i2O`Xbq ^TMi WZo"*_ӝR2_pe2:*񩸯>1לTf5|K& [C&+&X>*7[҆foPZl_CqcJf54#'j'O4j9%OqWެHzs r𨓂. 22X9Y:  JcR@<1 r9ׅ N>^WЦN`n @c(|AՉW$i-/KI-̑L5,Fߐ(̨g0řBQ`A\5*[ս鑟:S)CrxA+`B-\CMBF"$ Q;X>"_'L\aVsgL. [q)#80Y }a~$0. Nq) m[iMߥSdE6:>|^M׷^j@L > mE:S(lZd=d´[oz4B#=#!SfX=&NX~:|LK,QL_:k-+ wB^9wS$rwaTCs|,ށP֐nMșqJ wΝ3II|AI@tPDrh%Ǡ 7u[WF rwɆcKӔ Y=#-Jmnog}wrge*ykl~Μ a@l:W͉_AdH./;9;vS/>xKD/T> أ<Od@~?}J`IIgKrvrÑW6\[+tw4=Xꝺ(482 -8%YfGSix{ULۜ}(`@'U_{ ŀ] 鱟\\\.Q G{l cU"*R_3 N(-r ).>xsǟI[&pl)+JZ J/JZV?wsAj`ȅm/Qo@t4HV)×;Ǣ)7E;0T1H%laZ|QSb^η;vaʰŲINڵ;q"/flVce~~π^0db7@9CqEU)6R s$sט 3%fQFyX#VY,GFSiLfj-FZ{LC+5B!dE6)2n:Sra~3 fN0=emk nJ, M>ۉ** ^𮘵3ǬqkQt]@Fi*=D-+ s8@brw"te:~#\ze|p_:Ĭ/䟥lk$}DʔIkޕ-DeݢXZu/d;dµhFOBTZC6}]mo9SN ksjͭR ssW)q=gj(ySeDpXgQzg47}/S kX 9`urlD"8Ի~R^@|Bia5iX|wi𢡊 Ö"-1u"-%nf.5Wu-.wヷ>i#ذɳטڱճ447-S99汷/<2xYgS/{ƸAsy˅ak >T(z Fĺ :2XY[0 ^ 1/%0G1*)^m0c(܅"qBYeY5;ty)h hkRy# 5hB+j|mv >FžƸ+=><q{4JoWY/pD7ɆcK赢@`Aʈ[9<]rɥxOpW⍗߃>W P;_Ge±DQ ǀE߷-(C{O>1а1|٭˷vܔ֢(ڰ̞Eѓ6?ճq<5/$p4JnmUKrn|(N:R5RXZ2"j9 ?pxWPO6[*X@nL~Wcȥ(J؇^|=~B xA$}IL;AD@lJ -u[~.ed? lf9@C.+>;aX.\{zҋKTEgΆ£= cyyk1g|O_|7z֖t ֢YqqZk^OX',⾠uj(yK H1JI*̑^^0lrQބoBQIN̟l=~ϐmq8Lhg~&^ ngM1*LNf;j传8f@6a:p3~Օՙ`p&YH;]} Eoy=Q,`@PzQF0so7?Cm6P|v}/ *O=}'sQ ^ʎjĬk J/-%ul{TlQoP1Z3/ {O ޢqe8 +(oscwb |x΄5,̀& |45bxvdñ8Hl.@5! /9X>ΊGȲ֦]h:漦c֬=nB6SYnDfД 55~"%]ced`lIGF5 9hkԘ9)")9/hsT &FF>~KrmX3?iGHqITiq٥+e &ďω&*aiC4wC<pͷ#aKJ-1f< SZA&N|ȉn ^@lUFd-":޼)tu*O'g倧m]$ >պ껪5&?6Jm!J DFx5fN[uѭ B PKΟh>=FO޴)9hnZzZ 'Fj[p4kKRR^v| 1uYyCf8>]ڹ/0&]#ʲ"ΊTׯ4fƑbݢcһ8O{ݰp쥜=1/%ij)%ҋi쳾rȉ⎳~7W&܌:Տ[\Q<{0 ƀҋ\쩲ԃ|)M CP|.iGڡrh; °|mbnC>2;nCB: CKa3 ^&P˴DJIadnDi3I(LmD>6!۪"g ̻kMRS#Q*x"Gypj^RR^@Lʋm’ȃOpe G֎z{miUHV~s+ֺK.itW`Y)V4 QK_F^(W,Ai(ߍ#n9=0!'Du١xnq OMģ{I/beA6 [K6v(#;B*t#vV0;JcLfZF>\'dceuqi =7Rti%5r}6o j&OZj=sZkX+%ax=H氇1GA5; z͉i-?O?9^4ʊb@9c0*5:Vf0);r~,|}ϗ^w'C<Xc3b+;ZڷO=& _ωfQ'xpzd5rWqm6OՕ @<1K/z6rh6 N:NŰS T_# 3n&& Ӗj@L9;cb̠Yxkϝ~7|z`VTo|֡C_;5*C#My0(RZJ 'Y[sO?9 Gi0l-ħ7i8v]٬ISW,gu@a)9yB `p uBvTaJ#"84xvFJ7J[BD!eDS;`D$ftmZqld PyZXaiPsr!vs>"f. S)94@Ws]~,ؐo7^~VqȈ>% {*? se *^T>⛰qy,M;q5RyGEj8Kxlu8TNL=J1ٙQ5.|=|xX0 Oư>V 5rZ,  nmY]H/^4:Z䞣E~ 3tdZgnS{8u@Zj3YQKCnBǠ8u'f\ 7HvFר4hWӧDqĄ[C KF'%]1GTM5(L͜:Gk3 +JGr³2strGz{V < Zt$o/i)ԖDiFe&?~'dtܡlZ[߄aء#:(O#J֢tkషTp1{XdEQyKHyQ~N VgM#ϘBP'N^Fgr&d[FHPFSKItFsp 6))d \/aOs3n ʀ8:*ĞD Wo0>Fa/JÏ!;) {f| Ơӫ){Oyޘۯ}Ӥ:╮o3m a>"`3+XA uu&E9SRg(++yz)ɆgK* ě,(^,g˯>}$7"'CarFPi9...HIuZr)s`Q?g-o2Y rʎE̖mX}/K1v&XIDРˆak >цձLۊ»%W웒K{hdh*<Ӧ/Cq.H m}Z?._#RrX% :5`@,X%˜s TZ.^\mZ9a@ں*2o8V.9?I6<[*9JE;P̀7j}]Mj۟>pbɌ (NًhíUBU*^H֑JY (Jӯ vY;1ZkOmZϘoegOUeF_=e8dðhMzR/tX0n>}-YFhc@J.ab4kКØc q5B *?EX@k(%]#SjVL|f%w?cP[=8a@q,5QH4r=8A cH;xw~Y4am')tM2 vʆekî(3XP"2YVc]R~B#s:(s&kkzpDij ._*I݇|f,IVʋw f7;a!i^\Mbuݢ>ٔP0l-^g6Oz7$r߈yC981XaF!7U ̄SN\-SҎtLYkPh1M&nj "5BUM) -A Mq5&%U@<q.6 {FrYEl`ܐ9*M4RRYRBL9 `!QQ ]Je+UKa ަx"23r0~1QF we1ʖ/(+ ݠN8K^de#LtYQs).da6x>/EBRX3[;ƐB M]KO'oz{A1ϔI#ZcJ㖆Fd34!$e7-Z Rh1sbg&L\va٢-pբ1pTm [Sҋ>#xIT lk@L3[]on| AC7w>6F#HΌVvfbI;5(2cX4mL >7YG$dQZnY]ތ-(L-{$|A>{A#r~W-9|/UzR2 sԘgh=;Fd1R^H /F@a4YjtMk cٚÑ+BMg&-nvWJI&%G3 B)%N(ozg=j ⎾M oNkzQ١`ߎ㖛5g$o?^5OVJ$`@t*NçܲhaʨɵNm/I{Rv+^T(+WR9(EɻxY?SZ%AuYEis"g6/)ZamKeTYkWwtH$Q]k똯Oy Br &6a舩u *)۳6COcPȊNȞav/֌:  Hkۣ]vPq@6 [1)#TuΑW |Ox yY~~\xb 0])kPu~<(%'D۰~y}{_[>g3& 7ĸՓB>-°nWiLu=fZb*B11ͳX,I$cԨ˘F'L\xaRF Y 4-%9qԸO9q,S[vΥki7A{ZJ6i'V4sqEk{(>bߵ\g"P7DΚQ2?o$T±hΐ Y]0 v*؏?&J4r)-a;GA ^€@% aOi^ށw" J͟7:} NEy\1 f6(}_ywIM(ϴgealZ.ze ֢x&G gC;^vc9ʄ/hsڜ7MrR ss3Pi|勶^=qBʊ*"#hv|g4 77NTl!*-YY,oݥi1>%1ڣp踿˯#1ztćXP&\{x&bJ/sI,W\wZ~N#iXD䖟K4Q&,McTy9m셰 OjWl'Z^@{ɰJA )y947֚ƅi(LHYQOc5sx֞T U1)7h<<11JIf$ ggrh$7pܻkP_&ӺbA3OvE^EUpl)Q2 V <+G9u\nxPu]gɅco(/e@l*؏ӂ//h?彖WĠ0el-kb^g/QME[o_fPT(~e^kε]HΓHgc*?YQi^¤>mD3ob1j,JkZ*%0Gnݺ]֙h>Ar; )+ڱt᧣ƺM^JZwTOϏn*I[V@BLp2= i9\boQEs]~ӏ?b[\pUWcMH*w݇W^|;rR H/r|3EϞ59dgy:^.{NPW1 wz0nQ1u"Lc%\S5y|̛AV1wµ|mU).DOu__yg1|2-JQSNpl-lN@|5lzaȎ5EO+KXSk:)Y9yznr録e tzQDm΁`PIx&kz,:r/ inOIjoҥI@1k(d*M߃armX:{r#fK.%fQ/4͓FI° ^9i+HnĘWouޭNK.:su~F >[Siiҟ?D KT$hdi3)Y9L~,V̖g!KHɫPsϩfcC9hܞ@\2>:L7w if ϛUBDoUҵ$ESi:K7|qav6wK/s ?+|C&d!LqUԈJ 1 4 )9h~iwAZ;]LĶT^"MiChƁ̀/09 Ҭ8mp7 rc:wEpWʀ'o3(O#7SEkc@K ^΀XUɀx AmQ^GgZa|]vlWbeu\lmw{Ku7g^]_?E/e,aZI o=MhkQ"d%:sf*)`QJa`...a DK;$-ES> y/7{ph = ieU;͞)8'?¬YS82MQ -,r@E,s{mBvB J3z8}7/{Qs%2 N.<[ \uUZ1oDԉrY(SX;ZL#R2sSk˼1p$$m/Czd5Rl 9r0kzGBv?7 ^wכw` B,DKbd! ۿ7sGJaZq|xC5nɏ0al2|w(#raR4C1 my/7{[2c_CMݰbaYYޓUB _ sEy9MYU b IH剮^ )hɍ\[c"= R=-|-7wbQrX\tkX^EfZg=_&*Gˏ[r3m@|Zc*aȍiDj >}Cwσ󳧔<È Gl IDu!TiI4svHU4U[pBN)Mx=G/x9Teǔ=%ܬ[n4pi(auϿRQ}ҾO$(3~A#Wz+ 9ë)&gN=^$",5a T5#H_81{^y))NsjQw;nyȵvy8ʳr5-﷗.Rn4t2qabKou@Nb͉kR_r ^nz~]~AaZIa[ bWe~Y/>33ڰ3<f@L#-#%TSq[;4YK]_Ob z``Ѩ/:*Ezh4qڟ:w/H) YOiX?`sc1}JU4(|ʊdG#K|ZsUkL5x(#r64ű $ ,TS3&,h֔0uS4ES@K3w+ 7Ce{eM,w̿g$ "x2K/_|TJp:x%brq(z}Oi?|&_t\t2>/=jYپ(rZߋF> Bw-Sy. ̑9rs΢/gC\T[b%%6pu7=wם )Yeð[Gׯ:o֐8MrCOA/uRtx8{4eMWD\fj?| X[%NZcjPw0G1P.2BAUU91yRj`;ϢAP4Yhau8bF:j,x3i \bņfa%`t;[tFm I`?Sj 4 B.nQaJfN\y .K.7pT}-ܽV@N.q , J7n]L_2E;hy(-*GK[:gV;hzys66ưꊐHf_#EMTN%3K\&f錘?k=2됲RCik6Oˠ5ZGRrh1 W؆*jX!,t*څ^cjI-=ra-$ b@L;{~J(?% +:§ߕP_|;ˁ]t\TY@&ݔNoL,KOS;*\uJ⌦SQB.TW1 T|Pg!K}'_@juSW 0 f!9r(JYFiSꂃ\U30QZ;I3/TњVw1MkqQF߫(Np>j?( ss3~C#W^F 6G&r!'V*uhV hxдi?")h:"Z;B/ɑasWynl^G#BE/1]ZΚ؟5I KiTP9 ӗSȂSXb.-U Ӵ:)SRH.wNbRwseƕ#+ª f)QE}p*ċbrq\U0g:o?K"T-TRD>H%;g+SW 0 P6˳ 4$-#T@z?^pV9/nZc?S hmHbB+J԰j̝9|'߼:I~Zc i:BY |G` Q/fr锗\G[|/fl8Azvbwzzw!$(wZ8Bg;7=3uי\}};K[#p#sD4zYHʠJ^ +Yg&7g)Okyq?^\9< ȉN3~Vv*;Fg ;;}]{=}CqB~1>=W.[ oi nٸBU9 [No|k47p#Sgtt:X>8wͰ*ލrٰð977ȲѪᛀɅ.-!1$8ݴܳH"ܴ.M|>,ڊFiճks4Ǵڻ`0*h<;dҲZ 9^,t4sVi8Ln+!Srh%6aɼuAR\,pfEܽẔa ңNh䰳gJh$|ӭo_ΜzbIEY A@1B, #LritrTVGR Ӟg@HA ^KUSpV[w4@m^cw(gur|oHReDӔ Y}Hu\%Z/LiF-GwD4?}%vUCsX&[f@ߌ,Sw?try[:;/N"}H1H\ZIDATYZgM pm*EJ$n)@VFwx5PGkGd3A51eb!*)r@̀5,Vi^q4HtS9 ˅akL%8MۖDWWtUynT1h)rcf)>U03 .g@,7{mSSKr5v4D=򱲵F?qұ"=հڱWiB.o̡+zmҰ.`백8><FϧJ7WF JO*MǤQ9h\簺X3rg3x^Z9B,,O+ҟ/Y#(ƀL EHR! UBΫ|I+#S%R8kͣ N,G 9T hF`W )]zd$ e@L̳swEW\q%*&zAZS1pl) E81svExJ3oՋ7+=E/VYD`T̜܃w25ET<o aϋTp!޹b@<1|ŀqeл}}V,؀^6iz>]T. <'E07p3g]xጪ.؇eK7ì<衵&=^a`ݥq^MP%bikMkOgF57_g ljZG15Bg(̨ yhmOxid5y\>MP.[-ql ˊFˏq+9|*&-VeݼjUldiPc*~}ƠUk|QzNc^2 &]*!rX3w°Y>f,%8r[*=qJ}Q't(c'E!12_̉o$r5Y 4FD,E84Z:4(,+,1 6\%wW#N??g̚MGeñhvVnj5ϋL~9n8JB#ԩB>rD\sM'?P`%Z+kbB@Xz5i6m|~҄Q3/p ϳ+~ hQ&{Fy"XWEy& Ͻ?v13x.Dva=5ʤKM@|%p;YۂfON=#奻Kz`-8-󵷨ⰍX4;$-)`ߡh"ePa ޞƝ$Z6G=/> N)J壣 _6DX e@Tz56X!^h4)ĩ #/G5b_-dñ(?QW)S^D4 LӡY0fTYiؾ!9rZ'_֙oX3f.Eۺ1q s˫5`HZ{ < ]J\14]zvޖiAcTQ]H29Br0ԈcȜ'VQ ;Yc"(%rvVk%`_b?({-6QAj`@=(c[]KS;{u;o05(`/xy\6`j^ϼ j@LJ^i ."~-uwcռL ^@|McxNbqۖR8:!fY)%cv鮑0G07F <X6g%Bm@+ SC ixXCQ%H !5B"K/{C+=Ja`ǁ?bT9Q˱=/GP䮱j?S7qTX"vV:{)qd'El/x841'<ʫ|P%KS߿pW`yǟRb[-9L.{1y P{[$CIv{l7/s+Q?~;HESS²h}|>󲵲Բk0?Ϗԡ:Ƴ2?"Φ֘ۦʶِD#I°z%qқ<-*)kLw#MN g 5Bx6o1n~! ٚ1mZcTۺ܎7_T-wm˙AOSE/S?#y}2ƧK([G[!VհfSSFIo>2K9o/9@X ټ-ه[1{b^ P$k²ܴ^4r" 2kQImt+H**ap먻9 5+[ǀx&6MXE {V\mPd1fT f€# ϚY4#@^{KPW:J.G[6Ś+B'h/S8pz)2=G(,PȞ¢Ky yy#Nj,܍ 1%|#(|,aЕHP ڔ6TbYp7֘qZ-N&ϙ + vƙ`AYe}k"@9ZG(,qzb:bi-'iW141w°Jb vu3_)ҧ.] e@3ҡ(m⻵ӈb}J^|MG|dey ±+ ay/2܌9΢t pm-^^)|մ1k㬝4>sVr?|=-Z򋯱QŜLp졶 $z-=Iѹ(ͩ7_|oiHVAF5% i_`dϗB'Dڵ4Xh ο< 7IO#45tؼtb6ue] ?𦩽m Z 9AڪQ(ʮ^%< ;Kk  ke΍%W1\8k%Y}Xmcw1m%7{ϻϾmo~s/*ʄc/5) +^GuⅳVN 3r[B4f w zE|KKN>;[0>ӭYټY!²xB61־<֚QB'D>&N]Va0G0ESd *4:,KBmA%__ chJcZcX.LtJc,K֢tkv`!VIIKk= G',$ N.壱r+;Ĩlǧ/zȆaKc+|V.nP=`w޻,С#hP=wy ,Ѭ,;l=ʗ'oĈ ;c)^:Ofq4+E[-V3>ZwS2~Q[SUn%x[Z,&e^!_l^  q%3z8S4*g879s뱫(kM[5IZ'n#/Qwc{FRR%q@sZ_OG.vraKt;}qeZ.[KM1%1nV^Q?jK+هz /x9\әFClHPR gҔi⦞F-R5RSJyFbhK]}6FUHLؿS؁f ÷>h!,CW.pl 8q,CU*ȬŽmɈ M͊K1xp]SρX&{@լ)g]=L$BEAOӣ#Zg]o/QR1 f!9rvEA8ЈDϩՃ]n&-xJb[hyfϼe{Eu*%e h3Zq sSOyi9) T$$2l^{hgd7?c)ۜܵFw֛)-`FE=428k ,4Q Rx"(!r~>㳦~0ƊCĴ\!?9zzhoyD뭋s$ 5,2_"Rۼ/Hj< VifumwGq ssӚ4@oو^S" GBmO;y~5b<5R9y{Tm Mi/ߏ {CpT5G%_I@ʀ=[FYC7t\veqSq㍝[&ƾcR df՗ĶpsDpi;F !hDR. {a X"Q:4TS;t=uxg\{_/=^fհ@RR3 f!Er7t O#4W} 3w>͟_hvQqb[3kSif9Fxr>R[R#C9gu?0 1}$ą3*>ڮUݦ]zx,5nzgsZSkL1 gl/slUmPKdx eW9*TEjnE Ӧʁxw-߀̀ٺnzAHphc_·<=Ty@lКP=h]WJ?- bwdb/G4Y*6#6Lڮh)Y›b7)~5FENPCT*Ar'NϞzSyNo-8; 7>Ts#O>T[o}=Tu#+P'\l)ꌣߞM!ݰi J9|Ի\A ޸!JjuG9Ԛ81 3 N! >J־Q>p!cǕ >tgxږ?]ց!隫A/,w1m%-Ee$OM5|?D'$|=N_ yѾbxtSNxY{bcl%iixis/UW]eYz @R#L.;5yYcA#^cj4WQ֙vm_COj Fnyق, scвֆ6ݱFL:U4s` 4mNBqǜ"Wvm%z{Sߑs@<qzs>w%Dq)έ Ͽ  Pph=y2{:L>5Y.nҁX0gڷ~h!}>/ne Jk+QvO֢#InLaq:+Kl|u |XX%Rni]GW_~Vr(nak94o/QAi~b;ּ]^G9mItz~V1w?Vz<S!UìIH\W- CBB1ݦ{9M=ltZSL=Y8| Cf뾭i:YP+s$~5~DHѳ&_շ2҅ƪغ%*qvssט~_׊uB <^hRk yv3k5VGkpitOq)=ah'M`@\ŀ=kEAƵ2a6Mcgj]P(s5 q b`\SϡB9{ ܳ/2 M ^S5bZKL2n7×!G!?YzrБ^@1oK^ԉs "4/[^i=k#J7^X;p@5"(h+.d=1gCfX.0v*a5 ?p"0$$DJX[7Mkο򐔗dƐHkGȱ#窮boۂ!=Of ]hfĐ3xthVy'Q~[1kh]/?>ne ~1ҍG\x^ TRdE4OSn+5vۿ\5K ;~ӎ\ *oXL}`YKG8ƇdðT*ՕJWc'p[)UD!뇿G# xtb3-TlH9B&ܗoҘ~i]cZNΕYѴ ]U)2Rrtnfi-'YyՔY79WU%;Q]B;Pe1sY9֢1/b3Yz-T_9Gw?AϿzчEnFO\xϺbr@=ӫcbɂռ\i8ʡ3-=(GAHb0TL|IQ 1 p8KkipMYM?GA6 [j? Fw:w0KY̠Ծcظiz ߒ0G0wQ?绰Bg0h2T:?6j0FMk-s ]F!&)2*i"d f;*!ruܕ헿Z/v}$=s0N֢Ѷ?$ buH6n?ڵ}={⦅ĕW^/s޿;`'+VxJ^j@îR{aƔKO/>Eu8 j_nW\qcxz˅gQcqPFި30iHO,@zR2 k'4xV. [v2Wzs%1|Gx9BXx \{X91'}IO@ 8 5$$,Z?}BL9}ݦ{x{ *ƅ&L-@x`@la@ǀxtH?gO={\=8 pl)5A! x|T@&n ~3Έz/<"^z<' .q ^s\Wf@S7kz5FhJ߁|sg~^F xw?sg.M EyT/ ϠY(?Ӵ{[;°(~Ei y֢AZ GOs TqsS-ysݴz>]:a], mzIz3Sk-?JJxҞA WSg.* Ml9z7V~QwzmKLFqn5Jjk +\%brq*[SŞ?řUĮir[m6C-1yLFPÀ AkÀ>P]z͢)4HqYh oO-z[`(ȪPS S--a5ris!ikR^2*q]qssט􁷩7̏kCGHv)3 zaeNkz1d];SlO50'j?^:{9G!? ̝]uy^Qf{[my[E9ʲ ĴqV>CvZM48r8tCFR2PvD i8"|wyI8v:6 î:bR[b!>S%%*;/&}%>7NdEUٮ~ z; S`VMn>M6v"P!'U &QysiDѨ (<"ѩӵ"-!aI\)Yg|]1,<y5v[.X9sיy1Hin&ri̢:);^.4SLgo8B&2^CenklvZc܋Π6f2G|]\|\yY:I?_y0G!u\<# whf5o$%عԖɿ\8?"g93<@5ƿ:jjxZȥ3 b=nIcx)m?c ZIKTiZ *;BBg#ڐm>G)ɚܰ#*;"*5Ȏm<1x'bIw[_sbdNbR[bgY{1)Xh . |/]٩h VܘgCMQ| 4rVQ5f,up#.LtTzƏ^׀Aي͋+ƀ#NnՉ5ޱ o6S]wɉy\:UΓ9*777G ~."|og|G5vrRKKO:bi ֢i Vμ;2HփJWYE3Vh/"ta`|E1i څ .!MX]? =8ySiLL 1U;b9!<_auYRg ;OS =4͸;ƛy7W] ǖ@\@\@,/OEQ#¶Ģ8a֋ V<&7k[>ٕ3D.QXx@1>#la`n:㒞@#|]Z(a]ƏY7*޳Ix0GAoS/f¨ob qӭ-J?Yy4GfU7$%(+GUI)./l@){BrpZ;;ˋ6ЌLETi @_byw'mOuɥ3jo1]={ɬOUլw71cSnbC 6֙qWeEuJch h\ɜ=f,W8 r``;w8@L#ŻM`x/s qJ@DsIsIiiU,R1r@ubm%_Кw9\= Oi~ĘO3~?JoHqܒyuB-a Z?Kvr %I3q5+VmB_=*dWΣ9:Ӵ/jԃVlnºBg!%@,tƘd2 gU]3MKʇHI?W#JcOk<{UbFH\DgO?bcm e=YSRϙd;:\~epӲJPk-Lj\sM'~']vsZNsIsI Q.B>JS;ve n¬ֽ>2"9!֭ coK S~ѫWin:ƌuUP#$t[[5 Y~wK)ɚYwkG˪` CGP*<#񾦣7k L)BNZ rK\z 6aO  v. v. DnG6 k}&/z@,@\@l.VKcO׏'dD @Ҙ?utHLt:oD?K6mr5-LaJ[7R'Is|$/*W̉sMk'z|JcCP#i^FĀؿ)4V u Ͽ> LhSc2tM/ptb3KsI u !6ᦛo QK%XXoc.:[=rtQ^rf8r3)mn~YöG3b_[) 3BBU;#ju􁃹C1u[bVaN|XkG΀74Pk,g3gc=ene@85/acd'O4sd̴̈b{ -֘-}g.B4!!5=rt)̽c*HQWN(ߐ[.Gw\*õ⥮Ů/㙧ó<x),]ĀXAĎc`9GNFS;{!6&= t)mjvNݥ Rh /Ѵimڝ9jykdޖ1d` |z\E㨲(fZkȧI䌒3H }w~CFzb>?rD)UsIsI ѱr 6 *PWT_sQ$0FT|;W մn˖hw)3ƪT_zh\:3 V FH|֨o] SfPl8zZ Zsd?=#)>fڿ7\5ƿ&F@LpiCHߴ ^@\@\@|BTpᖢ:֛KSiLD!i`*4COi5TIjBS;j!½-IYRt8#M6rtQe0֮ U:S |g 977s Ru"RrJ{XXKKO|/?v.:< }%xӺpsi y|_Һ 1B,;zoF z 2.vʥ#|Dx9~00mIFaoz$0BBSċfl!?/IYsӘWLiL~v8`BԳ=d$iʹy ;>y._#:<ؓ[Tm}%ع$ع$:A[NxW_:rѼ֣󍝱>8wMzGc|gM; r::ctұ@0;Z?+l`1 R*dEH|:^"WkEmڬs+i]q4 e)[5($a64G]uQ]=5[_G'GkVnNڛtl-%%Vh?O>]ՓQS%WsKkqaqH:pl-ĎeƴҕSY^$K(ji 9t&o`,iibdEH6dtiss-OghɐѓG'&8oEw{ jiăE ]whמ#x'o3害;;[E#{ɸM;@FZ PQ܈xO{+ȅck v<ЙZ>cP=BI {4tӚ~0G7kӸI7bԈbtX k2͜F)){ʚZkтA#YkGr XEQ9lhċ[ؤ]Gj9 |o"NbbbhCu=@4eYVjڷoƋbaM3odyi,پri(Fq ʼj1O*SzaN16 b˰eYt@y s){ǽLݽ5 厠\("'1/CJkp~0#1]i^ yQ{}wn4jZ7`2[͏fjy=$ع$ع$r܌2#P*>0l-Ďi*>-\FlDVeІ`ji39FOZ bwi!kGP1bCF3uX.4ƙjV Ι鴯Foz=|MoJ?C͑DkitE |]9\ |iq{ԩr9rRKKOFrJ֛nkYT_g&b40:aT} g 7?Q7?&ݥSº*̛9騫E)ʚ8@'pՂnViJ7;so X,I?CрBS}o)MvIKd** v. v. >!Hp}՗_O>PwmBh/ vLc@mNe5Ŋg+7r?~O&gSTZaugϊ9 )!![:cȁ1p((͠ueܼ3=$1Kê-c.3Ϩ'=<<.~0]g{?6.IV`-+&b=\'3DBErÏb8WC,dܳ#7Z|Li-ӿ7J\Μŕj#ZN9PQRq*NՅ_Wu][ȠB~Ī|5콘2~Mʓ?ߢos!Ya J1Tyyh iHcpH pW=|Pk e^^NR[f6i8t2Kx v. v.u N?*GF{*<#|G}Djv[`Đbial}S̴b1Ѻ duZR)mݽ͏3gJkkN9HQRyX,Kl?۸Bf5,0k%pz~+z`|<V Br@V.ӉOX_Цޏ )Ǿk6mzyMA*Q%'eWYc+^@h"9!gE}:/ٺ~lkĎ,%Υ4GaV, Ɩ_AЊ XlVWmFCRqsb.:5jF#“*#֓-7IQҘ~ʹA]pE=Z\yU򊫭_~5  l ?{uÈ}X5# W]y ^.ҷ6q(6y ׼'[=s~ƕҨwNÓ/IpK|~HT+{$@1|6<Ti,z:sXhkG|@HQf'@|@\@\j@LIG}ѫ̔|S& vlce(ڪ1f9:OiAo Hima`Ru7gxNѦK'o OK.0 ݏ)CWp׳7L#-k~/97\wߏk4;_}phMҀW {ڰUHcnt?y Mצ(Q>Òɡc7Fp[R͟T88h)14UwXycPS ƲJ|C)kׅWw)CM0;sbb!ޏ*DnK@Zb>s~Rxo1%ŹլM=g]Ʌgk vls3iU:nV8@Lblt:z^2=R,.ưcwn)ji~p!Ďm'u|F^hhߙ\.uL~:z3b\0]c49gna#A,bˮ[ :U?z[qw@_3\o$0n7c0NDtf~c9&T~x~ނ;o=4xdG㸐 89&ؙw[bk=7ڬ9غ55QC__ ?ث#lc]KKOl^nO/1B,Lμ,Nya}_?ltg= *dk͡Cg291ב O<^xUE,4:\o>u=҇PZb_/>_xO=p͏:߾~NI[1}M_k\ s.'^GX 6bॸKZ]t9lE.È{z^zgޚ1\pic1G_|=w;ndq򊫰p8]Kt{ו_W-.< Msn'kY^ݭXneq?5mqSXMoݼc^Zs 6&%ع$ع$(t>0,&oŞeb7wO6٥riiO^2;Rȵr՗HcbF耻KF:#$ !.Eű^YeY\Gˁ6ì|Z8h31.Mt|a=}?0?3uJ;2|t]0n#T$}ƵGV5.8 7{|uC__a~~swQ噠iz1'}57!#ō _GL 3Jk+4-v&%ع$ع$蘥Q']vܗر#*\J3Ñ}baF픇 qY KK{Y!OVGo:5=MbTrPgGW?zk #zHkq l o0p1;\4U|Յ+w֌æ(^t z|,?|՝_;erk˿ot??3xx|)|7LCxxAG7mV ڧ|4EM.>OCO@%^~i`yD͜@ϵrDg"V!ppS7)l]KKi9i%!tcjPSRJM& vsӚ+7(>BLy GN!eN1e0\pK7x9>Ź<E KDXz|ηk;czjaa SF:@L&3}Wl_ve1}b~֭\U|-wa>">q>_9gO^W-l o5ڠOp?߸y%yrLlR^*&%ع$ع$*:.vZ8^ fZKɸ vsәI!y~QK&/:03rӘ)Liܠiw9S!86z9]C`W.%B=vv r/H A(߅ӵGy[N՟I#m]Q& AhsE-Jƿ?z]b>ٕ9fTnD; T+h >w v. v. eo!|Pz>`Wa^[KI@5~,M@_dq(KO{|A.MF3hUR4)m`-ҝ鈢Y9fQ8HD߸2p|'|˯[5# ,,]M;5_x|tә42L9k[wzT) >HM3->#¡hUk+$ ۴iK{;eZgʜ鸘LlUPUu K-IQ >w v. v. >MGTs/bqڍ:1RJji+9UkL =|Xl-5(4M1?")”6iM ZM9q5w v. v. >!p=%e>8#?v\{?[C{aڹi0mbSlew~>m0WAH1c$8:?gb%H|pUsoh/wZ dUn. DoƼ.ŏ?" &fqQcڨ+pk &Mzz7Qi_^ZX?yG ONӇnG'<3н[u'uc\eH4rN8ŭs|(ݲ,t^Zg:3~ihZ;BӦi {OJ̜rq+i]KKO w x7;ƛo9W^~ 4:/ofmZr!k˦-Ek7m{ɰq=aJ%5E8:'TG2&`i2Z=C~rpո[4|Ҏӏ=4>zk,I ӆ&`CږlZf\M(~Mw94>#޸(|:b>{xo0z #oO@>ҋyӏGXi? y{|{|A<'X7o ?x4?g(M*DO#Rv5Zc_@_&9#ǂL>VC S;;>ԔFEQ#JvʪQeZ vs՘TLmq|'s4YspnћaKf f7ΡB$Ak3RHzmBZR),ZK+(/OX^O3k3)qͽ*,]K#>џn.9-0OIӵyyz>15ײx0~V?<)INVGU|HfOJ@93՚[cQG9 VrQv1=91|W_RԄ)d]KKb˳w25yć>J$عϴꥱf1,)tq_IYSU1K[6Gۭ$G0?o#n%a sbbR[bK:B_G|>޻"&y6ڰsʲrz<=1ֽd4R)m:,S鍘>1Åt]8 ?Ӵ'WIV̚RlXw?W_GR5 (QPS.SehpxX"_;0(EG&%ع$ع$:(4;k֖ˇek v>5E;ZHgj/dN%05|ߋ\5o6&ڐ?MVR|ՅOn){˚gʒ&4Vٶ$xؘ)hF&%ع$ع$vɅa/ v>S4X ]p`'&8{kV#Lak30bӊFgN a΃3LӦ]p!K ֔I>BrSJ{>gU؟UuaԹpL:_[[c :ݓRT)l]KKKZ,z׭r mRDC*)”6=s-JBӜ?|0m%*LQ]hvJ4[xK\<&whs*!⅋נ8z)6.%%%i[n~h,P[mu^mqd*q9G |U~]::k˱hVu=ӯYfc[ꑱm'R6fz^fEcMLkInSG 麴 ,L)t}FhJj9}*tn뚛g8@gܰ@gio0*Tr$ȡXb3)2e]KKKT~ެM1̴bS{aݺ0Ў֬Nv߈`rΘu|Twe&cऍLWEHP?2k6~ Y apMMR)ˆYɃqSز$[0o~ ]! M܀U3`9_;ŷ)Cϧ_G[ǩU1?xs$v[|zu?*\2:ɑh`=h$]Z1.Zsbbbb5/)ew-n>VWʥўp5 JyE7R)i.:5jX3`y Kq oH cnĭu4Kc1h]UG߄z\r).jw*t}5,{e^c6׶k_=Vq޺,o\ϭ^~O~OM8=㖛nu7w^g#<.x}E3? QSّǿ>wr_Ҙ(o~%WșHIʃ6?!vӚ^Zsbbbb6V'y-6k13qN9̿Z'/տj_izj>fA3?|g{(/r f0L.:aT9[q,DFN<{mY޲8knQk7>4 O>a4151NDI,(ryDs ߶~~ vɏ..R{)t-h'? uf`c*}7}-4r\J¸QণݦM)21uɀFqS aMbd~LKsIsIsIs@mˑ@$%䜷 Y3H_)Lisqt \#=M0z)v.A*L+L45e 0&{UtJHp! p!p %ńp V-*efW+Y{KeU\n˲dE]r%S]&rn jVygٙ=g;;ߡ<ZR6{+{'?&vCwlgs商xgyT3zG) ˟J?/U&QOw-K}5]wEvWoOͯ}ipI;#g=f^҃\)g|Wc_pBd#cVj7+]zq7].A'!`%b{ d nn^E%\1C$f$2 k ޤ_9*+ZNkb& 8CfZ;2bTS)=TbS}}u2zvslZ!^:m7Xvɧ6ԘoWv;y]Clb ,Ful;Z q7կ|le[S&m>s?*;ߧwI=j{|6UU^%epc{Ɵg#ƕqU֦RYYX]E2]z;Љ!n`%b{ ^!?(S߂ꚞ:ۂgO\PmAyz qZ_zY)C0] '9EkhnZUY:oj[U;,CA6[ v;\g-lvc2˾Š!ߢ4{\ |l--2WkbF DB8Fn\Q]dRsñwmZNFO[ vXc0 Cl/K0'E&Mk mUe0ֵI.2.KI~v;x;O\.G4ؠ *0YufIidS_l2ǩt2#=눞MK|ڱZg£ʐ6VmvKUg(]}_h5^T="1kRweOf[Bђg96k-Y|adW[z@{Kxoh6[Lt7$dfF>ɍӌ^]7 o:IA1JMY  ^!`%bmdo̫Va/=GfuakW 8|o8&#TVXCgi&U+gQ!|:3~ҞϢgpQ~sW^Cz˭LEQ_s,}GhDikk*9QR~}훮4,*?W:̚@W_yLe~n1qqՋtQz[?mSF|W/%>o,?.5<*јݟ22 >6ؑLT`F%FzZrHӍ˩֮@'!`%b{ 818i)AQ5I޴䞕q1Y74k7 ޤ^dM˧7Al3V7S olFo2kVG^Zzs[?9USϟCTU >ZǟW_4BmsI /[gWLfC< 1rv5W[qer"CTB$i79_hvZNbr,xcƞ"ѵnaza4*rW$>71q!d7DN#"3qʬT[  ^!`% z3]\μ6$W^Ks @n@*A&J6I+q`$qs)j\yTozfSG׫aᬘ.PFn/,CPʹeĤsPS~J%o]N qCl/K0 qbЭ[56AV'c\I #W]xON>Т[hf6Lb (1|Z;^kWpלҫ+IR6- i@̞[Bdx[r<_0 Cl/'r?hp~vA{¦_9u,QfXӍK@KA`mn|7/X+IXVA ӛiM1)3+Oꮚm[]ni3PX$OwmOz$09 [֦A'!`%b{ 8qD"wq9Wm&LSc#uAǨG!C|֦AIC~C aWMiK/S٠2\EFƀO3&HKLc@q͜XBxnY ^!`%"U7{szd{Yj3%yfd Sճݺu'|AdZP/Z0%Z:1YDW}';EN9;))Nk4ICGWk5 5_ROS˚k3C~K0 Cp[pzNT9;qnn"=+2$dgv63VtKyy#iYIUOnl je~*ArBg3BZE pKC?`:5ǎHCxL nlM?jmtr`/b{ ^!`'Gg d޽uE2RUJoJv_6;辗 A1_XBK4ђI!J"$m$_7 *.mpc@֛2x Ua($"ȵ6l qCl/K0 qbD>$^JDͲtXlC,mH:ts o4 nSulZ2uaLC9/0˸*2WxtcIjOK }T9!A$1ij 7RZ0Mq"73b]}6U7T' 9}5:e0x=Y6!`%b{ 8qqy"_rq^z++Wӫ.2҈ɔ,-" IOc^ x.XOwRϼє!?<*61a3Ks/kc qaJҺqɩ>l qCl/K0 q"3h~$gЄt}#-ҽ 'W0B> ⍦*F"9C 7Yl I{pAIu(UtڐW;"`70eaM7 !n`%b{ ^!Nl3%/޵1^b#%{ /i_Z$)QM7ɱ[81()G!ٓҳr1d6Ҟ%Q)Y  qCl/K0 qbǥdF !dڌ\}'pE'7RfZGK&4RE.ZEva$\G";"t\x4wRzR Jm[)KM΍Z6!`%1h˦/! !>|8ѼN 6"_M4hx!b)CcSépZf;!aIXߌFGb!X\N7!׬]Mb^f5=8ezJ\'$xoqbC!N@R@"gϫ%tîÔaй7Z-#g#Ρ ʹ]z*ҌlrB{*Fmf';2۾Ν*grcEM4Z RザllP=;Е:u5:)@nvN{}0<+1ּ HMr`딾hzyX6m[*#tSeemhkq#˜t9Uc}?JÞɓK)0ĉzTYyi}P{ /`ņ<\2/peyT: hPEnZPsRFVTfV1jCw 7 [ =pB2s$]sC|u:sQ?HʴɧA1*]Qx8H0GL4^D2ZBՃnee%VI .c"كiqQ-F ge6 VajWKJ*-$I>hlsiis:yرpJumc5v+%ckj^$oq딾H:6s%y袩D>8Dj.17:9$0OAK#Xz[++k@ښ1~5Daغ%CFOaaĄۊ-( U^\$qf>M70 7 *22e JPFXUfc6 4%qL0M0[d:k5`C IHρ/p,F5?thM唰U+7);BoK"0nj"/1dH;XƚϘU7 >tr V@u:AiF2v5|.}@<\nL* wӂ; E(3\09諙ؑp.JUɄ>glJ QoF"iKC¥5=:[}̭Vb}OE?`hKFp\d!--1^)j,3ƥ^]3,C7$) hNO7:s3G>3*>wZʩKձx6ȴʳ;X<{L4nB.Rko~43K`;zj2qTЧ5yG viYԍ-b=z'2Ik>eln:|f $QD>]]rnd܄)) i^吝Sap}ٜ'.j oL˼?Ncy wיjwB/KҦ tVJNcw2T>R՗vuIӔgP˴;z: Ar~s v.;&:X M 4ln71; MӇ CJ[a[$|lxqg3 ڌ?Y K,XcKq\]\wᣚ5u80\Dl7Vȋ#҈)*Y |?XÑN+ -TAty5nXMH *a# >$#tゔ 3V#t'An38dMRC/ z2e sIⲴjO[י<<O[ ?WSrcʴ4{nO,zj&,3,!Kש-tR֩ !nLqQ)?x^bwNa.?T%۫uHO$Ӗ.%+gߪyx1tx+ٺN[pz'Fiߤ`nSj&ֱtE#e8KKfg pÓr@"gDPxzz ?L\"ݤT'Ov>izOVj7.gH1pK0 >^S Y8EM=5*D6\~=Vymn8JœffHUCJ{)/t˭N,f>55UOJ[}+Q cux*٘d'a9_3wRW[=y}Uky򛻨]"_/969Fu/:'f6o:OU$g~L5P%*[o.#izIXtXgx\׌ΓӓZ t~3 mAyXAqr?3!j\,QMkrdz2ׇ!N@Iܓ̚.4xlq)F[7{NkI%xd6T_K_ESJ璟ͦZ0?ke'uTu Fu/ȸK7EfmHG;ۮc*iھ_͇9g^5Ez TKZBR=_YӐ4w0ی` ^TllghKj;YUUuԻ`kXM7_qOu=R'pz PgY6oNȌzayisծLF'?k&Npazu@!|4Q9$O</2*S,Hji<&̢i3RYIgJ6T"9V9n'N;P>fNG-1ѷOA[1ֱQr,%ɤG򔱔pv[k %{<_NO#Ue2Κ)93^ſNp׫t7BoN7Ft:@!?TuoIja1l^]/y0y& Œod3W$&l31_HxL`ɜ &3I:Innu==^FIM |za-_z9S*=:1Rɲq.K󛯳E)FiH)9l6cLN01ɱckelguZ:5G5h⭚ªb$Ӭ,Y},Aޓe׽\ֵKx%& U鍍+jDY,B-%H c:][º,ֿfE?C ]#=^bRVkʗY{X;-aSOϬVYb d C Fͦ4淬{.K+,1k k=+$j!:!YpӃ5(:Yf= K̒u$?eӍS0 EZEͦ>nCO[TLb:s,jk=XqIXs,+991LL2nfS2HI$ВqZ1Y'Z/E\I vUڍ2Kߑ@UYƒ^ᯱI2OGi-bIl)3Vt_˂kaV+;:I-[n!"IENDB`DD$$If!vh#v`':V H0`'5`'/ 4d4 Hp ytDD$$If!vh#v`':V H0`',5`'/ 4d4 Hp yt$IfK$L$l!vh#v #v:V dG t0"5 5/ /  / 22 d4dpyt$IfK$L$l!vh#v #v:V d* t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V dG t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d* t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d* t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V dU t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V dG t0"5 5/ / / /  22 d4dpyt$IfK$L$l!vh#v #v:V d t0"5 5/ / / /  22 d4dpytDDDDDDDD$IfK$L$l!vh#vI#vg:V d: t0"5I5g/ /  / 22 d4dpyt$IfK$L$l!vh#vI#vg:V d: t0"5I5g/ / / /  22 d4dpyt$$If!vh#v`':V H0`',5`'4d4 Hp ytDDDD$$If!vh#v`':V H0`'5`'/ 22 H4d4 Hp yt$$If!vh#v`':V H0`'5`'4d4 Hp ytDdP  3 3"((DD$$If!vh#v`':V H0`',5`'/  4d4 Hp yt"Gx666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH66666666666666666666666666666666666666666666666666666666666666666p62&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666$OJPJQJ^J_HmH nHsH tH<`< Normal_HmH nHsH tH<@<  Heading 1$@&CJ aJ <@<  Heading 2$@&CJaJ@@@  Heading 3$@& >*CJaJ@@  Heading 4$@& 5CJaJ88  Heading 5$@&5@@  Heading 6$@& 6CJaJDA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List @>@ Title$$x 5CJHaJH^J^ Subtitle$$hP$6B*CJ0OJPJQJ^JaJ0phfff:: :V4d4 s442#2 :V4d44:3: :V4d4 s44:C: :V4d4 s442S2 :V4d44:c: :V4d4 s44:s: :V4d4 s4422 :V4 H4422 :V4 H4422 :V4 H4422 :V4 H4422 :V4 H4422 :V4 H4422 :V4 H4444  m,0Header B#.. m,0 Header Char4 4 "m,0Footer !B#.!. !m,0 Footer Char6U 16 m,0 Hyperlink >*B*phRv!AR m,0Unresolved MentionB*ph`^\q :S: :V%4d4 H44%:c: :V&4d4 H44&:s: :V'4d4 H44':: :V(4d4 H44(:: :V)4d4 H44):: :V*4d4 H44*:: :V+4d4 H44+:: :V,4d4 H44,:: :V-4d4 H44-:: :V.4d4 H44.:: :V/4d4 H44/:: :V04d4 H440:: :V14d4 H441:#: :V24d4 H442:3: :V34d4 H443:C: :V44d4 H444:S: :V54d4 H445:c: :V64d4 H446:s: :V74d4 H447:: :V84d4 H448:: :V94d4 H449:: :V:4d4 H44::: :V;4d4 H44;:: :V<4d4 H44<:: :V=4d4 H44=22 :V>4d44>22 :V?4d44?:: :V@4d4 H44@:: :VA4d4 H44A:#: :VB4d4 H44B424 D0 Comment TextC:A: C0Comment Text CharB' QB 0Comment ReferenceCJaJ@ b@KS0RevisionF_HmH nHsH tHPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vj\{cp/IDg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½|SˌDإbj|E7C<bʼNpr8fnߧFrI.{1fVԅ$21(t}kJV1/ ÚQL×07#]fVIhcMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ] C:= ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j z'^9J{rJЃ3Ax| FU9…i3Q/B)LʾRPx)04N O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr Zy4Sw3?WӊhPxzSq]y 1 +++. w $t).r39AG\h}N?ݏB7R.S]dhqz7Rm f E G ' 1 CqcNlu96 !N!!"o#$$1%%v&7' (7(((s))R* ++@,,S--..// 0j00q1123m33n44:FGkIuj1n׊>?|-~!S+ݤTUVWXYZ[\^_`abcefgijklmnoprstuvwxy{|}~3%u,v|v~M~r~ԋBŽ.2B'Z}ԛXXXXXXXXXXX!&(.! ,b$ x+cxYq]7# @ (    6!e!e"3"P>?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!I<drs/e2oDoc.xmlSێ0}G,\B5]]!8Xrl3v;a[ gs<>gf{E.4*DhnZO5y[5 GoF[F&ѮmM{m$b`ne ̣ 6bA%yOFÅs4>:׮sUS qmšw: ,&5^yF J5Hƙίudj^zfEԂqL_./XѺʡTL TuɊ͚k\ '&O8ܦ %YZi-? 3`3`<^_p3JTt<* ]{||1|9|NRMSə̙!"$%'(*+JKe l iQVo]h{ ""t#|#''(()#)k*u**545n7r788lBqBCCDDwGG`MhM.T8TV\]\xiimmoorr xxЂւJTuw%*fxLSR!"$%'(*+JK333333333333333333333333333333333333333333333333LLpUyUzUzUwWwWeXeX__ffjj8k8km m2n>dd,,}}3?[[ ~~˙˙̙̙QR-./4;?@HLLpUyUzUzUwWwWeXeX__ffjj8k8km m2n>dd,,}}3?[[ ~~˙˙̙̙QR-./4;?@HeFrTnY*.`gWfb<u {h8^8`OJQJo(hHh^`OJ QJ ^J o(hHoh ^ `OJ QJ o(hHh ^ `OJQJo(hHhx^x`OJ QJ ^J o(hHohH^H`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh ^ `OJQJo(hHhR^R`OJ QJ ^J o(hHoh"^"`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh ^ `OJQJo(hHhR^R`OJ QJ ^J o(hHoh"^"`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hH`^``OJPJQJ^Jo(^`OJ QJ ^J o(hHop^p`OJ QJ o(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJ QJ o(hH`^``OJQJo(hH^`OJ QJ ^J o(hHop^p`OJ QJ o(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJ QJ o(hHeFgWfu {TnY.`                   Ү           il) iddo(J4$KSM5E!@ ̙̙̙̙@Unknown G.[x Times New Roman5Symbol3. .[x Arial7..{$ CalibriG& `Source Sans Pro7GeorgiaW,|8DengXian LightI{~ LightC.,.{$ Calibri Light? |8DengXianI{~?= .Cx Courier New;WingdingsA$BCambria Math"qh5zG5zGM҄OgjP!`@20ЛCQ@P $P52! xx)E Claire AllisonClaire Allison      Oh+'0d   , 8DLT\Claire AllisonNormalClaire Allison2Microsoft Office Word@@NA@NAM҄ ՜.+,D՜.+,, hp|  OЛ  Title 8@ _PID_HLINKSApB`=http://www.shef.ac.uk/ssid:#https://www.sheffield.ac.uk/vision*|https://www.pharmacyregulation.org/students-and-trainees/education-and-training-providers/standards-education-and-training-pharmacistszjhttps://heops.org.uk/wp-content/uploads/bsk-pdf-manager/2019/09/1521730902HEOPS_Pharmacy_Students_fitness_standards_2013_v5.pdf|>https://heops.org.uk/guidance/|>https://heops.org.uk/guidance/=` /https://www.sheffield.ac.uk/study/policies/dbs^Q %http://www.sheffield.ac.uk/calendar/0pPhttps://www.sheffield.ac.uk/health/social-accountability/partnership-placements '(https://www.hesa.ac.uk/innovation/hecos Bhttps://www.hesa.ac.uk/support/documentation/jacs/jacs3-principal  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F׿\@ Data 21TablePUWordDocument SummaryInformation(DocumentSummaryInformation8MsoDataStore`\b\ERERETQSNBISNBIEQSNA==2`\b\Item  Properties(CompObj/r  !"#$%&')*+,-.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   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q